Document:

Document

NOTICE OF STOCK UNIT GRANT

SABRA HEALTH CARE REIT, INC.
2009 PERFORMANCE INCENTIVE PLAN

Name of Grantee:    [●]

Target Number 
of Stock Units:        [●]

Date of Grant:        [●]
Vesting:      In general, and with limited exceptions set forth below, your units are subject to two different vesting requirements.  The first requirement is a total shareholder return-based requirement.  To the extent it is satisfied, your units are subject to time-based vesting.  These requirements, and the limited exceptions, are set forth in more detail below.
Performance Vesting Condition.    Subject to earlier termination as provided in the Terms and Conditions of Stock Unit Award, your target units are subject to a vesting requirement based on the percentile ranking of the Corporation’s Total Shareholder Return among the Total Shareholder Returns for the stocks comprising the Comparison Group during a performance period beginning on January 1, 2021 and ending on December 31, 2023 (the “Performance Period”), with performance determined with reference to the goals set forth in the table below:
						
	Total Shareholder Return Percentile Rank	% of Target # of Units Becoming Earned and Vested
	<25%
	0%

	25%
	45%

	30%
	55%

	35%
	65%

	40%
	75%

	45%
	85%

	50%
	95%

	55%
	100%

	60%
	120%

	65%
	140%

	70%
	160%

	75%
	180%

	80%
	200%

 

Except as described below, all of your units will terminate at the end of the Performance Period if the Corporation achieves a Total Shareholder Return percentile ranking for the Performance Period below the threshold percentile listed in the table above.  If the Corporation achieves a Total Shareholder Return percentile ranking for the Performance Period between the percentiles listed in the table above, the percentage of your target units that will be subject to the time-based vesting requirements described below will be pro-rated on a straight-line basis between the closest two percentages listed in the table above.  The maximum percentage of your target units that may become subject to the time-based vesting requirements described below is the maximum percentage listed in the table above.  In addition, and notwithstanding anything in the table listed above to the contrary, if the Corporation’s absolute Total Shareholder Return during the Performance Period is less than zero (0), the maximum percentage of your target units that may become subject to the time-based vesting requirements described below is equal to 100% of your target number of units.  Any of your target units that are not eligible for time-based vesting at the end of the Performance Period based on the Corporation’s Total Shareholder Return percentile ranking for the Performance Period will automatically terminate at the end of the Performance Period. 
“Total Shareholder Return” means a company’s total shareholder return over the entire Performance Period assuming that any dividends are reinvested in the company’s stock on the payment date, and shall be calculated using (i) the average stock price at the close of regular trading for the relevant stock on the principal exchange on which the relevant stock is listed or traded for the 20-trading-day period ending with the last day on which the applicable exchange is open for trading preceding the first day of the Performance Period, and (ii) the average stock price at the close of regular trading for the relevant stock on the principal exchange on which the relevant stock is listed or traded for the 20-trading-day period ending with the last trading day of the Performance Period.  
The “Comparison Group” means each of the companies approved by the Corporation’s Compensation Committee as a comparison company that remains an independent publicly traded REIT for the entire Performance Period.   
Change in Control.  If a Change in Control (as defined in the Plan) occurs during the Performance Period while any of your target units are outstanding, the Performance Period will be deemed to end on the date of the Change in Control and performance will be measured based on the Corporation’s Total Shareholder Return percentile ranking through the date of the Change in Control.
Continued Service Vesting Condition.  Except as provided below in connection with certain terminations of your employment or services, any of your units that become eligible for time-based vesting based on the Corporation’s Total Shareholder Return percentile ranking (including any units becoming eligible in connection with a Change in Control) will become earned and vested if you are employed by or providing services to the Corporation or its subsidiaries on the last day of the normal Performance Period (e.g., any deemed termination of the Performance Period on the date of a Change in Control is ignored for these purposes).  If your employment or service terminates for any reason other than 
    2

described below prior to the applicable vesting date provided for above, your units shall terminate in accordance with the Terms and Conditions of Stock Unit Award.
Certain Terminations of Employment or Services.  If your employment or service with the Corporation or its subsidiaries terminates prior to the end of the Performance Period due to your death or Disability, then the target number of your units then outstanding shall become earned and vested on the date of such termination, and shall be paid in accordance with the Terms and Conditions of Stock Unit Award.  If your employment or service with the Corporation or its subsidiaries terminates prior to the end of the Performance Period due to the termination of your employment or service with the Corporation or its subsidiaries either by the Corporation (or subsidiary) without Good Cause or by you for Good Reason, but only if such termination of your employment or services without Good Cause or for Good Reason occurs (i) in connection with a Change in Control and within thirty (30) days before the date of the Change in Control or (ii) on the date of the Change in Control or during the eighteen month period following the date of a Change in Control, then any of your units eligible for time-based vesting in connection with the Change in Control shall become earned and vested on the date of such termination, and shall be paid in accordance with the Terms and Conditions of Stock Unit Award.  (In order to effect the foregoing 30-day protection, if your employment or service with the Corporation or its subsidiaries terminates as a result of a termination by the Corporation (or subsidiary) without Good Cause or by you for Good Reason in connection with a Change in Control then, notwithstanding anything to the contrary in the Terms and Conditions of Stock Unit Award, your units shall not terminate until the 31st day after your termination of employment, at which time they shall automatically terminate if a Change in Control does not occur in such 30-day period.)  For the avoidance of doubt, (i) if the termination of your employment or services occurs other than in the circumstances and the periods set forth in this paragraph, you will not be entitled to any vesting pursuant to this paragraph, and (ii) your target number of units will become earned and vested upon your termination due to death or Disability prior to the end of the Performance Period regardless of whether the Corporation’s Total Shareholder Return percentile ranking (including any ranking determined in connection with a Change in Control) would result in a number of units becoming earned and vested that is greater than, less than or equal to your target number of units. The terms Disability, Good Cause and Good Reason are used as defined in the Plan.
By signing your name below, you accept this stock unit award and acknowledge and agree that the units are granted under and governed by the terms and conditions of the Sabra Health Care REIT, Inc. 2009 Performance Incentive Plan (the “Plan”) and the Terms and Conditions of Stock Unit Award, both of which are hereby made a part of this document.
						
	“GRANTEE”

_________________________________
Signature
	SABRA HEALTH CARE REIT, INC.,
a Maryland corporation
__________________________________
By:  Harold W. Andrews, Jr.
Its:  Chief Financial Officer

    3

TERMS AND CONDITIONS OF STOCK UNIT AWARD

SABRA HEALTH CARE REIT, INC. 
2009 PERFORMANCE INCENTIVE PLAN

1.Grant of Stock Units.  
(a)    Award.  These Terms and Conditions of Stock Unit Award (these “Terms”) apply to a particular stock unit award (the “Award”) if incorporated by reference in the Notice of Stock Unit Grant  (the “Grant Notice”) corresponding to that particular grant.  The recipient of the Award identified in the Grant Notice is referred to as the “Grantee.”  The effective date of grant of the Award as set forth in the Grant Notice is referred to as the “Date of Grant.”  The Award was granted under and subject to the Sabra Health Care REIT, Inc. 2009 Performance Incentive Plan (the “Plan”).  The number of shares covered by the Award are subject to adjustment under Section 7.1 of the Plan.  Capitalized terms are defined in the Plan if not defined herein.  The Award has been granted to the Grantee in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Grantee.  The Grant Notice and these Terms are collectively referred to as the “Award Agreement” applicable to the Award.
(b)    Stock Units.  As used herein, a “Stock Unit” is a non-voting unit of measurement which is deemed for bookkeeping purposes to be equivalent in value to one outstanding share of Common Stock of the Corporation.  The Stock Units shall be used solely as a device for the determination of any payment to eventually be made to the Grantee if and when such Stock Units vest and become earned pursuant to Section 2.  The Stock Units create no fiduciary duty to the Grantee and shall create only a contractual obligation on the part of the Corporation to make payments, subject to vesting and the other terms and conditions hereof, as provided in Section 6 below.  The Stock Units shall not be treated as property or as a trust fund of any kind.  No assets have been secured or set aside by the Corporation with respect to the Award and, if amounts become payable to the Grantee pursuant to this Award Agreement, the Grantee’s rights with respect to such amounts shall be no greater than the rights of any general unsecured creditor of the Corporation. 
2.Vesting.  As set forth in the Grant Notice, this Award shall vest and become earned in percentage installments, subject to earlier termination or acceleration and subject to adjustment as provided herein and in the Plan.  Except as expressly provided in the Grant Notice, no portion of the Award will be earned or vested (regardless of performance) unless the applicable time-based vesting requirement is satisfied.  The Award may be subject to time and/or performance-based vesting conditions, as set forth in the Grant Notice.  Continued employment will not entitle the Grantee to any proportionate vesting or avoid or mitigate a termination of rights or benefits in connection with the end of a performance period to the extent the related performance condition(s) are not satisfied.
3.Continuance of Employment/Service Required; No Employment/Service Commitment.  The vesting schedule requires continued employment or service through each applicable vesting date as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Award Agreement.  Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Grantee to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 7 below or under the Plan.
 

Nothing contained in this Award Agreement or the Plan constitutes a continued employment or service commitment by the Corporation or any of its Subsidiaries, affects the Grantee’s status, if he or she is an employee, as an employee at will who is subject to termination without cause, confers upon the Grantee any right to remain employed by or in service to the Corporation or any Subsidiary, interferes in any way with the right of the Corporation or any Subsidiary at any time to terminate such employment or service, or affects the right of the Corporation or any Subsidiary to increase or decrease the Grantee’s other compensation.  Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Grantee under any written employment agreement with the Corporation.
4.Dividend and Voting Rights.  
(a)    Limitations on Rights Associated with Units.  The Grantee shall have no rights as a stockholder of the Corporation, no dividend rights (except as expressly provided in Section 4(b) hereof) and no voting rights with respect to the Stock Units or any shares of Common Stock issuable in respect of such Stock Units, until shares of Common Stock are actually issued to and held of record by the Grantee.  No adjustments will be made for dividends or other rights of a holder for which the record date is prior to the date of issuance of the stock certificate evidencing the shares.
(b)    Dividend Equivalent Reinvestment.  As of each date that the Corporation pays an ordinary cash dividend on its outstanding Common Stock for which the related record date occurs after the Date of Grant and prior to the date all Stock Units subject to the Award have either been paid or have terminated, the Corporation shall credit the Grantee with an additional number of Stock Units equal to (a) the amount of the ordinary cash dividend paid by the Corporation on a single share of Common Stock on that date, multiplied by (b) the number of Stock Units subject to the Award outstanding and unpaid as of such record date (including any Stock Units previously credited under this Section 4(b) and with such total number subject to adjustment pursuant to Section 7.1 of the Plan), divided by (c) the closing price of a share of Common Stock on that date.  Any Stock Units credited pursuant to the foregoing provisions of this Section 4(b) will be subject to the same vesting, payment, termination and other terms, conditions and restrictions as the original Stock Units to which they relate.  No crediting of Stock Units will be made pursuant to this Section 4(b) with respect to any Stock Units which, as of the related record date, have either been paid or have terminated.
5.Restrictions on Transfer.  Prior to the time the Stock Units are vested and paid, neither the Stock Units comprising the Award nor any interest therein or amount payable in respect thereof may be sold, assigned, transferred, pledged or otherwise disposed of, alienated or encumbered, either voluntarily or involuntarily, other than by will or the laws of descent and distribution.
6.Timing and Manner of Payment of Stock Units.  The Stock Units subject to this Award Agreement shall be paid in an equivalent number of whole shares of Common Stock (with any fractional Stock Units credited in respect of the Stock Units that are paid initially rounded up to the nearest whole number of shares of Common Stock and subsequently rounded down to the nearest whole number of shares of Common Stock as necessary to arrive at the appropriate whole number of shares in the aggregate) pursuant to the terms of this Section 6.  Any Stock Units subject to this Award Agreement that become earned and vested pursuant to the vesting schedule set forth in the Grant Notice shall be paid on the first to occur of (1) the fifth calendar year following the calendar year in which the Date of Grant occurs, (2)  within thirty (30) days after the first anniversary of the date of the Grantee’s Separation from Service, (3) within thirty (30) days after the date of the Grantee’s Disability and (4) within thirty (30) days after the date of the Grantee’s death.  In the event there is a Change in Control prior to the time that all Stock Units subject to this Award Agreement have been paid, the following rules shall apply (A) if the Change in 
    2
 

Control occurs on or after the last day of the Performance Period, any Stock Units that have become earned and vested pursuant to the time- and performance-based vesting schedule set forth in the Grant Notice shall be paid within thirty (30) days after the Change in Control, and (B) if the Change in Control occurs before the last day of the Performance Period, the Stock Units shall be paid as provided for in the preceding sentence, provided that if any Stock Units become payable as a result of the Grantee’s Separation from Service within the two year period following the date of the Change in Control, the Stock Units shall be paid within thirty (30) days after the date of the Grantee’s Separation from Service instead.  Except for any payment made on or following the date of a Change in Control or the Grantee’s death or Disability, in no event shall any Stock Units be paid earlier than the first anniversary of the applicable vesting date.  For purposes of this Section 6, references to a Change in Control shall mean a change in the ownership or effective control of the Corporation, or in the ownership of a substantial portion of the assets of the Corporation, within the meaning of Section 409A of the Code.  Each such payment of Stock Units shall be subject to the tax withholding provisions of Section 9 hereof and Section 8.5 of the Plan and subject to adjustment as provided in Section 7.1 of the Plan and shall be in complete satisfaction of such earned and vested Stock Units.  The Grantee or any other person entitled under the Plan to receive a payment of shares of Common Stock shall deliver to the Corporation any representations or other documents or assurances required pursuant to Section 8.1 of the Plan.  The Grantee shall have no rights to designate the calendar year in which the Stock Units are paid.  Notwithstanding the foregoing provisions of this Section 6, the Administrator may provide for payment of any Stock Units in accordance with the requirements of Treasury Regulation 1.409A-3(j)(4)(ix)(A), (B) or (C) promulgated under Section 409A of the Code (or any similar successor provision), which regulation generally provides that a deferred compensation arrangement may be terminated in limited circumstances following a dissolution or change in control of the Corporation.
7.Effect of Termination of Employment or Services.  Except as otherwise provided in the Grant Notice, the Grantee’s Stock Units shall terminate to the extent such units have not become earned and vested upon the first date the Grantee is no longer employed by or providing services to the Corporation or one of its Subsidiaries, regardless of the reason for the termination of such employment or services, whether with or without cause, voluntarily or involuntarily.  If the Grantee is employed by a Subsidiary and that entity ceases to be a Subsidiary, such event shall be deemed to be a termination of employment of the Grantee for purposes of this Award Agreement, unless the Grantee otherwise continues to be employed by the Corporation or another of its Subsidiaries following such event.  If the Grantee is not an employee or director of the Corporation or a Subsidiary, the Administrator shall be the sole judge for purposes of this Award Agreement whether the Grantee continues to render services to the Corporation or a Subsidiary and the date, if any, upon which such services shall be deemed to have terminated.  The Corporation shall have no obligation as to any Stock Units that are terminated pursuant to the Grant Notice or this Section 7.
8.Adjustments Upon Specified Events.  Upon the occurrence of certain events relating to the Corporation’s stock contemplated by Section 7.1 of the Plan, the Administrator will make adjustments if appropriate in the number of Stock Units contemplated hereby and the number and kind of securities that may be issued in respect of the Award.
9.Tax Withholding.  The Corporation shall reasonably determine the amount of any federal, state, local or other income, employment, or other taxes which the Corporation or any of its affiliates may reasonably be obligated to withhold with respect to the grant, vesting, payment or other event with respect 
    3
 

to the Stock Units.  Except for any employment taxes becoming due as a result of the vesting of any Stock Units, the Corporation shall withhold a sufficient number of shares of Common Stock in connection with the vesting or payment of the Stock Units at the then fair market value of the Common Stock (determined either as of the date of such withholding or as of the immediately preceding trading day, as determined by the Corporation in its discretion) to satisfy any applicable withholding obligations that arise with respect to the vesting or payment of such Stock Units.  Except for any employment taxes becoming due as a result of the vesting of any Stock Units, the Corporation may take such action(s) without notice to the Grantee and shall remit to the Grantee the balance of any proceeds from withholding such shares in excess of the amount reasonably determined to be necessary to satisfy such withholding obligations.  The Grantee shall have no discretion as to the satisfaction of tax withholding obligations in such manner.  Upon the vesting of any Stock Units or if any withholding event occurs with respect to the Stock Units other than the vesting or payment of such units, or if the Corporation for any reason does not satisfy the withholding obligations with respect to the vesting or payment of the Stock Units as provided above in this Section 9, the Corporation shall be entitled to require a cash payment by or on behalf of the Grantee and/or to deduct from other compensation payable to the Grantee the amount of any such withholding obligations.
10.Notices.  Any notice to be given under the terms of this Award Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Grantee at the Grantee’s last address reflected on the Corporation’s records, or at such other address as either party may hereafter designate in writing to the other.  Any such notice shall be given only when received, but if the Grantee is no longer an employee of the Corporation or one of its Subsidiaries, shall be deemed to have been duly given by the Corporation when enclosed in a properly sealed envelope addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.
11.Plan.  The Award and all rights of the Grantee under this Award Agreement are subject to, and the Grantee agrees to be bound by, all of the terms and conditions of the provisions of the Plan, incorporated herein by this reference.  The Grantee agrees to be bound by the terms of the Plan and of this Award Agreement.  The Grantee acknowledges reading and understanding the Plan, the Prospectus for the Plan, and this Award Agreement.  Unless otherwise expressly provided in other sections of this Award Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Grantee unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan after the date hereof.
12.Entire Agreement.  This Award Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Award Agreement may be amended pursuant to Section 8.6 of the Plan.  Such amendment to this Award Agreement must be in writing and signed by the Corporation.  The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Grantee hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.
    4
 

13.Counterparts.  This Award Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  
14.Section Headings.  The section headings of this Award Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.
15.Governing Law.  This Award Agreement and the rights of the parties hereunder with respect to the Award shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.
16.Clawback Policy.  The Stock Units are subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Stock Units or any shares of Common Stock or other cash or property received with respect to the Stock Units (including any value received from a disposition of the shares acquired upon payment of the Stock Units).
17.Six-Month Delay.  Notwithstanding any provision of these Terms to the contrary, if the Grantee is a “specified employee” as defined in Section 409A of the Code, the Grantee shall not be entitled to any payment with respect to the Award in connection with the Grantee’s Separation from Service until the date which is six (6) months after the Grantee’s Separation from Service.  Any amounts otherwise payable to the Grantee following the Grantee’s Separation from Service that are not so paid by reason of this Section 17 shall be paid as soon as practicable for the Corporation (and in all events within thirty (30) days) after the date that is six (6) months after the Grantee’s Separation from Service.  The provisions of this Section 17 shall only apply if, and to the extent, required to comply with Section 409A of the Code.
18.Construction.  It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Award Agreement shall be construed and interpreted consistent with that intent.
    5sbraex1011

EXECUTION VERSION    [[5258451]]  SABRA HEALTH CARE REIT, INC.  $400,000,000 of  Shares of Common Stock  (par value $0.01 per share)  Equity Distribution Agreement  December 11, 2019  Barclays Capital Inc.  745 Seventh Avenue  New York, New York 10019    BMO Capital Markets Corp.  3 Times Square, 25th Floor  New York, New York 10036    BofA Securities, Inc.  One Bryant Park  New York, New York 10036    Citigroup Global Markets Inc.  388 Greenwich Street  New York, New York 10013    Credit Agricole Securities (USA) Inc.  1301 Avenue of the Americas  New York, New York 10019    Fifth Third Securities, Inc.  424 Church Street, Suite 600  Nashville, Tennessee 37219    The Huntington Investment Company  41 South High Street  Columbus, Ohio 43215    Jefferies LLC  520 Madison Avenue  New York, New York 10022    KeyBanc Capital Markets Inc.  127 Public Square, 4th Floor  Cleveland, Ohio 44114    Mizuho Securities USA LLC  

 

  2  [[5258451]]  320 Park Avenue – 12th Floor  New York, New York 10022    Morgan Stanley & Co. LLC  1585 Broadway  New York, New York 10036    MUFG Securities Americas Inc.  1221 Avenue of the Americas, 6th Floor  New York, New York 10020    Raymond James & Associates, Inc.  880 Carillon Parkway  St. Petersburg, Florida 33716    RBC Capital Markets, LLC  200 Vesey Street  New York, New York 10281    Scotia Capital (USA) Inc.  250 Vesey Street, 24th Floor  New York, New York 10281    SMBC Nikko Securities America, Inc.  277 Park Avenue, 5th Floor  New York, New York 10172    Stifel, Nicolaus & Company, Incorporated  501 North Broadway  Saint Louis, Missouri 63102    SunTrust Robinson Humphrey, Inc.  3333 Peachtree Rd., NE, 11th Floor  Atlanta, Georgia 30326    Wells Fargo Securities, LLC  375 Park Avenue  New York, New York 10152    As Agents    Barclays Bank PLC  745 Seventh Avenue  New York, New York 10019    Bank of Montreal  

 

  3  [[5258451]]  3 Times Square, 25th Floor  New York, New York 10036    Bank of America, N.A.  One Bryant Park  New York, New York 10036    Citibank, N.A.  388 Greenwich Street  New York, New York 10013    Crédit Agricole Corporate and Investment Bank  c/o Credit Agricole Securities (USA) Inc., as agent   1301 Avenue of the Americas  New York, New York 10019    Jefferies LLC  520 Madison Avenue  New York, New York 10022    KeyBanc Capital Markets Inc.  127 Public Square, 4th Floor  Cleveland, Ohio 44114    Morgan Stanley & Co. LLC  1585 Broadway  New York, New York 10036    MUFG Securities EMEA plc  Ropemaker Place  25 Ropemaker Street London EC2Y 9AJ, United Kingdom     Raymond James & Associates, Inc.  880 Carillon Parkway  St. Petersburg, Florida 33716    Royal Bank of Canada  200 Vesey Street  New York, New York 10281    The Bank of Nova Scotia   250 Vesey Street, 24th Floor  New York, New York 10281    Wells Fargo Bank, National Association  375 Park Avenue  

 

  4  [[5258451]]  New York, New York 10152    As Forward Purchasers  Ladies and Gentlemen:  SABRA HEALTH CARE REIT, INC., a Maryland corporation (the “Company”) confirms its  agreement (this “Agreement”) with each of Barclays Capital Inc., BMO Capital Markets Corp.,  BofA Securities, Inc., Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc.,  Fifth Third Securities, Inc., The Huntington Investment Company, Jefferies LLC, KeyBanc  Capital Markets Inc., Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG  Securities Americas Inc., Raymond James & Associates, Inc., RBC Capital Markets, LLC,  Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., Stifel, Nicolaus & Company,  Incorporated, SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC, each as  agent, forward seller and/or as principal under any Terms Agreement (as defined in Section 3  below) (in any such capacity, each an “Agent”, and collectively, the “Agents”) and Barclays  Bank PLC, Bank of Montreal, Bank of America, N.A., Citibank, N.A., Crédit Agricole  Corporate and Investment Bank c/o Credit Agricole Securities (USA) Inc., as agent, Jefferies  LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, MUFG Securities EMEA plc,  Raymond James & Associates, Inc., Royal Bank of Canada, The Bank of Nova Scotia and Wells  Fargo Bank, National Association, each as forward purchaser (in such capacity, each a “Forward  Purchaser”, and collectively, the “Forward Purchasers”). For purposes of clarity, it is understood  and agreed by the parties hereto that, if Shares (as defined below) are offered or sold through any  Agent acting as Forward Seller (as defined below), then such Agent, as Forward Seller, shall be  acting solely in its capacity as sales agent for such Forward Purchaser and not as sales agent for  the Company with respect to the offering and sale of such Shares, and, except in cases where this  Agreement expressly refers to an Agent acting as sales agent for the Company or unless  otherwise expressly stated or the context otherwise requires, references in this Agreement to any  Agent acting as sales agent shall also be deemed to apply to such Agent when acting as forward  seller, mutatis mutandis.  It is also understood and agreed by the parties hereto that, if Shares are  offered or sold through any Agent acting as sales agent for the Company, then such Agent shall  be acting solely in its capacity as sales agent for the Company, and not as sales agent for any  Forward Purchaser, with respect to the offering and sale of such Shares.   The Company proposes to issue, offer and sell to or through the Agents, in the  manner and subject to the terms and conditions set forth herein of up to $400,000,000 aggregate  gross proceeds (the “Maximum Amount”) of shares of the Company’s common stock, par value  $0.01 per share (the “Common Stock”) (including shares of Common Stock borrowed and sold  pursuant to a Confirmation (as defined below), the “Shares”).  The Company agrees that  whenever it determines to sell Shares directly to one or more Agents as principal, it will enter  into a separate agreement (a “Terms Agreement”), relating to such sale in accordance with  Section 3(g) of this Agreement, in substantially the form attached hereto as Exhibit 3(g).  For the  avoidance of doubt, any references in this Agreement to “Shares” shall not include any  Confirmation Shares (as defined below).    The Company may also enter into one or more forward stock purchase  transactions with any of the Forward Purchasers as set forth in separate forward sale transaction  

 

  5  [[5258451]]  confirmations, each in substantially the form attached hereto as Exhibit 3(b) (each, a  “Confirmation” and, collectively, the “Confirmations”).  In connection therewith, the Company  and each Forward Purchaser understand that the applicable Forward Purchaser or an affiliate  thereof will attempt to borrow and then offer, through the applicable Forward Seller (which shall  be either the same entity as the Forward Purchaser or an affiliate of the Forward Purchaser), the  applicable Placement Shares (as defined below) for sale on the terms set forth in this Agreement  (any such Placement Shares, “Forward Hedge Shares”).  Any shares of Common Stock to be  delivered by the Company to the Forward Purchaser in settlement of all or any portion of the  Company’s obligations under any Confirmation are hereinafter referred to as “Confirmation  Shares”.  The issuance and sale of Shares in accordance with this Agreement will be  effected pursuant to the Registration Statement (as defined below) that became automatically  effective when filed by the Company with the Securities and Exchange Commission (the  “Commission”) on December 11, 2019, although nothing in this Agreement shall be construed as  requiring the Company to use the Registration Statement to issue Shares.  The Company, each Agent and each Forward Purchaser agree as follows:  1. Issuance and Sale of Shares.  The Company has prepared and filed, in accordance with  the provisions of the Securities Act of 1933, as amended, and the rules and regulations  promulgated thereunder (collectively, the “Securities Act”), with the Commission a  registration statement on Form S-3 (File No. 333-235449), which contains a base  prospectus, relating to certain securities, including the Shares to be issued from time to  time by the Company, and which incorporates by reference documents that the Company  has filed or will file in accordance with the provisions of the Securities Exchange Act of  1934, as amended, and the rules and regulations promulgated thereunder (collectively, the  “Exchange Act”).  The Company has prepared a prospectus supplement specifically  relating to the Shares (the “Prospectus Supplement”) to the base prospectus included as  part of such registration statement.  The Company will furnish to the Agents and Forward  Purchasers, for use by the Agents and Forward Purchasers, copies of the prospectus  included as part of such registration statement, as amended and as supplemented by the  Prospectus Supplement, relating to the Shares.  Except where the context otherwise  requires, such registration statement, including all documents filed as part thereof or  incorporated by reference therein, and including any information contained in or  incorporated by reference in a Prospectus (as defined below) subsequently filed with the  Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of  such registration statement pursuant to Rule 430B or 430C under the Securities Act, is  called the “Registration Statement”.  The base prospectus, including all documents  incorporated therein by reference, included in the Registration Statement, as it may be  supplemented by the Prospectus Supplement, in the form in which such prospectus and/or  Prospectus Supplement have most recently been filed by the Company with the  Commission pursuant to Rule 424(b) under the Securities Act, together with any issuer  free writing prospectus (as defined below), is called the “Prospectus”.  As used herein,  “issuer free writing prospectus” has the meaning set forth in Rule 433 under the  Securities Act, and “free writing prospectus” has the meaning set forth in Rule 405 under  the Securities Act.  All references in this Agreement to (i) the Registration Statement or  

 

  6  [[5258451]]  the Prospectus, or any amendments or supplements to any of the foregoing, shall include  any copy thereof filed with the Commission pursuant to its Electronic Data Gathering,  Analysis and Retrieval system (or any successor system) (“EDGAR”) and (ii) the  Prospectus shall be deemed to include the “electronic Prospectus” (as defined below)  provided for use in connection with the offering of the Shares as contemplated by Section  7(y) of this Agreement.  2. Placements.  (a) Each time that the Company wishes to issue and sell Shares hereunder (each, a  “Placement”), it will notify an Agent (and an affiliated Forward Purchaser, if  applicable) selected by the Company to sell certain Shares either (i) on behalf of  the Company as sales agent (such Agent, in such capacity, the “Direct Seller”) or  (ii) on behalf of the applicable Forward Purchaser (a “Placement Forward  Purchaser”) as forward seller (such Agent, in such capacity, the “Forward  Seller”), as instructed by the Company by email notice or other method mutually  agreed to in writing by the Company and the applicable Direct Seller or Forward  Seller and Forward Purchaser, as applicable, containing the parameters in  accordance with which it desires the Shares to be sold (such notice, a “Notice”),  which shall specify whether (x) such Shares will be sold through the Direct Seller,  as sales agent (a “Direct Sale”) in accordance with Section 2(a) below or (y)  Forward Hedge Shares will be borrowed by or on behalf of the Placement  Forward Purchaser and sold through the Forward Seller, as sales agent and  forward seller, in connection with hedging a forward stock purchase transaction  pursuant to a Confirmation (a “Forward Sale”) in accordance with Section 3(b)  below.  As used herein, “Placement Agent” shall refer to the Direct Seller or the  Forward Seller, as applicable.  The Notice, forms of which are attached hereto as  Schedules 1-A (Direct Instruction Notice) and 1-B (Forward Instruction Notice),  shall at a minimum include (I) the maximum number of Shares to be issued and  sold, or with respect to a Forward Sale, borrowed and sold (in each case, the  “Placement Shares”), which number may instead be listed as an amount of  aggregate gross proceeds, (II) the Trading Day(s) (as defined below) on which  Placement Shares subject to such Placement are intended to be sold (each, a  “Purchase Date”), (III) any limitation on the number of Placement Shares that  may be sold on any single Trading Day and (IV) any minimum price below which  Shares shall not be sold.  With respect to a Forward Sale, such Notice shall also  include, for purposes of (and as defined under) the related Confirmation, the  proposed input in the definition of “Maturity Date”, “Hedge Completion Date”,  percentage for purposes of the “Initial Forward Price”, “Spread”, “Initial Stock  Loan Rate”, “Minimum Settlement Shares”, “Maximum Stock Loan Rate”,  “Forward Price Reduction Dates” and “Forward Price Reduction Amounts”;  provided, however, that the Company shall not deliver a Notice in respect of a  proposed Forward Sale if the delivery of such Notice would result in (I) the sum  of (1) the number of Confirmation Shares issued under all Confirmations that  have settled as of the contemplated date of delivery, (2) the aggregate “Share  Cap” (as defined in each Confirmation) under all Confirmations outstanding as of  the contemplated date of delivery that have not settled and (3) the proposed  

 

  7  [[5258451]]  “Share Cap” for the Confirmation related to such Notice exceeding (II) 19.99% of  the number of shares of Common Stock outstanding as of the date of this  Agreement.  Notwithstanding the above, the Company shall not deliver a Notice  to any Agent or Forward Purchaser, or execute a Confirmation or Terms  Agreement with any Forward Purchaser or Agent if, at or after any Representation  Date, the Agents and Forward Purchasers have not received the certificate  required under Section 7(n), the opinions required under Section 7(o), the comfort  letters required under Sections 7(p)(i) and 7(p)(ii) and the opinion required under  Section 9(f), with respect to such Representation Date. The Notice shall originate  from the Company and be sent by any of the individuals from the Company set  forth on Schedule 2 attached hereto (with a copy to each of the other individuals  from the Company listed on such schedule), and shall be addressed to each of the  individuals from such Placement Agent (and the Placement Forward Purchaser, if  applicable) named in such Notice, as set forth on Schedule 2 (as such Schedule 2  may be amended from time to time).  With respect to a Direct Sale, if the terms of  a Notice contemplate that Placement Shares shall be sold on more than one  Purchase Date, then the Company and such Placement Agent shall mutually agree  to such additional terms and  conditions as they deem necessary in respect of such  multiple Purchase Dates, and such additional  terms and conditions shall be set  forth in the relevant Notice and confirmed by the relevant  Placement Notice (as  defined below) and be binding to the same extent as any other terms contained  therein.  (b) Any Notice with respect to a Direct Sale shall be effective as to a Direct Seller  and the Company only upon receipt and confirmation of acceptance in writing by  such Direct Seller to the Company of the terms of such Placement Notice by any  means permissible under Section 14 (including by email) (a “Direct  Acceptance”).  With respect to a Notice delivered by the Company in connection  with a Forward Sale, the Placement Forward Purchaser and the Forward Seller  (each acting in its sole discretion) shall promptly, and in any event prior to the  opening of trading on the Trading Day following the Trading Day on which such  Notice was received, notify the Company that it chooses to (x) accept the terms  proposed in such Notice, (y) decline to participate in the proposed Forward Sale  or (z) propose an amended notice setting forth the terms upon which the  Placement Forward Purchaser and the Forward Seller would participate in the  proposed Forward Sale (such amended notice, an “Amended Notice”); provided,  however, that in the case of clause (z), the Company may accept or reject the  terms of such Amended Notice in its sole discretion no later than on the Trading  Day following the Trading Day on which such Amended Notice was delivered (a  Notice accepted by the Forward Seller and the Placement Forward Purchaser or  Amended Notice accepted by the Company in accordance with this sentence, a  “Forward Instruction Notice”).  Promptly upon the acceptance of a Forward  Instruction Notice (a “Forward Acceptance”) (and in any event prior to the  opening of trading on the immediately following Trading Day), the Company and  the Placement Forward Purchaser shall enter into a Confirmation substantially in  the form of Exhibit 3(b) hereto and consistent with such Forward Instruction  Notice.  As used herein, a “Placement Notice” shall refer to a Notice with respect  

 

  8  [[5258451]]  to a Direct Sale accepted by a Direct Acceptance or a Forward Instruction Notice,  as applicable.  As used herein, a “Placement Acceptance” shall refer to a Direct  Acceptance or Forward Acceptance, as applicable.   (c) Upon a Placement Acceptance, the Placement Notice shall be effective as to such  Placement Agent and the Company unless and until (i) the entire amount of the  Placement Shares have been sold, (ii) the Company, the Placement Agent or, if  applicable, the Placement Forward Purchaser suspends, cancels or terminates the  Placement Notice, (iii) the Company issues a subsequent Placement Notice to the  Placement Agent (and the Placement Forward Purchaser, if applicable) with  parameters superseding those of the earlier dated Placement Notice; (iv) the  Placement Notice or this Agreement has been terminated under the provisions of  Section 13 or (v) with respect to a Forward Sale, the entry into the relevant  Confirmation.  The suspension, cancellation or termination of a, or the issuance of  a subsequent, Placement Notice as set forth in the prior sentence shall not affect  or impair the Placement Agent’s or, if applicable, the Placement Forward  Purchaser’s respective rights or obligations with respect to Placement Shares sold  or borrowed and sold under such Placement Notice prior to such suspension,  cancellation or termination (including with respect to Placement Shares sold that  have not yet settled and, in the case of any Shares borrowed by or on behalf of the  Placement Forward Purchaser and sold by or through a Placement Agent in  connection with a Forward Instruction Notice, the obligation to enter into the  resulting Confirmation).  The parties agree that no such notice under this Section  shall be effective against another party to this Agreement unless it is made in  writing (including by email) by one of the individuals named on Schedule 2 as  being an authorized agent for notices in respect of such party, to one of the  individuals named on Schedule 2 as being an authorized agent for notices with  respect to such other party (as such Schedule 2 may be amended from time to  time) (the foregoing, the “Notice Principles”).  (d) The amount of compensation to be paid by the Company to the Agents in  connection with a Direct Sale of the Placement Shares shall be determined based  on a rate to be agreed upon by the Company and the Agents, and shall be  disbursed in accordance with Section 5(a) or as otherwise agreed by the Company  and the Agents. The compensation described in the previous sentence shall not  apply (i) when an Agent acts as principal pursuant to a Terms Agreement, in  which case the Company may sell Shares to such Agent as principal at a price  agreed upon in such Terms Agreement or (ii) when an Agent acts as forward  seller pursuant to a Forward Sale, in which case the compensation payable with  respect to the sale of Forward Hedge Shares shall be paid by the Company  exclusively through the determination of “Initial Forward Price” under the  applicable Confirmation.   (e) Under no circumstances shall the Company cause or request the offer or sale of  any Placement Shares at a price lower than the minimum price authorized from  time to time by the Company’s board of directors or duly authorized committee  thereof and notified to the Agents in writing, nor shall the Company cause or  

 

  9  [[5258451]]  request the offer or sale of any Placement Shares in a number or with an  aggregate gross or net sales price in excess of the number or aggregate gross or  net sales price, as the case may be, authorized from time to time to be issued and  sold under this Agreement, any Terms Agreement or any Confirmation, in each  case by the Company’s board of directors or duly authorized committee thereof,  or in a number in excess of the number of Shares approved for listing on the  Exchange (as defined below), or in excess of the number or amount of Shares  available for issuance on the Registration Statement. The Agents and the Forward  Purchasers shall have no responsibility for maintaining records with respect to  Shares or Confirmation Shares available for sale under the Registration Statement  or approved for listing on the Exchange or for determining the number or  aggregate gross or net sales price of Shares or Confirmation Shares duly  authorized by the Company.  (f) It is expressly acknowledged and agreed that none of the Company, any Agent or  any Forward Purchaser will have any obligation whatsoever with respect to a  Placement or any Shares unless and until (i) with respect to a Direct Sale, the  Company delivers a Notice, and the applicable Placement Agent accepts the  Notice through a Direct Acceptance, (ii) with respect to a Forward Sale, the  Company and a Forward Purchaser enter into a Confirmation pursuant to a  Forward Instruction Notice or (iii) with respect to a sale directly to an Agent as  principal, the Company and such Agent enter into a Terms Agreement, and then  only upon the terms specified in such Placement Notice, Confirmation or Terms  Agreement, as applicable, and in this Agreement.  In the event of a conflict  between the terms of this Agreement and the terms of a Placement Notice, the  terms of the Placement Notice will control.  In the event of a conflict between the  terms of this Agreement and the terms of a validly executed Confirmation, the  terms of the Confirmation will control.  In the event of a conflict between the  terms of this Agreement and the terms of a validly executed Terms Agreement,  the terms of the Terms Agreement will control.  (g) The Company agrees that any offer to sell Shares, any solicitation of an offer to  buy Shares or any sales of Shares shall only be effected by or through one Agent,  acting as Direct Seller or Forward Seller, as applicable, on any Purchase Date.  The Company shall in no event request that more than one Direct Seller or  Forward Seller, as applicable, offer or sell Shares on the same Purchase Date.  3. Sale of Placement Shares by the Agents  (a) Upon the basis of the representations and warranties and subject to the terms and  conditions herein set forth, upon the Company’s issuance of a Notice to a Direct  Seller with respect to a Direct Sale, receipt of which is promptly confirmed by  such Direct Seller through a Direct Acceptance, and unless the sale of the  Placement Shares described therein has been declined, suspended, canceled or  otherwise terminated in accordance with the terms of this Agreement, the Direct  Seller, for the period specified in such Notice, will use its commercially  reasonable efforts consistent with its normal trading and sales practices and  

 

  10  [[5258451]]  applicable state and federal laws, rules and regulations and the rules of the Nasdaq  Global Select Market (the “Exchange”), to sell such Placement Shares up to the  amount specified in such Notice, and otherwise in accordance with the terms of  such Notice.  For the purposes hereof, “Trading Day” means (i) with respect to  Direct Sales, any day on which the Common Stock is traded on the Exchange, and  (ii) with respect to Forward Sales, a Scheduled Trading Day as defined in the  related Confirmation.  (b) Upon the basis of the representations and warranties and subject to the terms and  conditions herein set forth, upon the Company’s issuance of a Notice to a Forward  Seller and Placement Forward Purchaser with respect to a Forward Sale, which is  promptly amended as necessary and agreed among the Company, Forward Seller  and Placement Forward Purchaser through a Forward Acceptance and execution  of a Confirmation, and unless the sale of the Placement Shares described therein  has been declined, suspended, canceled or otherwise terminated in accordance  with the terms of this Agreement or (x) an event that would permit the Placement  Forward Purchaser to designate a “Termination Settlement Date” or an “Early  Termination Date” (as each such term is defined in the relevant Confirmation)  under, and pursuant to the provisions of Section 11 of the relevant Confirmation  or (y) a “Bankruptcy Termination Event” (as such term is defined in the relevant  Confirmation) has occurred, (i) the Placement Forward Purchaser (or agent  thereof) will use its commercially reasonable efforts consistent with its normal  trading and sales practices for similar transactions and applicable state and federal  laws, rules and regulations and the rules of the Exchange, to borrow the number  of Placement Shares up to the amount specified in the Forward Instruction Notice  and (ii) the Forward Seller, for the period specified in the Forward Instruction  Notice, will use its commercially reasonable efforts consistent with its normal  trading and sales practices and applicable state and federal laws, rules and  regulations and the rules of the Exchange, to sell such borrowed Placement Shares  up to the amount specified in the Forward Instruction Notice, and otherwise in  accordance with the terms of such Forward Instruction Notice and Confirmation.  (c) With respect to Direct Sales, the Direct Seller will provide written confirmation to  the Company no later than the opening of the Trading Day immediately following  the Trading Day on which it has made sales of Placement Shares hereunder  setting forth the number of Placement Shares sold on such day, the prices at  which such Placement Shares were sold, the aggregate gross proceeds from such  sales, the compensation payable by the Company to the Direct Seller pursuant to  Section 2(c) with respect to such sales, an itemization of any deductions made by  the Direct Seller (as set forth in Section 5(a)) for Transaction Fees (as defined  below) payable in respect of such sales and the Net Proceeds (as defined below)  payable to the Company.  (d) With respect to Forward Sales, the Forward Seller or the Placement Forward  Purchaser will provide written notice to the Company no later than the Trading  Day immediately following the final Trading Day on which sales of Forward  Hedge Shares pursuant to a Confirmation occur setting forth the “Hedge  

 

  11  [[5258451]]  Completion Date” (as defined in the related Confirmation), the aggregate number  of borrowed Placement Shares sold through the Forward Seller as Forward Hedge  Shares (as of such “Hedge Completion Date”, the “Base Amount” for each such  Confirmation) and the “Initial Forward Price” under the applicable Confirmation.  (e) Unless otherwise set forth in the Placement Notice, the Placement Agent may sell  Placement Shares by any method permitted by law deemed to be an “at the market  offering” as defined in Rule 415(a)(4) of the Securities Act, including, without  limitation, sales made directly on the Exchange, on any other existing trading  market for the Common Stock or to or through a market maker (which may  include block transactions).  (f) With prior consent of the Company, and subject to the terms of the Placement  Notice, the Placement Agent may also sell Placement Shares in privately  negotiated transactions.  (g) The Company may also offer to sell Shares directly to an Agent, as principal, in  which event such parties will enter into a separate agreement (each, a “Terms  Agreement”) in substantially the form of Exhibit 3(g) hereto (with such changes  thereto as may be agreed upon by the Company and such Agent from time to  time), relating to such sale.  Any sales of Shares pursuant to a Terms Agreement  will be made in accordance with the terms of this Agreement and the applicable  Terms Agreement. The commitment of an Agent to purchase Shares pursuant to  any Terms Agreement shall be deemed to have been made on the basis of the  representations and warranties of the Company contained herein and shall be  subject to the terms and conditions herein set forth.  (h) The Company acknowledges and agrees that (i) there can be no assurance that any  Agent will be successful in selling Placement Shares as sales agent or that any  Forward Purchaser or any of its affiliates will be successful in borrowing and  selling Placement Shares through the applicable Forward Seller and (ii) no  Placement Agent, Forward Purchaser or affiliate thereof will incur any liability or  obligation to the Company or any other person or entity if it does not sell  Placement Shares (whether acting as Direct Seller or as Forward Seller) for any  reason other than a failure by a Placement Agent, Forward Purchaser or affiliate  thereof to use its commercially reasonable efforts consistent with its normal  trading and sales practices and applicable law and regulations to borrow, if  applicable, and sell such Placement Shares as required under this Section 3, and  no Agent shall be under any obligation to purchase Shares on a principal basis  pursuant to this Agreement, except as may otherwise be agreed upon by such  Agent and the Company in a Terms Agreement or pursuant to a Confirmation.  (i) The aggregate number of Shares that may be sold pursuant to this Agreement and  any Terms Agreement shall not exceed the Maximum Amount.  Notwithstanding  anything to the contrary contained herein, the parties hereto agree that compliance  with the limitation set forth in this paragraph on the number of Shares issued and  sold under this Agreement and any Terms Agreement shall be the sole  

 

  12  [[5258451]]  responsibility of the Company, and the Agents and Forward Purchasers shall have  no obligation in connection with such compliance.  (j) At each Applicable Time (as defined in Section 22(a)), execution of any  Confirmation and execution of any Terms Agreement, the Company shall be  deemed to have affirmed each representation and warranty contained in this  Agreement as if such representation and warranty were made as of such date,  modified as necessary to relate to the Registration Statement and the Prospectus  as amended as of such date.  Any obligation of the Placement Agents to sell  Shares as Direct Sellers or Forward Sellers or the Placement Forward Purchasers  or their affiliates to borrow Shares, as described in this Section 3, shall be subject  to the continuing accuracy of the representations and warranties of the Company  herein, to the performance by the Company of its obligations hereunder and to the  continuing satisfaction of the additional conditions specified in Section 9 of this  Agreement.  4. Suspension of Sales.  (a) The Company may, upon notice to the Agents and the Forward Purchasers in  writing (by email correspondence to each of the individuals of the Agents and  Forward Purchasers set forth on Schedule 2, if receipt of such correspondence is  actually acknowledged by any of the individuals to whom the notice is sent, other  than via auto-reply) or by telephone (confirmed immediately by verifiable  facsimile transmission or email correspondence to each of the individuals of the  Agents and Forward Purchasers set forth on Schedule 2), suspend any sale of  Shares for any reason at any time, until the earlier of (i) the date the Company  instructs the Agents to sell Shares or the Forward Purchasers to borrow and sell  Shares through the applicable Agents under this Agreement pursuant to the terms  hereof or (ii) the date on which the Company instructs the Agents and Forward  Purchasers that it is revoking its prior notice that it does not intend to sell Shares  pursuant to this Agreement (such time period, a “Suspension Period” and, the  dates referenced in clauses (i) and (ii) of this Section 4(a), a “Suspension  Rescission Date”); provided, however, that such suspension shall not affect or  impair any party’s obligations with respect to any Shares sold under this  Agreement prior to the receipt of such notice, including with respect to any Shares  sold that have not yet settled, or with respect to Shares that are subject to any  Terms Agreement or outstanding Confirmation entered into prior to the receipt of  such notice.  (b) Notwithstanding any other provision of this Agreement, but subject to  Section 4(c) below, the Company shall not offer or sell, or request the offer or  sale of, any Shares and, by notice to the applicable Agents and Forward  Purchasers in writing (including by email correspondence to each of the  individuals of such Agent and Forward Purchaser set forth on Schedule 2 if  receipt of such correspondence is actually acknowledged by any of the individuals  to whom the notice is sent, other than via auto-reply) or by telephone (confirmed  immediately by verifiable facsimile transmission or email correspondence to each  

 

  13  [[5258451]]  of the individuals of such Agent and Forward Purchaser set forth on Schedule 2),  shall cancel any instructions for the offer or sale of any Shares, and the Agents  shall not be obligated to offer or sell any Shares, (i) during any period in which  the Company is in possession of material non-public information or (ii) at any  time during the period commencing on the fourteenth day of the first month of  any fiscal quarter and ending after the second full business day following the  release of the Company’s earnings for the immediately preceding quarter.  (c) If the Company wishes to offer or sell any Shares during any period described in  Section 4(b)(ii) above (each such period, a “Blackout Period”), the Company will,  as a condition to the giving or continuation of any Placement Notice, the entering  into of any Confirmation or the entering into of any Terms Agreement, certify in  writing to the applicable Agents (and Forward Purchasers, as applicable) that the  Company is not in possession of any material non-public information, which  certification shall be deemed to remain in effect during the applicable Blackout  Period or time period specified in the applicable Placement Notice, Confirmation  or Terms Agreement, whichever ends earlier, unless withdrawn by the Company.  (d) If any party hereto has reason to believe that the exemptive provisions set forth in  Rule 101(c)(1) of Regulation M (as defined below) are not satisfied with respect  to the Company or the Shares, it shall promptly notify the other parties hereto and  sales of Shares under any Placement Notice, Confirmation or Terms Agreement  shall be suspended until such exemptive provisions or other exemptive provisions  have been satisfied in the judgment of each party thereto unless otherwise agreed  by an Agent and the Company pursuant to a Terms Agreement.  (e) Upon receipt of any written notice contemplated in Section 7(j) (Notice of Other  Sales) hereof, an Agent or Forward Purchaser may suspend its activity under any  Placement Notice or any Terms Agreement for such period of time as such Agent  or Forward Purchaser deems appropriate.  (f) In the event that either (i) a Forward Purchaser (or an agent thereof) is unable to  borrow and deliver Forward Hedge Shares to the Forward Seller for sale with  respect to a Forward Instruction Notice after using commercially reasonable  efforts, consistent with its normal trading and sales practices for similar  transactions and applicable state and federal laws, rules and regulations and the  rules of the Exchange or (ii) in the commercially reasonable judgment of such  Forward Purchaser, it is impracticable to do so or such Forward Purchaser (or an  agent thereof) would incur a stock loan cost that is equal to or greater than the  “Maximum Stock Loan Rate” (as specified in the relevant Forward Instruction  Notice) to do so, then the obligation herein of the applicable Forward Seller with  respect to such Forward Instruction Notice shall only extend to the aggregate  number of Shares that the Forward Purchaser is able to, and that in the  commercially reasonable judgment of such Forward Purchaser it is practicable to,  so borrow below such cost.  

 

  14  [[5258451]]  5. Settlement of Placement Shares.  (a) Unless otherwise specified in the applicable Placement Notice, settlement for  sales of Placement Shares will occur (i) in respect of a Direct Sale, on the second  (2nd) Trading Day (or such earlier day as is industry practice for regular-way  trading) following the date on which such sales are made (each such date, a  “Direct Settlement Date”, or (ii) in respect of a Forward Sale, as determined  pursuant the relevant Confirmation (each such date, a “Hedge Settlement Date”  and, each Direct Settlement Date or Forward Settlement Date, a “Settlement  Date”).  The amount of proceeds to be delivered by the Direct Seller to the  Company will be either (i) in the event the Company and the Direct Seller and  have so mutually agreed, equal to the aggregate gross sales price tendered to the  Direct Seller for the sale of Placement Shares (the “Gross Proceeds”) or (ii) equal  to the aggregate gross sales price tendered to the Direct Seller for the sale of  Placement Shares, minus the Direct Seller’s compensation for such sales payable  by the Company pursuant to Section 2 hereof, and minus any further deduction  (the “Transaction Fees”) for any transaction fees, transfer taxes or similar taxes or  fees imposed by any governmental, regulatory or self-regulatory organization in  respect of such sales (the “Net Proceeds”).  The Placement Agent shall notify the  Company as promptly as practicable if there will be any deduction on account of  any applicable Transaction Fees, and shall provide an itemization of any  deductions to the Company in accordance with Section 3(b).  In the event the  Company and the Agent have mutually agreed to the delivery of Gross Proceeds  on the Direct Settlement Date, the compensation payable to such Agent shall be  set forth and invoiced in a periodic statement from the Agent to the Company and  payment shall be made by the Company promptly after its receipt thereof.  (b) On or before each Direct Settlement Date, the Company will, or will cause its  transfer agent to, electronically transfer the Placement Shares being sold by  crediting the Direct Seller’s or its designee’s account (provided the Direct Seller  shall have given the Company written notice of such designee prior to the  Settlement Date) at The Depository Trust Company through its Deposit and  Withdrawal at Custodian System or by such other means of delivery as may be  mutually agreed upon by the parties hereto which in all cases shall be freely  tradeable, transferable, registered shares in good deliverable form.  On each  Direct Settlement Date, the Direct Seller will deliver the Net Proceeds (or Gross  Proceeds, as applicable) in same day funds to an account designated by the  Company.  (c) Default by Company or Transfer Agent.  The Company agrees that if it, or its  transfer agent (if applicable), defaults in its obligation to deliver Placement Shares  on a Direct Settlement Date, in addition to and in no way limiting the rights and  obligations set forth in Sections 10(a) (Indemnification of Each Agent) and 11  (Contribution) below, it will indemnify and hold each applicable Agent subject to  a Placement Notice with respect to such Placement Shares harmless against any  loss, claim, damage, or expense (including reasonable legal fees and expenses), as  actually and reasonably incurred, arising out of or in connection with such default  

 

  15  [[5258451]]  by the Company, and notwithstanding any such default by the Company, will pay  to such Agent the commission, discount, or other compensation to which it would  otherwise have been entitled absent such default.  6. Representations, Warranties and Covenants of the Company.  The Company represents  and warrants to each Agent and each Forward Purchaser as of each Applicable Time, and  covenants with each Agent and each Forward Purchaser, as follows:  (a) Compliance with Registration Requirements.  The Registration Statement became  effective when filed with the Commission under the Securities Act.  No stop order  suspending the effectiveness of the Registration Statement is in effect and no  proceedings for such purpose, pursuant to Rule 401(g)(2) or pursuant to  Section 8A of the Securities Act have been instituted or are pending or, to the  knowledge of the Company, threatened by the Commission.  The Company meets  the requirements for use of Form S-3 under the Securities Act and has prepared  and filed with the Commission the Registration Statement, which is an automatic  shelf registration statement, as defined in Rule 405 under the Securities Act, on  Form S-3 (File No. 333-235449).  (i) (A) At the time of filing the Registration Statement, (B) at the time of the  most recent amendment thereto for the purposes of complying with  Section 10(a)(3) of the Securities Act (whether such amendment was by  post-effective amendment, incorporated report filed pursuant to  Sections 13 or 15(d) of the Exchange Act or form of prospectus) and (C)  as of each Applicable Time (with such date being used as the  determination date for purposes of this clause (C)), the Company was or is  (as the case may be) a “well-known seasoned issuer” as defined in Rule  405 under the Securities Act.  (ii) The Prospectus, when filed and as of its date, complied in all material  respects with the Securities Act and, if filed by electronic transmission  pursuant to EDGAR (except as may be permitted by Regulation S-T under  the Securities Act), was identical to the copies thereof delivered to the  Agents and Forward Purchasers for use in connection with the offer and  sale of the Shares.  The Registration Statement and any post-effective  amendment thereto, at the time it became effective and each deemed  effective date with respect to the Agents and Forward Purchasers pursuant  to Rule 430B(f)(2) of the Securities Act and at each Settlement Date,  complied and will comply in all material respects with the Securities Act  and did not and will not contain any untrue statement of a material fact or  omit to state a material fact required to be stated therein or necessary to  make the statements therein not misleading.  The documents incorporated  or deemed to be incorporated by reference in the Prospectus, at the time  they were filed with the Commission under the Exchange Act, complied in  all material respects with the requirements of the Exchange Act.  The  Prospectus (including any Prospectus wrapper), as amended or  supplemented, as of its date, at each Applicable Time, and at each  

 

  16  [[5258451]]  Representation Date (as defined in Section 7(n)), did not and will not  contain any untrue statement of a material fact or omit to state a material  fact necessary in order to make the statements therein, in the light of the  circumstances under which they were made, not misleading.  The  representations and warranties set forth in the two immediately preceding  sentences do not apply to statements in or omissions from the Registration  Statement or any post-effective amendment thereto, the Prospectus or any  amendments or supplements thereto, made in reliance upon and in  conformity with information relating to the Agents or Forward Purchasers  furnished to the Company in writing by the Agents or Forward Purchasers  expressly for use therein, it being understood and agreed that the only such  information furnished by the Agents or Forward Purchasers to the  Company consists of the Agent Information (as defined herein).  There are  no contracts or other documents required to be described in the Prospectus  or to be filed as exhibits to the Registration Statement which have not  been described or filed as required.  (iii) The Company is not an “ineligible issuer” in connection with the offering  of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.   Any free writing prospectus that the Company is required to file pursuant  to Rule 433(d) under the Securities Act has been, or will be, filed with the  Commission in accordance with the requirements of the Securities Act.   Each free writing prospectus that the Company has filed, or is required to  file, pursuant to Rule 433(d) under the Securities Act or that was prepared  by or on behalf of or used or referred to by the Company complies or will  comply in all material respects with the requirements of Rule 433 under  the Securities Act, including timely filing with the Commission or  retention where required and legending, and each such free writing  prospectus, as of its issue date and as of each Applicable Time, did not,  does not and will not include any information that conflicted, conflicts  with or will conflict with the information contained in the Registration  Statement or the Prospectus, including any document incorporated by  reference therein, that has not been superseded or modified.  Except for  the free writing prospectuses, if any, identified in Schedule 3 hereto  furnished to the Agents and Forward Purchasers before first use, the  Company has not prepared, used or referred to, and will not, without prior  consent of the Agents and Forward Purchasers, prepare, use or refer to,  any free writing prospectus.  (b) Offering Materials Furnished to the Agents and Forward Purchasers.  The  Company has delivered to the Agents and the Forward Purchasers (i) a complete  copy of the Registration Statement, each amendment thereto and each opinion,  consent and certificate of experts filed as a part thereof, (ii) conformed copies of  the Registration Statement, each amendment thereto and the Prospectus, as  amended or supplemented and (iii) any free writing prospectus reviewed and  consented to by the Agents and Forward Purchasers, in the case of the preceding  

 

  17  [[5258451]]  clauses (i)-(iii), in such quantities and at such places as such Agent or Forward  Purchaser has reasonably requested.  (c) Distribution of Offering Material by the Company.  The Company has not  distributed and will not distribute, prior to the completion of a Placement Agent’s  sale (whether acting as Direct Seller or Forward Seller) of all of the Placement  Shares pursuant to this Agreement, any offering material in connection with the  offering and sale of the Shares, other than the Prospectus, any free writing  prospectus reviewed and consented to by such Agent and the Registration  Statement.  (d) The Agreements.  This Agreement has been, and any Confirmation or Terms  Agreement will have been, duly authorized, executed and delivered.  (e) Authorization of the Shares.  The Shares have been duly authorized for issuance  and sale pursuant to this Agreement and any Confirmation or Terms Agreement  and, when issued and delivered by the Company pursuant to this Agreement or  Terms Agreement, will be validly issued, fully paid and nonassessable, and the  issuance and sale of the Shares is not subject to any preemptive rights, rights of  first refusal or other similar rights to subscribe for or purchase the Shares.  Any  Confirmation Shares have been duly authorized and reserved by the Company for  issuance and sale to the applicable Forward Purchaser pursuant to such  Confirmation and, if and when issued and delivered by the Company pursuant to  the applicable Confirmation against payment of any consideration specified  therein, will be validly issued, fully paid and non-assessable, and will not be  subject to any preemptive rights, rights of first refusal or other similar rights to  subscribe for or purchase the Shares.  (f) No Applicable Registration or Other Similar Rights.  There are no persons with  registration or other similar rights to have any equity or debt securities registered  for sale under the Registration Statement or included in the offering contemplated  by this Agreement or any Confirmation or Terms Agreement.  (g) No Material Adverse Change.  Except as otherwise disclosed in the Prospectus,  subsequent to the respective dates as of which information is given in the  Prospectus: (i) there has been no material adverse change, or any development  that could reasonably be expected to result in a material adverse change, in the  condition, financial or otherwise, or in the properties, business, results of  operations or prospects, whether or not arising from transactions in the ordinary  course of business, of the Company and its subsidiaries, considered as one entity  (any such change is called a “Material Adverse Change”); (ii) the Company and  its subsidiaries, considered as one entity, have not incurred any material liability  or obligation, indirect, direct or contingent, other than in the ordinary course of  business, nor entered into any material transaction or agreement other than in the  ordinary course of business; and (iii) there has been no dividend or other  distribution of any kind declared, paid or made by the Company (other than  regular quarterly cash dividends consistent with past practice) or, except for  

 

  18  [[5258451]]  dividends paid to the Company or other subsidiaries, any of its subsidiaries on any  class or series of capital stock or repurchase or redemption by the Company or  any of its subsidiaries of any class or series of capital stock.  (h) Independent Accountants.  PricewaterhouseCoopers LLP, who have expressed  their opinion with respect to the financial statements (which term as used in this  Agreement includes the related notes thereto) of the Company and its subsidiaries   incorporated by reference in the Registration Statement and the Prospectus are  (A) independent public or certified public accountants as required by the  Securities Act and the Exchange Act and (B) in compliance with the applicable  requirements relating to the qualification of accountants under Rule 2-01 of  Regulation S-X under the Exchange Act (“Regulation S-X”).  (i) Preparation of the Financial Statements.  The financial statements of the Company  and its subsidiaries included and incorporated by reference in the Registration  Statement and the Prospectus present fairly the consolidated financial position of  the Company and its subsidiaries as of and at the dates indicated and the results of  their operations and cash flows for the periods specified.  Such financial  statements have been prepared in conformity with GAAP (as defined in  Section 22(b)), except as may be expressly stated in the related notes thereto. No  other financial statements or supporting schedules of the Company and its  subsidiaries are required to be included or incorporated by reference in the  Registration Statement or the Prospectus. The pro forma consolidated financial  statements of the Company and its subsidiaries and the related notes thereto  included or incorporated by reference in the Prospectus and in the Registration  Statement present fairly the information contained therein, have been prepared in  accordance with Article 11 of Regulation S-X with respect to pro forma financial  statements and have been properly presented on the bases described therein, and  the assumptions used in the preparation thereof are reasonable and the  adjustments used therein are appropriate to give effect to the transactions and  circumstances referred to therein.  All disclosures contained in the Prospectus and  the Registration Statement regarding “non-GAAP financial measures” (as such  term is defined by the rules and regulations of the Commission) comply with  Regulation G of the Exchange Act and Item 10 of Regulation S-K under the  Securities Act, to the extent applicable.  The interactive data in eXtensible  Business Reporting Language incorporated by reference in the Registration  Statement and the Prospectus fairly presents the required information called for in  all material respects and has been prepared in accordance with the Commission’s  rules and guidelines applicable thereto.  (j) [Reserved].  (k) Company’s Accounting System.  The Company and each of its subsidiaries  maintain a system of internal accounting controls sufficient to provide reasonable  assurance that (i) transactions are executed in accordance with management’s  general or specific authorization; (ii) transactions are recorded as necessary to  permit preparation of financial statements in conformity with GAAP and to  

 

  19  [[5258451]]  maintain accountability for assets; (iii) access to assets is permitted only in  accordance with management’s general or specific authorization; and (iv) the  recorded accountability for assets is compared with existing assets at reasonable  intervals and appropriate action is taken with respect to any differences.  Except  as otherwise disclosed in the Prospectus, there have not been and are no  significant deficiencies or material weaknesses in the Company’s internal control  over financial reporting (whether or not remediated), and except as otherwise  disclosed in the Prospectus, since the date of the Company’s most recent Annual  Report on Form 10-K or Quarterly Report on Form 10-Q (as applicable), there has  been no change in the Company’s internal control over financial reporting that has  materially affected, or is reasonably likely to materially affect, the Company’s  internal control over financial reporting.  (l) Incorporation and Good Standing of the Company and Its Subsidiaries.  Each of  the Company and its Significant Subsidiaries (as defined in Rule 1-02(w) of  Regulation S-X) has been duly incorporated or organized, as the case may be, and  is validly existing as a corporation, partnership, limited liability company or trust,  as applicable, in good standing under the laws of the jurisdiction of its  incorporation or organization and has the power and authority (corporate or other)  to own, lease and operate its properties and to conduct its business as described in  the Prospectus and, in the case of the Company, to enter into and perform its  obligations under this Agreement or any Confirmation or Terms Agreement.   Each of the Company and each Significant Subsidiary is duly qualified as a  foreign corporation, partnership, limited liability company or trust, as applicable,  to transact business and is in good standing in each jurisdiction in which such  qualification is required, whether by reason of the ownership or leasing of  property or the conduct of business, except where the failure to be so qualified  and in good standing would not, individually or in the aggregate, result in a  Material Adverse Change.  All of the issued and outstanding capital stock or other  equity or ownership interests of each Significant Subsidiary have been duly  authorized and validly issued, are fully paid and nonassessable and, except as set  forth in the Prospectus, are owned by the Company, directly or through  subsidiaries, free and clear of any security interest, mortgage, pledge, lien,  encumbrance or adverse claim.  Except as otherwise disclosed in the Prospectus,  the Company does not own or control, directly or indirectly, any corporation,  association or other entity other than (i) the subsidiaries listed in Exhibit 21.1 to  the Company’s most recent Annual Report on Form 10-K and (ii) such other  entities omitted from Exhibit 21.1 which, when such omitted entities are  considered in the aggregate as a single subsidiary, would not constitute a  “significant subsidiary” within the meaning of Rule 1-02(w) of Regulation S-X.  (m) Capitalization and Other Capital Stock Matters.  The authorized, issued and  outstanding capital stock of the Company is as set forth in the Prospectus (other  than for subsequent issuances, if any, described in the Prospectus or pursuant to  employee benefit plans described in the Prospectus or upon the exercise of  outstanding options described in the Prospectus, and other than Shares sold  pursuant to this Agreement or any Terms Agreement or Confirmation Shares  

 

  20  [[5258451]]  delivered in settlement of any Confirmation, in each case prior to the filing of the  Company’s next Annual Report on Form 10-K or Quarterly Report on Form 10- Q).  The Shares and Confirmation Shares conform in all material respects to the  description thereof contained in the Prospectus.  All of the issued and outstanding  Shares and Confirmation Shares have been or will be duly authorized and, if and  when issued and delivered by the Company pursuant to the applicable  Confirmation against payment of the applicable consideration specified therein,  validly issued and are or will be fully paid and nonassessable.  None of the  outstanding Shares or Confirmation Shares was, is, or will be issued in violation  of any preemptive rights, rights of first refusal or other similar rights to subscribe  for or purchase securities of the Company.  (n) Stock Exchange Listing.  The Shares and Confirmation Shares are registered  pursuant to Section 12(b) or 12(g) of the Exchange Act and are listed on the  Exchange, and the Company has taken no action designed to, or likely to have the  effect of, terminating the registration of the Shares or Confirmation Shares under  the Exchange Act or delisting the Shares or Confirmation Shares from the  Exchange, nor has the Company received any notification that the Commission or  the Exchange is contemplating terminating such registration or listing.  (o) Non-Contravention of Laws and Existing Instruments; No Further Authorizations  or Approvals Required.  Neither the Company nor any of its Significant  Subsidiaries is (i) in breach or violation of (A) its charter or bylaws, partnership  agreement or operating agreement or similar organizational document, as  applicable, (B) any applicable federal, state, local or foreign law, regulation or  rule or (C) any applicable rule or regulation of any self-regulatory organization or  other non-governmental regulatory authority (including, without limitation, the  rules and regulations of the Exchange), except in the case of the preceding clauses  (B) and (C), for such breaches or violations as would not, individually or in the  aggregate, result in a Material Adverse Change or (ii) in default (or, with the  giving of notice or lapse of time, would be in default) (a “Default”) under any  indenture, mortgage, loan or credit agreement, note, contract, franchise, lease or  other instrument to which the Company or any of its subsidiaries is a party or by  which it or any of them may be bound (including, without limitation, any credit  agreement, indenture, pledge agreement, security agreement or other instrument  or agreement evidencing, guaranteeing, securing or relating to indebtedness of the  Company or any of its subsidiaries), or to which any of the property or assets of  the Company or any of its subsidiaries is subject (each, an “Existing Instrument”),  except in the case of such Defaults as would not, individually or in the aggregate,  result in a Material Adverse Change.  The Company’s execution, delivery and  performance of this Agreement and any Confirmation or Terms Agreement,  consummation of the transactions contemplated hereby and thereby and by the  Prospectus and the issuance and sale of the Shares and Confirmation Shares (i)  have been duly authorized by all necessary action (corporate or other) and will not  result in any violation of the provisions of the charter or bylaws, partnership  agreement or operating agreement or similar organizational document of the  Company or any subsidiary, as applicable, (ii) will not conflict with or constitute  

 

  21  [[5258451]]  a breach of, or a Default or a Debt Repayment Triggering Event (as defined  below) under, or result in the creation or imposition of any lien, charge or  encumbrance upon any property or assets of the Company or any of its  subsidiaries pursuant to, or require the consent of any other party to, any Existing  Instrument and (iii) will not result in any violation of any federal, state, local or  foreign law, regulation or rule, administrative or court decree or any rule or  regulation of any self-regulatory organization or other non-governmental  regulatory authority (including, without limitation, the rules and regulations of the  Exchange) applicable to the Company or any subsidiary, except in the case of the  preceding clauses (ii) and (iii), for those conflicts, breaches, Defaults, Debt  Repayment Triggering Events or violations that would not, individually or in the  aggregate, result in a Material Adverse Change.  No consent, approval,  authorization or other order of, or registration or filing with, any court or other  governmental or regulatory authority or agency, is required for the Company’s  execution, delivery and performance of this Agreement or any Confirmation or  Terms Agreement and consummation of the transactions contemplated hereby or  thereby and by the Prospectus, except such as have been obtained or made by the  Company and are in full force and effect under the Securities Act, or applicable  state securities and blue sky laws.  As used herein, a “Debt Repayment Triggering  Event” means any event or condition which gives, or with the giving of notice or  lapse of time would give, the holder of any note, debenture or other evidence of  indebtedness (or any person acting on such holder’s behalf) the right to require  the repurchase, redemption or repayment of all or a portion of such indebtedness  by the Company or any of its subsidiaries.  (p) No Material Actions or Proceedings.  There are no legal or governmental actions,  suits or proceedings pending or, to the Company’s knowledge, threatened  (i) against or affecting the Company or any of its subsidiaries, (ii) which have as  the subject thereof any officer or director of, or property owned or leased by, the  Company or any of its subsidiaries or (iii) relating to environmental or  discrimination matters, where in any such case (A) there is a reasonable  possibility that such action, suit or proceeding might be determined adversely to  the Company, such subsidiary or such officer or director and, if so determined  adversely, would reasonably be expected to result in a Material Adverse Change  or adversely affect the consummation of the transactions contemplated by this  Agreement or any Confirmation or Terms Agreement or (B) any such action, suit  or proceeding is or would be material in the context of the sale of Shares or the  issuance of Confirmation Shares.  No material labor dispute with the employees  of the Company or any of its subsidiaries exists or, to the Company’s knowledge,  is threatened or imminent, except where such dispute or disputes, individually or  in the aggregate, would not have a Material Adverse Change.  (q) Intellectual Property Rights.  The Company and its subsidiaries own or possess  sufficient trademarks, trade names, patent rights, copyrights, domain names,  licenses, approvals, trade secrets and other similar rights (collectively,  “Intellectual Property Rights”) reasonably necessary to conduct their businesses  as now conducted, except where the failure to own or possess such rights would  

 

  22  [[5258451]]  not, individually or in the aggregate, reasonably be expected to result in a  Material Adverse Change.  Neither the Company nor any of its subsidiaries has  received any notice of infringement or conflict with asserted Intellectual Property  Rights of others, which infringement is material to the business of the Company  and its subsidiaries, except where such infringement would not reasonably be  expected to result in a Material Adverse Change.  (r) All Necessary Permits, etc.  The Company and each subsidiary possess such valid  and current certificates, authorizations, licenses or permits issued by the  appropriate state, local, federal or foreign regulatory agencies or bodies necessary  to conduct their respective businesses, except as would not, individually or in the  aggregate, reasonably be expected to result in a Material Adverse Change, and  neither the Company nor any subsidiary has received any notice of proceedings  relating to the revocation or modification of, or non-compliance with, any such  certificate, authorization, license or permit which, singly or in the aggregate, if the  subject of an unfavorable decision, ruling or finding, would reasonably be  expected to result in a Material Adverse Change.  (s) Title to Properties.  Except as disclosed in the Prospectus, each of the Company  and its subsidiaries has good and marketable title to all of the real and personal  property and other assets reflected as owned in the financial statements referred to  in Section 6(i) above (or elsewhere in the Prospectus), in each case free and clear  of any security interests, mortgages, liens, encumbrances, equities, adverse claims  and other defects, except such as would not reasonably be expected to result in a  Material Adverse Change.  Except as disclosed in the Prospectus, none of the real  property so owned by the Company or any of its subsidiaries (the “Real  Property”) is subject to any options or rights of first refusal to purchase all or part  of such real property or any interest therein, except as would not reasonably be  expected to result in a Material Adverse Change.  The real property,  improvements, equipment and personal property held under lease by the  Company or any subsidiary are held under valid and enforceable leases, with such  exceptions as would not reasonably be expected to result in a Material Adverse  Change.  (t) No Violation of Laws Pertaining to Real Properties.  None of the Company or any  of its subsidiaries is in violation of any municipal, state or federal law, rule or  regulation (including those pertaining to environmental matters) concerning any  of the Real Property, except for such violations which would not, individually or  in the aggregate, reasonably be expected to result in a Material Adverse Change.   No written notice of any condemnation of or zoning change affecting the Real  Properties or any parts thereof has been received, or, to the knowledge of the  Company, threatened, that if consummated would, individually or in the  aggregate, reasonably be expected to result in a Material Adverse Change.  Each  of the Real Properties complies with all applicable zoning laws, ordinances,  regulations, development agreements, reciprocal easement agreements and deed  restrictions or other covenants in all material respects and, if and to the extent  

 

  23  [[5258451]]  there is a failure to comply, such failure would not reasonably be expected to  result in a Material Adverse Change.    (u) Tax Law Compliance.  The Company and its subsidiaries have filed all necessary  federal, state, local and foreign income and franchise tax returns and have paid all  taxes required to be paid by any of them and, if due and payable, any related or  similar assessment, fine or penalty levied against any of them, except in any case  in which the failure to file or pay would not, individually or in the aggregate,  reasonably be expected to result in a Material Adverse Change.  The Company  and its subsidiaries have made adequate charges, accruals and reserves in the  applicable financial statements referred to in Section 6(i) above in respect of all  federal, state, local and foreign income and franchise taxes for all periods as to  which the tax liability of the Company or any of its subsidiaries has not been  finally determined.  No subsidiary of the Company that is a limited partnership or  limited liability company has made an election under Section 7701 of the Internal  Revenue Code of 1986, as amended (the “Code”), to change its default  classification for federal income tax purposes, except for any taxable REIT  subsidiary (TRS) of the Company formed in the ordinary course of business of the  Company that has been organized as a limited partnership or limited liability  company.  (v) Investment Company Act.  The Company is not, and will not be, after receipt of  payment for the Shares, after the settlement of any Confirmation or after the  application of the proceeds from either as described under “Use of Proceeds” in  the Prospectus, an “investment company” within the meaning of the Investment  Company Act of 1940, as amended.  (w) Insurance.  Each of the Company and its subsidiaries is insured with policies in  such amounts and with such deductibles and covering such risks as it reasonably  deems adequate for its business, and the Real Property is appropriately insured by  institutions the Company reasonably believes to be financially sound.   (x) No Price Stabilization or Manipulation; Compliance with Regulation M.  The  Common Stock is an “actively traded security” excepted from the requirements of  Rule 101 of Regulation M under the Exchange Act by subsection (c)(1) of such  rule.  Neither the Company nor any of its subsidiaries nor any of their respective  directors, officers, affiliates or controlling persons has taken, directly or  indirectly, any action designed to or that might be reasonably expected to cause or  result in stabilization or manipulation of the price of the Shares or any other  “reference security” (as defined in Rule 100 of Regulation M under the Exchange  Act (“Regulation M”)) whether to facilitate the sale or resale of the Shares or  otherwise, and has taken no action which would directly or indirectly violate  Regulation M.  The Company acknowledges that the Agents and the Forward  Purchasers may engage in passive market making transactions in the Shares on  the Exchange in accordance with Regulation M.  The Company acknowledges  and agrees that each Agent and each Forward Purchaser has informed the  Company that it may, to the extent permitted under the Exchange Act, purchase  

 

  24  [[5258451]]  and sell shares of Common Stock for its own account and for the account of its  clients while this Agreement or any Confirmation or Terms Agreement is in  effect.  (y) [Reserved].  (z) Statistical and Market-Related Data.  As of the effective date of the Registration  Statement, the statistical, demographic and market-related data included in the  Registration Statement and the Prospectus are (i) based on or derived from  sources that the Company has no reason to believe are unreliable or inaccurate or  (ii) represent the Company’s good faith estimates that are made on the basis of  data derived from such sources.  (aa) No Unlawful Contributions or Other Payments.  Neither the Company nor any of  its subsidiaries nor any director, officer or employee acting on behalf of the  Company or any of its subsidiaries, nor, to the Company’s knowledge, any agent,  affiliate or other person associated with or acting on behalf of the Company or  any of its subsidiaries (i) has made any contribution or other payment to any  official of, or candidate for, any federal, state or foreign office in violation of any  law or of the character required to be disclosed in the Registration Statement and  the Prospectus; (ii) used any corporate funds for any unlawful contribution, gift,  entertainment or other unlawful expense relating to political activity; (iii) made or  taken an act in furtherance of an offer, promise or authorization of any direct or  indirect unlawful payment or benefit to any foreign or domestic government  official or employee, including of any government-owned or controlled entity or  of a public international organization, or any person acting in an official capacity  for or on behalf of any of the foregoing, or any political party or party official or  candidate for political office; (iv) is aware of or has taken any action, directly or  indirectly, that has resulted or would result in a violation of any provision of the  Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations  thereunder (the “FCPA”), including, without limitation, making use of the mails  or any means or instrumentality of interstate commerce corruptly in furtherance of  an offer, payment, promise to pay or authorization of the payment of any money,  or other property, gift, promise to give, or authorization of the giving of anything  of value to any “foreign official” (as such term is defined in the FCPA) or any  foreign political party or official thereof or any candidate for foreign political  office, in contravention of the FCPA, or any applicable law or regulation  implementing the OECD Convention on Combating Bribery of Foreign Public  Officials in International Business Transactions, or committed an offence under  the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery  or anti-corruption law; or (v) made, offered, agreed, requested or taken an act in  furtherance of any unlawful bribe or other unlawful benefit, including, without  limitation, any rebate, payoff, influence payment, kickback or other unlawful or  improper payment or benefit.  The Company and its subsidiaries have instituted,  maintain and enforce, and will continue to maintain and enforce, policies and  procedures designed to promote and ensure compliance with all applicable anti- bribery and anti-corruption laws.  The Company and its subsidiaries and, to the  

 

  25  [[5258451]]  knowledge of the Company, the Company’s affiliates have conducted their  respective businesses in compliance with the FCPA and all applicable anti-bribery  and anti-corruption laws.  (bb) Disclosure Controls and Procedures; Deficiencies in or Changes to Internal  Control over Financial Reporting and Compliance with Sarbanes-Oxley.  The  Company, its subsidiaries and the Company’s directors or officers, in their  capacities as such, are in compliance, in all material respects, with all applicable  provisions of the Sarbanes-Oxley Act of 2002, as amended, and the rules and  regulations promulgated in connection therewith, including Section 402 related to  loans and Sections 302 and 906 related to certifications.  The Company has  established and maintains disclosure controls and procedures (as defined in  Exchange Act Rules 13a-15(e) and 15d-15(e)), which (i) are designed to ensure  that material information relating to the Company, including its consolidated  subsidiaries, is made known to the Company’s principal executive officer and its  principal financial officer by others within those entities, particularly during the  periods in which the periodic reports required under the Exchange Act are being  prepared; (ii) have been evaluated by management of the Company for  effectiveness as of the end of the Company’s most recent fiscal quarter; and  (iii) are effective in all material respects to perform the functions for which they  were established.  Except as otherwise disclosed in the Prospectus, the Company  is not aware of any fraud, whether or not material, that involves management or  other employees who have a significant role in the Company’s internal control  over financial reporting.  Except as otherwise disclosed in the Prospectus, the  Company is not aware of any change in its internal control over financial  reporting that has occurred during its most recent fiscal quarter that has materially  affected, or is reasonably likely to materially affect, the Company’s internal  control over financial reporting.  (cc) Compliance with Environmental Laws.  Except as would not, singly or in the  aggregate, reasonably be expected to result in a Material Adverse Change,  (i) neither the Company nor any of its subsidiaries is in violation of any federal,  state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule  of common law or any judicial or administrative interpretation thereof, including  any judicial or administrative order, consent, decree or judgment, relating to  pollution or protection of human health, the environment (including, without  limitation, ambient air, surface water, groundwater, land surface or subsurface  strata) or wildlife, including, without limitation, laws and regulations relating to  the release or threatened release of chemicals, pollutants, contaminants, wastes,  toxic substances, hazardous substances, petroleum or petroleum products  (collectively, “Hazardous Materials”) or to the manufacture, processing,  distribution, use, treatment, storage, disposal, transport or handling of Hazardous  Materials (collectively, “Environmental Laws”), (ii) the Company and its  subsidiaries have all permits, authorizations and approvals required under any  applicable Environmental Laws and are each in compliance with their  requirements and (iii) there are no pending or, to the Company’s knowledge,  threatened administrative, regulatory or judicial actions, suits, demands, demand  

 

  26  [[5258451]]  letters, claims, liens, notices of noncompliance or violation, investigations or  proceedings relating to any Environmental Law against the Company or any of its  subsidiaries.  (dd) ERISA Compliance.  Except as otherwise disclosed in the Prospectus, the  Company and its subsidiaries and any “employee benefit plan” (as defined under  the Employee Retirement Income Security Act of 1974, as amended, and the  regulations and published interpretations thereunder (collectively, “ERISA”))  established or maintained by the Company, its subsidiaries or their ERISA  Affiliates (as defined below) are in compliance with ERISA, except as would not,  individually or in the aggregate, reasonably be expected to result in a Material  Adverse Change.  None of the Company, its subsidiaries or any of their ERISA  Affiliates has incurred or reasonably expects to incur any material liability under  (i) Title IV of ERISA with respect to termination of, or withdrawal from, any  “employee pension benefit plan” (as defined under ERISA) or (ii) Sections 412,  4971 or 4975 of the Code.  As used herein, “ERISA Affiliate” means, with  respect to the Company or a subsidiary, any member of any group of  organizations described in Sections 414(b), (c), (m) or (o) of the Code of which  the Company or such subsidiary is a member.  (ee) Brokers.  Except as otherwise disclosed in the Prospectus or pursuant to this  Agreement or any Confirmation or Terms Agreement, there is and will be no  broker, finder or other party that is entitled to receive from the Company or any of  its subsidiaries any brokerage or finder’s fee or other fee or commission as a  result of any transactions contemplated by this Agreement or any Confirmation or  Terms Agreement.  (ff) Dividend Restrictions.  Except as otherwise disclosed in the Prospectus and  except for limitations imposed with respect to the frequency (but not the amount)  of dividends that may be paid by those subsidiaries of the Company with  outstanding indebtedness owed to the U.S. Department of Housing and Urban  Development (as of the date of this Agreement or any Confirmation or Terms  Agreement), no subsidiary of the Company is prohibited or restricted, directly or  indirectly, from paying dividends to the Company or any other subsidiary of the  Company, or from making any other distribution with respect to such subsidiary’s  equity securities or from repaying to the Company or any other subsidiary of the  Company any amounts that may from time to time become due under any loans or  advances to such subsidiary from the Company or any other subsidiary of the  Company or from transferring any property or assets to the Company or to any  other subsidiary of the Company.  (gg) [Reserved].  (hh) Money Laundering Laws.  The operations of the Company and its subsidiaries  are, and have been conducted at all times, in compliance in all material respects  with applicable financial recordkeeping and reporting requirements of the  Currency and Foreign Transactions Reporting Act of 1970, as amended, the  

 

  27  [[5258451]]  money laundering statutes of all applicable jurisdictions, the rules and regulations  thereunder and any related or similar applicable rules, regulations or guidelines,  issued, administered or enforced by any governmental agency (collectively, the  “Money Laundering Laws”) and no action, suit or proceeding by or before any  court or governmental agency, authority or body or any arbitrator involving the  Company or any of its subsidiaries with respect to the Money Laundering Laws is  pending or, to the knowledge of the Company, threatened.  (ii) REIT Status.  Commencing with the Company’s taxable year beginning January  1, 2011, the Company has been organized and has operated in conformity with the  requirements for qualification and taxation as a “real estate investment trust” (a  “REIT”) under Sections 856 through 860 of the Code; and the current and  proposed method of operation for the Company and its subsidiaries as described  in the Prospectus will enable the Company to continue to meet the requirements  for qualification and taxation as a REIT under the Code.  (jj) No Conflicts with Sanctions Laws.  Neither the Company nor any of its  subsidiaries nor any director, officer or employee acting on behalf of the  Company or any of its subsidiaries, nor, to the knowledge of the Company, any  agent, affiliate or other person associated with or acting on behalf of the Company  or any of its subsidiaries is currently the subject or the target of any sanctions  administered or enforced by the U.S. government (including, without limitation,  the Office of Foreign Assets Control of the U.S. Department of the Treasury  (“OFAC”) or the U.S. Department of State and including, without limitation, the  designation as a “specially designated national” or “blocked person”), the United  Nations Security Council (“UNSC”), the European Union, Her Majesty’s  Treasury (“HMT”) or other relevant sanctions authority (collectively,  “Sanctions”), nor is the Company, or any of its subsidiaries located, organized or  resident in a country or territory that is the subject or target of Sanctions,  including, without limitation, Crimea, Cuba, Iran, North Korea and Syria (each, a  “Sanctioned Country”); and the Company will not directly or indirectly use the  proceeds from the offering of Shares hereunder or under any Terms Agreement or  proceeds from the settlement of any Confirmation Shares under any applicable  Confirmation, or lend, contribute or otherwise make available such proceeds to  any subsidiary, joint venture partner or other person or entity (i) to fund or  facilitate any activities of or business with any person in any country or territory  that, at the time of such funding or facilitation, is the subject or target of  Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned  Country or (iii) in any other manner that will result in a violation by any person  (including any person participating in the transaction, whether as agent,  underwriter, advisor, investor or otherwise) of Sanctions.  For the past five years,  the Company and its subsidiaries have not knowingly engaged in and are not now  knowingly engaged in any dealings or transactions (i) with any person that at the  time of the dealing or transaction is or was the subject or the target of Sanctions or  (ii) with any Sanctioned Country.  

 

  28  [[5258451]]  (kk) Regulations T, U, X.  Neither the Company nor any of its subsidiaries nor any  agent thereof acting on their behalf has taken, and none of them will take, any  action that would reasonably be expected to cause this Agreement, any Terms  Agreement or the issuance or sale of the Shares to violate Regulation T,  Regulation U or Regulation X of the Board of Governors of the Federal Reserve  System.  (ll) Accurate Disclosure.  The statements set forth in the Prospectus under the  captions “Description of Capital Stock” and “Material U.S. Federal Income Tax  Considerations”, insofar as such statements summarize legal matters, agreements,  documents or proceedings discussed therein, are accurate summaries of such legal  matters, agreements, documents or proceedings in all material respects.  (mm) AIFMD.  Neither the Company nor any of its subsidiaries is an alternative  investment fund nor an alternative investment fund manager as each term is  understood for purposes of the European Union’s Alternative Investment Fund  Managers Directive (No. 2011/61/EU) (the “AIFMD”) and any subordinate  legislation enacted thereunder, as each has been amended, extended or re-enacted  from time to time, including the applicable implementing legislation and  regulations of each member state of the European Economic Area.  (nn) Cybersecurity; Data Protection.  The Company and its subsidiaries’ information  technology assets and equipment, computers, systems, networks, hardware,  software, websites, applications, and databases (collectively, “IT Systems”) are  adequate for, and operate and perform in all material respects as required in  connection with the operation of the business of the Company and its subsidiaries  as currently conducted, free and clear of all material bugs, errors, defects, Trojan  horses, time bombs, malware and other corruptants.  The Company and its  subsidiaries have implemented and maintained commercially reasonable controls,  policies, procedures, and safeguards to maintain and protect their material  confidential information and the integrity, continuous operation, redundancy and  security of all IT Systems and data (including all personal, personally identifiable,  sensitive, confidential or regulated data (“Personal Data”)) used in connection  with their businesses, and there have been no known breaches, violations, outages  or unauthorized uses of or accesses to same, except as would not, individually or  in the aggregate, result in a Material Adverse Change, nor any incidents under  internal review or investigations relating to the same. The Company and its  subsidiaries are presently in material compliance with all applicable laws or  statutes and all judgments, orders, rules and regulations of any court or arbitrator  or governmental or regulatory authority, internal policies and contractual  obligations relating to the privacy and security of IT Systems and Personal Data  and to the protection of such IT Systems and Personal Data from unauthorized  use, access, misappropriation or modification.  (oo) Confirmations. Each Confirmation will have been, as of its date, duly authorized,  executed and delivered by the Company and when executed and delivered by the  Placement Forward Purchaser, such Confirmation will constitute a valid and  

 

  29  [[5258451]]  binding obligation of the Company, enforceable against the Company in  accordance with its terms, except as enforcement thereof may be limited by  bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium or  other similar laws relating to or affecting creditors’ rights generally or by general  equity principles (regardless of whether enforcement is considered in a  proceeding in equity or at law). The description of the form of Confirmation set  forth in the General Disclosure Package, Prospectus and any Issuer Free Writing  Prospectus is correct in all material respects.  Any certificate signed by any officer of the Company or any of its subsidiaries and delivered to  the Agents, the Forward Purchasers or counsel for the Agents and Forward Purchasers shall be  deemed a representation and warranty by the Company to the Agents and the Forward  Purchasers, as applicable, as to the matters covered thereby.  The Company acknowledges that the Agents, Forward Purchasers and, for purposes of the  opinions to be delivered pursuant to Section 7 hereof, counsel to the Company and counsel to the  Agents and Forward Purchasers, will rely upon the accuracy and truthfulness of the foregoing  representations and hereby consents to such reliance.  7. Additional Covenants of the Company.  The Company further covenants and agrees with  each Agent and Forward Purchaser that:  (a) Registration Statement Amendments; Securities Act Compliance.  After the date  of this Agreement and during any period in which a Prospectus relating to any  Shares is required to be delivered by the Agents and Forward Purchasers under  the Securities Act (including in circumstances where such requirement may be  satisfied pursuant to Rules 153 and 172 under the Securities Act), the Company  shall (i) promptly advise the Agents and Forward Purchasers in writing of the  receipt of any comments of, or requests for additional or supplemental  information from, the Commission that are reasonably related to the transactions  contemplated by this Agreement; (ii) promptly advise the Agents and Forward  Purchasers, as applicable, in writing of the time and date of any filing of any post- effective amendment to the Registration Statement or any amendment or  supplement to any free writing prospectus or the Prospectus; (iii) promptly advise  the Agents and Forward Purchasers in writing of the time and date that any post- effective amendment to the Registration Statement becomes effective; (iv)  promptly advise the Agents and Forward Purchasers in writing of the issuance by  the Commission of any stop order suspending the effectiveness of the Registration  Statement or any post-effective amendment thereto or any amendment or  supplement to the Prospectus or of any order preventing or suspending the use of  any free writing prospectus or the Prospectus, or of any proceedings to remove,  suspend or terminate from listing or quotation the Shares from any securities  exchange upon which they are listed for trading or included or designated for  quotation, or of the threatening or initiation of any proceedings for any of such  purposes or pursuant to Section 8A of the Securities Act; (v) prepare and file with  the Commission, promptly upon an Agent’s or Forward Purchaser’s request, any  amendments or supplements to the Registration Statement or Prospectus that, in  

 

  30  [[5258451]]  such Agent’s or Forward Purchaser’s reasonable opinion, may be necessary or  advisable in connection with the distribution of the Shares by the Agents  (provided, however, that the failure of such Agent or Forward Purchaser to make  such request shall not relieve the Company of any obligation or liability  hereunder, or affect such Agent’s or Forward Purchaser’s right to rely on the  representations and warranties made by the Company in this Agreement); and  (vi) furnish to each Agent and each Forward Purchaser at the time of filing thereof  a copy of any document that upon filing is deemed to be incorporated by  reference into the Registration Statement or Prospectus, except in the case of  clauses (ii), (iii) and (vi) for those documents available via EDGAR.  If the  Commission shall enter any such stop order described in clause (iv) at any time,  the Company will use its reasonable efforts to obtain the lifting of such order at  the earliest possible moment.  Additionally, the Company agrees that it shall  comply with the provisions of Rule 424(b), Rule 433, Rule 430B and Rule 430C,  as applicable, under the Securities Act and will use its reasonable efforts to  confirm that any filings made by the Company under such Rule 424(b) or Rule  433 are made in a timely manner.  (b) Delivery of Registration Statement and Prospectus.  The Company shall furnish to  each Agent and each Forward Purchaser and its counsel, without charge, as many  copies as each Agent or Forward Purchaser may reasonably request of the  Registration Statement (including exhibits thereto), the Prospectus (including all  documents incorporated by reference therein) and all amendments and  supplements to the Registration Statement or Prospectus that are filed with the  Commission during any period in which a Prospectus relating to the Shares is  required to be delivered under the Securities Act (including all documents filed  with the Commission during such period that are deemed to be incorporated by  reference therein), in each case as soon as reasonably practicable, and, at an  Agent’s or Forward Purchaser’s request, will also furnish copies of the Prospectus  to each exchange or market on which sales of the Shares may be made; provided,  however, that the Company shall not be required to furnish any document (other  than the Prospectus) to an Agent or Forward Purchaser to the extent such  document is available to such Agent, Forward Purchaser or the public on  EDGAR.  (c) Agents’ and Forward Purchasers’ Review of Proposed Amendments and  Supplements.  Prior to amending or supplementing the Registration Statement or  the Prospectus in connection with the transactions contemplated by this  Agreement, the Company shall furnish to the Agents and Forward Purchasers for  review, a reasonable amount of time prior to the proposed time of filing or use  thereof, a copy of each such proposed amendment or supplement, and the  Company shall not file or use any such proposed amendment or supplement  without the Agents’ and Forward Purchasers’ consent (not to be unreasonably  withheld or delayed), and shall file with the Commission within the applicable  period specified in Rule 424(b) under the Securities Act any prospectus required  to be filed pursuant to such Rule with respect to the transactions contemplated by  this Agreement.  

 

  31  [[5258451]]  (d) Free Writing Prospectuses.  The Company shall furnish to the Agents and  Forward Purchasers for review, a reasonable amount of time prior to the proposed  time of filing or use thereof, a copy of each proposed issuer free writing  prospectus or any amendment or supplement thereto to be prepared by or on  behalf of, used by, or referred to by the Company and the Company shall not file,  use or refer to any issuer proposed free writing prospectus or any amendment or  supplement thereto without the Agents’ and Forward Purchasers’ consent (not to  be unreasonably withheld or delayed).  The Company shall furnish to the Agents  and Forward Purchasers, without charge, as many copies of any free writing  prospectus prepared by or on behalf of, or used by, the Company, as the Agents  and Forward Purchasers may reasonably request.  If at any time when a  prospectus is required by the Securities Act (including, without limitation,  pursuant to Rule 173(d)) to be delivered in connection with sales of the Shares,  there occurred or occurs an event or development as a result of which any free  writing prospectus prepared by or on behalf of, used by, or referred to by the  Company conflicted or would conflict with the information contained in the  Registration Statement or, when taken together with the Registration Statement,  included or would include an untrue statement of a material fact or omitted or  would omit to state a material fact necessary in order to make the statements  therein, in the light of the circumstances prevailing at that time, not misleading,  the Company shall promptly amend or supplement such free writing prospectus to  eliminate or correct such conflict or so that the statements in such free writing  prospectus as so amended or supplemented will not include an untrue statement of  a material fact or omit to state a material fact necessary in order to make the  statements therein, in the light of the circumstances prevailing at such time, not  misleading, as the case may be; provided, however, that prior to amending or  supplementing any such free writing prospectus, the Company shall furnish to the  Agents and Forward Purchasers for review, a reasonable amount of time prior to  the proposed time of filing or use thereof, a copy of such proposed amended or  supplemented free writing prospectus and the Company shall not file, use or refer  to any such amended or supplemented free writing prospectus without the Agents’  and Forward Purchasers’ consent (not to be unreasonably withheld or delayed).  (e) Delivery of Prospectus; Subsequent Changes.  During any period in which a  Prospectus relating to the Shares is required to be delivered by an Agent or  Forward Purchaser under the Securities Act with respect to a pending sale of the  Shares (including in circumstances where such requirement may be satisfied  pursuant to Rules 153 or 172 under the Securities Act), the Company will comply  in all material respects with the requirements imposed upon it by the Securities  Act, as from time to time in force, and shall file on or before their respective due  dates all reports and any definitive proxy or information statements required to be  filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14,  15(d) or any other provision of or under the Exchange Act.  If during such period  any event shall occur or condition exist as a result of which it is necessary to  amend or supplement the Prospectus so that the Prospectus does not include an  untrue statement of a material fact or omit to state a material fact necessary in  order to make the statements therein, in the light of the circumstances then  

 

  32  [[5258451]]  existing, not misleading, or if in the opinion of the Company or such Agent,  Forward Purchaser or counsel for such Agent or Forward Purchaser it is otherwise  necessary to amend or supplement the Prospectus to comply with applicable law,  including the Securities Act, the Company will promptly notify such Agent or  Forward Purchaser to suspend the offering of Shares during such period and the  Company agrees (subject to Sections 7(c) and 7(d)) to promptly prepare, file with  the Commission and furnish at its own expense to the Agents and Forward  Purchasers, amendments or supplements to the Prospectus so that the statements  in the Prospectus as so amended or supplemented will not include an untrue  statement of a material fact or omit to state a material fact necessary in order to  make the statements therein, in the light of the circumstances then existing, not  misleading or so that the Prospectus, as amended or supplemented, will comply  with applicable law, including the Securities Act.  Neither the Agents’ nor  Forward Purchasers’ consent to, nor delivery of, any such amendment or  supplement shall constitute a waiver of any of the Company’s obligations under  Sections 7(c) or (d).  (f) Listing of Placement Shares.  During any period in which the Prospectus relating  to the Shares is required to be delivered by any Agent or Forward Purchaser under  the Securities Act with respect to a pending sale of the Shares (including in  circumstances where such requirement may be satisfied pursuant to Rules 153 or  172 under the Securities Act) and until all obligations under any Confirmation  have been discharged, the Company will use its reasonable efforts to effect and  maintain the listing of the Shares on the Exchange.  (g) Earnings Statement.  The Company shall make generally available to its security  holders, as soon as practicable, but in any event no later than fifteen months after  the effective date of the Registration Statement (as such date is defined in  Rule 158(c) under the Securities Act), an earnings statement of the Company and  its subsidiaries (which need not be audited) complying with Section 11(a) of the  Securities Act and the rules and regulations of the Commission thereunder.  (h) Expenses.  The Company will pay or cause to be paid all costs, fees and expenses  incurred in connection with the performance of its obligations hereunder and in  connection with the transactions contemplated hereby, whether or not the  transactions contemplated hereby are consummated, including without limitation  (i) all expenses incident to the issuance and delivery of the Shares and  Confirmation Shares (including all printing and engraving costs); (ii) all fees and  expenses of the registrar and transfer agent of the Shares and Confirmation  Shares; (iii) all necessary issue, transfer and other stamp taxes or governmental  duties in connection with the issuance and sale of the Shares and Confirmation  Shares to the Agents or Forward Purchasers, as applicable; (iv) all fees and  expenses of the Company’s counsel, independent public or certified public  accountants and other advisors; (v) all costs and expenses incurred in connection  with the preparation, printing, filing, shipping and distribution of the Registration  Statement (including financial statements, exhibits, schedules, consents and  certificates of experts), the Prospectus, any free writing prospectuses prepared by  

 

  33  [[5258451]]  or on behalf of, used by, or referred to by the Company, and all amendments and  supplements thereto, this Agreement, any Confirmation and any Terms  Agreement; (vi) all filing fees, attorneys’ fees and expenses incurred by the  Company, the Forward Purchasers or the Agents in connection with qualifying or  registering (or obtaining exemptions from the qualification or registration of) all  or any part of the Shares for offer and sale under the securities laws of the United  States, state securities or “blue sky” laws, the provincial securities laws of Canada  or other jurisdictions designated by the Agents or Forward Purchasers, and, if  requested by any Agent or Forward Purchaser, preparing and printing a “Blue Sky  Survey” or memorandum and a “Canadian wrapper”, and any supplements  thereto, advising such Agent or Forward Purchaser of such qualifications,  registrations and exemptions; (vii) the filing fees incident to, and the reasonable  fees and expenses of counsel for the Agents and Forward Purchasers in  connection with, review by the Financial Industry Regulatory Authority, Inc.  (“FINRA”), if any, and approval of any Agent’s or Forward Purchaser’s  participation in the offering and distribution of the Shares; (viii) the fees and  expenses associated with including the Shares on the Exchange; (ix) all other fees,  costs and expenses of the nature referred to in Item 14 of Part II of the  Registration Statement; and (x) all reasonable fees, disbursements and expenses  of Cravath, Swaine & Moore LLP, counsel to the Agents and Forward Purchasers,  in connection with the transactions contemplated by this Agreement (including,  for the avoidance of doubt, the expenses in connection with the deliverables and  associated due diligence at each Representation Date), any Confirmation or Terms  Agreement and as agreed upon from time to time by the Company, the Agents  and Forward Purchasers (such expenses in clause (x) above, the “Agent and  Forward Purchaser Legal Expenses”).  The Agent and Forward Purchaser Legal  Expenses shall be due and payable by the Company reasonably promptly upon  written request.  Except as provided in this Section 7(h), Section 10 and Section  11 hereof, or as otherwise agreed by the parties hereto, each Agent and each  Forward Purchaser shall pay its own expenses, including the fees and  disbursements of its counsel.  (i) Use of Proceeds.  The Company will apply the Net Proceeds from the sale of the  Shares to be sold by it hereunder in the manner described under the caption “Use  of Proceeds” in the Prospectus.  (j) Notice of Other Sales.  During the pendency of any Placement Notice given  hereunder or any Confirmation or Terms Agreement, the Company shall provide  the applicable Agents or Forward Purchasers notice as promptly as reasonably  practicable before it offers to sell, contracts to sell, sells, pledges, grants any  option to sell or otherwise disposes of any shares of Common Stock (other than  Placement Shares offered pursuant to the provisions of this Agreement or Shares  offered pursuant to any Confirmation or Terms Agreement) or securities  convertible into or exchangeable for Common Stock, warrants or any rights to  purchase or acquire Common Stock; provided that such notice shall not be  required in connection with (i) the issuance, grant or sale of Common Stock,  restricted stock units, options to purchase Common Stock or Common Stock  

 

  34  [[5258451]]  issuable upon the vesting or exercise of options or other equity awards pursuant to  any stock option, stock bonus or other stock or compensatory plan or arrangement  described in the Prospectus, (ii) the issuance of securities in connection with an  acquisition, merger or sale, joint venture, or purchase of assets described in the  Prospectus, (iii) the issuance or sale of Common Stock pursuant to any dividend  reinvestment plan that the Company may adopt from time to time provided the  implementation of such is disclosed to the Agents and Forward Purchasers in  advance or (iv) the issuance of any Common Stock issuable upon the redemption  of outstanding partnership units in accordance with the limited partnership  agreement of Sabra Health Care Limited Partnership.  (k) Change of Circumstances.  The Company will, at any time during a fiscal quarter  in which the Company tenders a Notice or Placement Notice, sells Placement  Shares, enters into a Terms Agreement or sells Shares pursuant to a Terms  Agreement or enters into a Confirmation, advise the Agents or Forward  Purchasers, as applicable, as promptly as reasonably practicable prior to the  delivery of such Notice or Placement Notice or entering into of such Terms  Agreement or Confirmation, of any information or fact that would alter or affect  in any material respect any opinion, certificate, letter or other document provided  to the Agents and Forward Purchasers pursuant to this Agreement.  (l) Due Diligence Cooperation.  The Company will cooperate with any commercially  reasonable due diligence review conducted by the Agents and Forward  Purchasers, or their respective agents, in connection with the transactions  contemplated hereby, including, without limitation, providing information and  making available documents and senior officers, upon reasonable notice during  regular business hours and at the Company’s principal offices, as any of the  Agents or Forward Purchasers may reasonably request (i) on or prior to the date  that the first Shares are sold pursuant to the terms of this Agreement or any  Confirmation or Terms Agreement and (ii) prior to each Representation Date.   The Company will make available its appropriate officers and cause such officers  to participate in a call, or such other due diligence session, in form and substance  reasonably satisfactory to the Agents and Forward Purchasers and their counsel  prior to each Representation Date (including, without limitation, the availability  of the chief financial officer to respond to questions regarding the business and  financial condition of the Company) or otherwise as any of the Agents or Forward  Purchasers may reasonably request from time to time; such call or due diligence  session shall be for the purpose of updating the Agents’ and Forward Purchasers’  due diligence review of the Company in connection with the transactions  contemplated hereby.  The obligations set forth in the preceding sentence of this  Section 7(l) shall be suspended during a Suspension Period.  On a Suspension  Rescission Date, the provisions of this Section 7(l) shall once again be operative.  (m) Required Filings Relating to Placement and Sale of Shares.  The Company agrees  that on or prior to such dates as the Securities Act shall require, the Company will  (i) file and disclose in a prospectus supplement with the Commission under the  applicable paragraph of Rule 424(b) under the Securities Act or (ii) disclose in its  

 

  35  [[5258451]]  Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q or Current  Reports on Form 8-K, as applicable, the number of Shares sold through the  Agents under this Agreement or any Confirmation or Terms Agreement, the Net  Proceeds to the Company, the compensation paid by the Company with respect to  sales of Shares pursuant to this Agreement or any Confirmation or Terms  Agreement during the relevant period and any other information regarding the  Shares that the Company reasonably believes is required to comply with the  Securities Act.  The Company agrees to deliver such number of copies of each  such prospectus supplement (if any) to each exchange or market on which such  sales were effected as may be required by the rules or regulations of such  exchange or market.  If, to the knowledge of the Company, any filing required by  Rule 424 in connection with an offering of Shares shall not have been made, or if  the representations and warranties of the Company contained in this Agreement  shall not be true and correct on the applicable Settlement Date (or date of sale of  Shares pursuant to a Confirmation or Terms Agreement), the Company will offer  to any person who has agreed to purchase Shares from or through the Agents (or,  in the case of a sale to an Agent pursuant to a Terms Agreement, such Agent  itself) the right to refuse to purchase and pay for such Shares.  (n) Representation Dates; Certificate.  On the date of this Agreement and on or prior  to the date that the first Shares are sold pursuant to the terms of this Agreement or  any Confirmation or Terms Agreement and (A) each time the Company (i) files  the Prospectus relating to the Shares or amends or supplements the Registration  Statement or the Prospectus relating to the Shares (other than a prospectus  supplement filed in accordance with Section 7(m) of this Agreement) by means of  a post-effective amendment, sticker or supplement but not by means of  incorporation of documents by reference into the Registration Statement or the  Prospectus relating to the Shares; (ii) files an Annual Report on Form 10-K under  the Exchange Act; (iii) files its Quarterly Reports on Form 10-Q under the  Exchange Act; or (iv) files a Current Report on Form 8-K containing amended  financial information (other than an earnings release, to “furnish” information  pursuant to Items 2.02 or 7.01 of Form 8-K, and other than a report on Form 8-K  containing financial information of a tenant of the Company or its subsidiaries)  under the Exchange Act and (B) upon a Suspension Rescission Date and as  reasonably requested (each date of filing of one or more of the documents referred  to in clauses (i) through (iv) above and any Suspension Rescission Date referred  to in clause (B) shall be a “Representation Date”); the Company shall furnish the  Agents and Forward Purchasers with a certificate, in the form attached hereto as  Exhibit 7(n) within three (3) Trading Days of any Representation Date if  requested by any Agent, Forward Purchaser or its counsel.  The requirement to  provide a certificate under this Section 7(n) is hereby waived for any  Representation Date occurring at a time at which no Placement Notice is pending  or at which no Confirmation or Terms Agreement is outstanding, which waiver  shall continue until the earlier to occur of the date the Company delivers a Notice  hereunder or enters into a Confirmation or Terms Agreement (which, in each case  for such calendar quarter, shall be considered a Representation Date) and the next  occurring Representation Date; provided, however, that such waiver shall not  

 

  36  [[5258451]]  apply for any Representation Date referred to in clause (A)(i) and (ii) of this  Section 7(n); provided further, however, that the obligation of the Company under  this Section 7(n) shall be deferred during any Suspension Period and shall  recommence upon any Suspension Rescission Date.  Notwithstanding the  foregoing, if the Company subsequently decides to sell Shares following a  Representation Date when the Company relied on such waiver and did not  provide the Agents and Forward Purchasers with a certificate under this Section  7(n), then before the Company delivers the Notice, executes a Terms Agreement  or Confirmation Notice or any Agent sells any Shares (whether as Placement  Shares (including Forward Hedge Shares sold pursuant to a Confirmation) or  Shares sold pursuant to a Terms Agreement), the Company shall provide the  Agents and Forward Purchasers with a certificate, in the form attached hereto as  Exhibit 7(n), dated the date of such Notice, Confirmation or Terms Agreement.  (o) Legal Opinion of Counsel for the Company.  On or prior to the date that the first  Shares are sold pursuant to the terms of this Agreement or any Confirmation or  Terms Agreement and within three (3) Trading Days of any Representation Date  with respect to which the Company is obligated to deliver a certificate in the form  attached hereto as Exhibit 7(n) for which no waiver is applicable, the Company  shall cause to be furnished to the Agents the written opinions of each of (i)  O’Melveny & Myers LLP, (ii) Venable LLP and (iii) Fried, Frank, Harris, Shriver  & Jacobson LLP, or other counsel satisfactory to the Agents and Forward  Purchasers, in form and substance satisfactory to the Agents, the Forward  Purchasers and their counsel, dated the date that each opinion is required to be  delivered, substantially similar to the forms attached hereto as Exhibit 7(o)(1),  Exhibit 7(o)(2) and Exhibit 7(o)(3), respectively, modified, as necessary, to relate  to the Registration Statement and the Prospectus as then amended or  supplemented; provided, however, that in lieu of such opinions for subsequent  Representation Dates, counsel may furnish the Agents and Forward Purchasers  with a letter (a “Reliance Letter”) to the effect that the Agents and Forward  Purchasers may rely on a prior opinion delivered under this Section 7(o) to the  same extent as if it were dated the date of such letter (except that statements in  such prior opinion shall be deemed to relate to the Registration Statement and the  Prospectus as amended or supplemented at such Representation Date).  The  obligation of the Company under this Section 7(o) shall be deferred during any  Suspension Period and shall recommence upon a Suspension Rescission Date.  (p) Comfort Letter.   (i) On or prior to the date that the first Shares (including Forward Hedge  Shares) are sold pursuant to the terms of this Agreement or any  Confirmation or Terms Agreement and within three (3) Trading Days of  any Representation Date with respect to which the Company is obligated  to deliver a certificate in the form attached hereto as Exhibit 7(n) for  which no waiver is applicable, the Company shall cause (a)  PricewaterhouseCoopers LLP, independent public or certified public  accountants for the Company, to furnish the Agents and Forward  

 

  37  [[5258451]]  Purchasers a letter dated the date the letter is delivered and addressed to  the Agents and Forward Purchasers, in form and substance satisfactory to  the Agents and Forward Purchasers, (i) containing statements and  information of the type ordinarily included in accountants’ “comfort  letters” to underwriters, delivered according to Auditing Standard 6101 (or  any successor bulletin), with respect to the audited and unaudited financial  statements and certain financial information of the Company and its  subsidiaries contained or incorporated by reference in the Registration  Statement, the Prospectus, and each free writing prospectus, if any, and,  with respect to each letter dated the date hereof only, the Prospectus and  (ii) confirming that they are (A) independent public or certified public  accountants as required by the Securities Act and the Exchange Act and  (B) in compliance with the applicable requirements relating to the  qualification of accountants under Rule 2-01 of Regulation S-X (the “PwC  Comfort Letter”, and the first such letter, the “Initial PwC Comfort  Letter”) and (b) PricewaterhouseCoopers LLP to update the Initial  Comfort Letter with any information that would have been included in the  Initial Comfort Letter had it been given on such later date and modified as  necessary to relate to the Registration Statement and the Prospectus, as  amended and supplemented to the date of such letter.  The obligations of  the Company under this Section 7(p)(i) shall be deferred during any  Suspension Period and shall recommence upon a Suspension Rescission  Date.  (ii) On or prior to the date that the first Shares (including Forward Hedge  Shares) are sold pursuant to the terms of this Agreement or any  Confirmation or Terms Agreement and within three (3) Trading Days of  any Representation Date with respect to which the Company is obligated  to deliver a certificate in the form attached hereto as Exhibit 7(n) for  which no waiver is applicable, but only for so long as financial statements  of Care Capital Properties, Inc. (“CCP”) and its subsidiaries are required  to be presented in the Registration Statement pursuant to Rule 3- 05(b)(4)(iii) of Regulation S-X, the Company shall cause KPMG LLP,  independent public or certified public accountants for CCP, to furnish the  Agents and Forward Purchasers a letter dated the date the letter is  delivered and addressed to the Agents and Forward Purchasers, in form  and substance satisfactory to the Agents and Forward Purchasers,  containing statements and information of the type ordinarily included in  accountants’ “comfort letters” to underwriters, delivered according to  Auditing Standard 6101 (or any successor bulletin), with respect to the  audited and unaudited financial statements and certain financial  information of CCP and its subsidiaries contained or incorporated by  reference in the Registration Statement, the Prospectus, and each free  writing prospectus, if any, and, with respect to each letter dated the date  hereof only, the Prospectus (the “KPMG Comfort Letter”, and the first  such letter, the “Initial KPMG Comfort Letter”; the KPMG Comfort  Letter, together with the PwC Comfort Letter, the “Comfort Letters”).  

 

  38  [[5258451]]  (q) Insurance.  Each of the Company and its subsidiaries shall maintain, or cause to  be maintained, insurance in such amounts and with such deductibles and covering  such risks as it reasonably deems adequate for their businesses, and the real  property owned by the Company and its subsidiaries is appropriately insured by  institutions the Company reasonably believes to be financially sound.  (r) Compliance with Laws.  The Company and each of its subsidiaries shall maintain,  or cause to be maintained, all material environmental permits, licenses and other  authorizations required by federal, state, local or foreign law in order to conduct  their respective businesses as described in the Prospectus, and the Company and  each of its subsidiaries shall conduct their businesses, or cause their businesses to  be conducted, in substantial compliance with such permits, licenses and  authorizations and with applicable environmental laws, except where the failure  to maintain or be in compliance with such permits, licenses and authorizations  could not reasonably be expected to result in a Material Adverse Change.  (s) REIT Treatment.  The Company currently intends to continue to qualify as a  REIT under the Code and to use commercially reasonable efforts to enable the  Company to continue to meet the requirements for qualification and taxation as a  REIT under the Code for subsequent tax years that include any portion of the term  of this Agreement or any Terms Agreement.  (t) Securities Act and Exchange Act.  The Company will use its commercially  reasonable efforts to comply with all requirements imposed upon it by the  Securities Act and the Exchange Act as from time to time in force, so far as  necessary to permit the continuance of sales of, or dealings in, the Shares as  contemplated by the provisions hereof and the Prospectus, including the filing of  any and all documents required to be filed with the Commission pursuant to  Section 13, 14 or 15 of the Exchange Act in the manner and within the time  periods required by the Exchange Act.  (u) No Offer to Sell.  Other than a free writing prospectus approved in advance in  writing by the Company and an Agent in its capacity as agent hereunder or as  principal pursuant to a Terms Agreement, the Company (including its agents and  representatives, other than an Agent or Forward Purchaser in its capacity as such)  will not, directly or indirectly, use, authorize, approve or refer to any free writing  prospectus relating to the Shares to be sold by an Agent as agent hereunder or as  principal pursuant to a Terms Agreement.  (v) Filing of Free Writing Prospectuses.  The Company shall not take any action that  would result in any Agent, any Forward Purchaser or the Company being required  to file with the Commission pursuant to Rule 433(d) under the Securities Act a  free writing prospectus prepared by or on behalf of an Agent that such Agent  otherwise would not have been required to file thereunder.  (w) Blue Sky Compliance.  The Company (i) shall cooperate with the Agents,  Forward Purchasers and counsel for the Agents and Forward Purchasers to qualify  

 

  39  [[5258451]]  or register the Shares for sale under (or obtain exemptions from the application  of) the state securities or blue sky laws or Canadian provincial securities laws of  those jurisdictions designated by any Agent or Forward Purchaser, (ii) shall  comply with such laws and (iii) shall continue such qualifications, registrations  and exemptions in effect so long as required for the distribution of the Shares.   The Company shall not be required to qualify as a foreign corporation or to take  any action that would subject it to general service of process in any such  jurisdiction where it is not presently qualified or where it would be subject to  taxation as a foreign corporation.  The Company will advise the Agents and  Forward Purchasers promptly of the suspension of the qualification or registration  of (or any such exemption relating to) the Shares for offering, sale or trading in  any jurisdiction or any initiation or threat of any proceeding for any such purpose,  and in the event of the issuance of any order suspending such qualification,  registration or exemption, the Company shall use its reasonable efforts to obtain  the withdrawal thereof at the earliest possible moment.  (x) Transfer Agent.  The Company shall engage and maintain, at its expense, a  registrar and transfer agent for the Shares.  (y) Company to Provide Copy of the Prospectus in Form that May Be Downloaded  from the Internet.  The Company shall cause to be prepared and delivered, at its  expense, within one business day from the effective date of this Agreement, to the  Agents and Forward Purchasers an “electronic Prospectus” to be used by the  Agents in connection with the offering and sale of the Shares.  As used herein, the  term “electronic Prospectus” means a form of the Prospectus, and any amendment  or supplement thereto, that meets each of the following conditions:  (i) it shall be  encoded in an electronic format satisfactory to the Agents and Forward  Purchasers that may be transmitted electronically by the Agents and Forward  Purchasers to offerees and purchasers of the Shares; (ii) it shall disclose the same  information as the paper Prospectus, except to the extent that graphic and image  material cannot be disseminated electronically, in which case such graphic and  image material shall be replaced in the electronic Prospectus with a fair and  accurate narrative description or tabular representation of such material, as  appropriate; and (iii) it shall be in or convertible into a paper format or an  electronic format, satisfactory to the Agents and Forward Purchasers, that will  allow investors to store and have continuously ready access to the Prospectus at  any future time, without charge to investors (other than any fee charged for  subscription to the Internet as a whole and for on-line time).  (z) Future Reports to the Agents and Forward Purchasers.  For so long as the delivery  of a prospectus is required in connection with the offer and sale of the Shares, the  Company will furnish to the Agents and Forward Purchasers at the applicable  addresses set forth on Schedule 4 attached hereto:  (i) as soon as practicable after  the filing thereof, copies of each proxy statement, Annual Report on Form 10-K,  Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed  by the Company with the Commission, FINRA or any securities exchange; and  (ii) as soon as available, copies of any report or communication of the Company  

 

  40  [[5258451]]  mailed generally to holders of its capital stock; provided that, in each case, the  Company will be deemed to have furnished the foregoing documents as required  by this Section to the extent they are filed with the Commission and publicly  accessible on EDGAR.  (aa) Renewal of Registration Statement.  The date of this Agreement or any Terms  Agreement is not more than three years subsequent to the initial effective date of  the Registration Statement (the “Renewal Date”).  If, immediately prior to the  Renewal Date, this Agreement or any Confirmation or Terms Agreement has not  terminated and a prospectus is required to be delivered or made available by any  Agent or Forward Purchaser under the Securities Act or the Exchange Act in  connection with the sale of Shares, the Company will, prior to the Renewal Date,  file, if it has not already done so, a new shelf registration statement or, if  applicable, an automatic shelf registration statement relating to such Shares, and,  if such registration statement is not an automatic shelf registration statement, will  use its commercially reasonable efforts to cause such registration statement to be  declared effective within 60 days after the Renewal Date, and will take all other  reasonable actions necessary or appropriate to permit the public offer and sale of  such Shares to continue as contemplated in the expired registration statement  relating to such Securities.  References herein to the “Registration Statement”  shall include such new shelf registration statement or automatic shelf registration  statement, as the case may be.  (bb) No Stabilization or Manipulation.  None of the Company or its subsidiaries, or  any affiliate of the Company or its subsidiaries, will take, directly or indirectly,  any action which is designed, or would be expected, to cause or result in, or which  constitutes or might reasonably be expected to constitute, the stabilization or  manipulation of the price of any security of the Company to facilitate the sale or  resale of any Shares or to result in a violation of Regulation M under the  Exchange Act.  (cc) Reservation of Shares of Common Stock.  The Company shall reserve and keep  available at all times, free of preemptive rights, a number of authorized and  unissued shares of Common Stock sufficient to enable the Company to satisfy its  obligations to issue all Shares and Confirmation Shares pursuant to this  Agreement, any Confirmation and any Terms Agreement.  8. Covenant of Each Agent and Forward Purchaser.  Each Agent and Forward Purchaser  covenants with the Company not to take any action that would result in the Company  being required to file with the Commission pursuant to Rule 433(d) under the Securities  Act a free writing prospectus prepared by or on behalf of such Agent or Forward  Purchaser that otherwise would not be required to be filed by the Company thereunder,  but for the action of such Agent or Forward Purchaser.  9. Conditions to the Agents’ Obligations.  The obligations of the Agents and Forward  Purchasers hereunder and under each Confirmation and Terms Agreement, as applicable,  shall be subject to the continuing accuracy of the representations and warranties on the  

 

  41  [[5258451]]  part of the Company set forth in Section 6 hereof, to the timely performance by the  Company of its covenants and other obligations hereunder and under each Confirmation  and Terms Agreement, as applicable, to the completion by the Agents and Forward  Purchasers of a due diligence review satisfactory to each Agent and each Forward  Purchaser in its reasonable judgment and to the continuing satisfaction (or waiver by the  Agents and Forward Purchasers in their sole discretion) of each of the following  additional conditions:  (a) Registration Statement Effective.  The Registration Statement shall be effective  and shall be available for (i) all sales of Placement Shares issued pursuant to all  prior Placement Notices; (ii) the sale of all Placement Shares contemplated to be  issued by any Placement Notice; and (iii) all sales of Shares (including Forward  Hedge Shares) pursuant to any Confirmation or Terms Agreement.  (b) No Material Notices.  None of the following events shall have occurred and be  continuing: (i) receipt by the Company of any notification with respect to the  suspension of the qualification or exemption from qualification of any Shares for  sale in any jurisdiction or the initiation or threatening of any proceeding for such  purpose; (ii) receipt by the Company or any of its subsidiaries of any request for  additional information from the Commission or any other self-regulatory  organization or federal, state, local or foreign governmental or regulatory  commission, board, authority, agency, court, administrative or other governmental  body having jurisdiction over the Company, during the period of effectiveness of  the Registration Statement, the response to which would require any post- effective amendments or supplements to the Registration Statement or the  Prospectus; and (iii) the occurrence of any event that makes any material  statement made in the Registration Statement or the Prospectus or any material  document incorporated or deemed to be incorporated therein by reference untrue  in any material respect or that requires the making of any changes in the  Registration Statement, related Prospectus or such documents so that, in the case  of the Registration Statement, it will not contain any untrue statement of a  material fact or omit to state any material fact required to be stated therein or  necessary to make the statements therein not misleading and that, in the case of  the Prospectus, it will not contain any untrue statement of a material fact or omit  to state any material fact required to be stated therein or necessary to make the  statements therein, in the light of the circumstances under which they were made,  not misleading.  (c) No Misstatement or Material Omission.  The Registration Statement and  Prospectus, and any amendment or supplement thereto, shall not contain any  untrue statement of a material fact, or omit to state a material fact that is required  to be stated therein or is necessary to make the statements therein not misleading.  (d) Material Changes.  Except as otherwise disclosed in the Prospectus, or disclosed  in the Company’s reports filed with the Commission, there shall not have  occurred (i) any Material Adverse Change in the judgment of the Agents and  Forward Purchasers and (ii) any downgrading in the rating accorded any  

 

  42  [[5258451]]  securities of the Company or any of its subsidiaries by any “nationally recognized  statistical rating organization” as such term is defined in Section 3(a)(62) of the  Exchange Act that is so material as to make it impracticable or inadvisable in the  sole judgment of the Agents and Forward Purchasers to proceed with the offering  of the Shares on the terms and in the manner contemplated in the Prospectus.  (e) Company Counsel Legal Opinion.  The Agents and Forward Purchasers shall  have received the opinions or reliance letter, as applicable, of each of (i)  O’Melveny & Myers LLP, (ii) Venable LLP and (iii) Fried, Frank, Harris, Shriver  & Jacobson LLP required to be delivered pursuant to Section 7(o) on or before the  date on which such delivery of such opinion is required pursuant to Section 7(o).  (f) Opinion of Counsel for the Agents and Forward Purchasers.  On or prior to the  date that the first Shares (including Forward Hedge Shares) are sold pursuant to  the terms of this Agreement, any Confirmation or any Terms Agreement and  within three (3) Trading Days of each Representation Date with respect to which  the Company is obligated to deliver a certificate in the form attached hereto as  Exhibit 7(n) for which no waiver is applicable, the Agents and Forward  Purchasers shall have received from Cravath, Swaine & Moore LLP, counsel for  the Agents and Forward Purchasers, such opinion or opinions, dated the date that  the opinion is required to be delivered, with respect to such matters as the Agents  and Forward Purchasers may require, and the Company shall have furnished to  such counsel such documents as they request for the purpose of enabling them to  pass upon such matters; provided, however, that the obligation of Cravath, Swaine  & Moore LLP under this Section 9(f) shall be deferred during any Suspension  Period and shall recommence upon a Suspension Rescission Date.  (g) Comfort Letter.  The Agents and Forward Purchasers shall have received the  Comfort Letters required to be delivered pursuant to Sections 7(p)(i) and 7(p)(ii)  on or before the date on which such delivery of such letters is required pursuant to  Sections 7(p)(i) and 7(p)(ii).  (h) Representation Certificate.  The Agents and Forward Purchasers shall have  received the certificate required to be delivered pursuant to Section 7(n) on or  before the date on which delivery of such certificate is required pursuant to  Section 7(n).  (i) No Stop Order.  No stop order suspending the effectiveness of the Registration  Statement or any post-effective amendment to the Registration Statement shall be  in effect and no proceedings for such purpose, pursuant to Rule 401(g)(2) or  pursuant to Section 8A of the Securities Act, shall have been instituted or are  pending or, to the knowledge of the Company, threatened by the Commission.  (j) No Suspension.  Trading in the Shares shall not have been suspended on the  Exchange.  

 

  43  [[5258451]]  (k) Other Materials.  On each date on which the Company is required to deliver a  certificate pursuant to Section 7(n), the Agents, Forward Purchasers and their  counsel shall have received such information, documents and opinions as they  may reasonably request for the purposes of enabling them to pass upon the  issuance and sale of the Shares as contemplated herein, in any applicable  Confirmation or Terms Agreement, or in order to evidence the accuracy of any of  the representations and warranties, or the satisfaction of any of the conditions or  agreements, herein contained, including, without limitation, certain certificates  signed by the Chief Financial Officer of the Company in his capacity as such on  behalf of the Company, in the form reasonably requested by the Agents; and all  proceedings taken by the Company in connection with the issuance and sale of the  Shares as contemplated herein and in connection with the other transactions  contemplated by this Agreement, any Confirmation or Terms Agreement shall be  satisfactory in form and substance to the Agents, Forward Purchasers and their  counsel.  (l) Securities Act Filings Made.  All filings with the Commission required by Rule  424 under the Securities Act to have been filed prior to the issuance of any Notice  hereunder or the commencement of any sales pursuant to any Confirmation or  Terms Agreement shall have been made within the applicable time period  prescribed for such filing by Rule 424.  (m) Approval for Listing.  Either (i) the Shares shall have been approved for listing on  the Exchange, subject only to notice of issuance, or (ii) the Company shall have  filed an application for listing of the Shares on the Exchange at, or prior to, the  issuance of any Notice or the commencement of any sales pursuant to any  Confirmation or Terms Agreement.  (n) Actively-Traded Security.  The Common Stock shall be an “actively-traded  security” exempted from the requirements of Rule 101 of Regulation M under the  Exchange Act by subsection (c)(1) of such rule.  (o) No Termination Event.  There shall not have occurred any event that would  permit the Agents to terminate this Agreement, any Confirmation or any Terms  Agreement pursuant to Section 13(a).  If any condition specified in this Section 9 is not satisfied when and as required to  be satisfied, this Agreement, any Confirmation or any Terms Agreement may be terminated by  any Agent or Forward Purchaser, as applicable (as to itself only), by notice to the Company at  any time, which termination shall be without liability on the part of any party to any other party,  except that Section 7(h), Section 9 and Section 10 shall at all times be effective and shall survive  such termination.  10. Indemnification.  (a) Indemnification of Each Agent and Each Forward Purchaser.  The Company  agrees to indemnify and hold harmless each Agent and each Forward Purchaser,  

 

  44  [[5258451]]  their affiliates, officers, directors, employees and agents, and each person, if any,  who controls such Agent or Forward Purchaser within the meaning of the  Securities Act or the Exchange Act against any loss, claim, damage, liability or  expense, as incurred, to which such Agent or Forward Purchaser or such affiliate,  officer, director, employee, agent or controlling person may become subject,  under the Securities Act, the Exchange Act, other federal or state statutory law or  regulation, or at common law or otherwise (including in settlement of any  litigation), insofar as such loss, claim, damage, liability or expense (or actions in  respect thereof as contemplated below) arises out of or is based upon (i) any  untrue statement or alleged untrue statement of a material fact contained in the  Registration Statement, or any amendment thereto, including any information  deemed to be a part thereof pursuant to Rule 430B under the Securities Act, or the  omission or alleged omission therefrom of a material fact required to be stated  therein or necessary to make the statements therein not misleading; or (ii) any  untrue statement or alleged untrue statement of a material fact contained in the  Prospectus or any free writing prospectus that the Company has used, referred to  or filed, or is required to file, pursuant to Rule 433(d) of the Securities Act or the  Prospectus (or any amendment or supplement thereto), or the omission or alleged  omission therefrom of a material fact necessary in order to make the statements  therein, in the light of the circumstances under which they were made, not  misleading; or (iii) any act or failure to act or any alleged act or failure to act by  such Agent or Forward Purchaser in connection with, or relating in any manner  to, the Shares or the offering contemplated hereby, and which is included as part  of or referred to in any loss, claim, damage, liability or action arising out of or  based upon any matter covered by clause (i) or (ii) above; and to reimburse such  Agent or Forward Purchaser and each such affiliate, officer, director, employee,  agent or controlling person for any and all expenses (including the fees and  disbursements of counsel chosen by such Agent or Forward Purchaser) as such  expenses are reasonably incurred by such Agent or Forward Purchaser or such  affiliate, officer, director, employee, agent or controlling person in connection  with investigating, defending, settling, compromising or paying any such loss,  claim, damage, liability, expense or action; provided, however, that the foregoing  indemnity agreement shall not apply to any loss, claim, damage, liability or  expense to the extent, but only to the extent, arising out of or based upon any  untrue statement or alleged untrue statement or omission or alleged omission  made in reliance upon and in conformity with written information relating to such  Agent or Forward Purchaser furnished to the Company by such Agent expressly  for use in the Registration Statement, any such free writing prospectus or the  Prospectus (or any amendment or supplement thereto), it being understood and  agreed that the only such information furnished by such Agent or Forward  Purchaser to the Company consists of the Agent Information.  The indemnity  agreement set forth in this Section 10(a) shall be in addition to any liabilities that  the Company may otherwise have.  (b) Indemnification of the Company, Its Directors and Officers.  Each Agent and each  Forward Purchaser agrees, severally and not jointly, to indemnify and hold  harmless the Company, each of its directors, each of its officers who signed the  

 

  45  [[5258451]]  Registration Statement and each person, if any, who controls the Company within  the meaning of the Securities Act or the Exchange Act, against any loss, claim,  damage, liability or expense, as incurred, to which the Company, or any such  director, officer or controlling person may become subject, under the Securities  Act, the Exchange Act, or other federal or state statutory law or regulation, or at  common law or otherwise (including in settlement of any litigation, if such  settlement is effected with the written consent of such Agent or Forward  Purchaser), insofar as such loss, claim, damage, liability or expense (or actions in  respect thereof as contemplated below) arises out of or is based upon (i) any  untrue statement or alleged untrue statement of a material fact contained in the  Registration Statement, or any amendment thereto, including any information  deemed to be a part thereof pursuant to Rule 430B under the Securities Act, or the  omission or alleged omission therefrom of a material fact required to be stated  therein or necessary to make the statements therein not misleading; or (ii) any  untrue statement or alleged untrue statement of a material fact contained in the  Prospectus or any free writing prospectus that the Company has used, referred to  or filed, or is required to file, pursuant to Rule 433(d) of the Securities Act or the  Prospectus (or any amendment or supplement thereto), or arises out of or is based  upon the omission or alleged omission to state therein a material fact necessary in  order to make the statements therein, in the light of the circumstances under  which they were made, not misleading, in each case of clauses (i) and (ii) above  to the extent, but only to the extent, that such untrue statement or alleged untrue  statement or omission or alleged omission was made in the Registration  Statement, the Prospectus or such free writing prospectus that the Company has  used, referred to or filed, or is required to file, pursuant to Rule 433(d) of the  Securities Act, in reliance upon and in conformity with the Agent Information,  and to reimburse the Company, or any such director, officer or controlling person  for any legal and other expense reasonably incurred by the Company, or any such  director, officer or controlling person in connection with investigating, defending,  settling, compromising or paying any such loss, claim, damage, liability, expense  or action.  The Company hereby acknowledges that, with respect to each Agent  and each Forward Purchaser, “Agent Information” shall mean only the  information that such Agent or Forward Purchaser has furnished to the Company  expressly for use in the Registration Statement, the Prospectus and any free  writing prospectus that the Company has filed, or is required to file, pursuant to  Rule 433(d) of the Securities Act or the Prospectus (or any amendment or  supplement thereto), which consists exclusively of the names of the Agents and  Forward Purchasers set forth on the front and back cover of the Prospectus  Supplement. The indemnity agreement set forth in this Section 10(b) shall be in  addition to any liabilities that such Agent or Forward Purchaser may otherwise  have.    (c) Notifications and Other Indemnification Procedures.  Promptly after receipt by an  indemnified party under this Section 10 of notice of the commencement of any  action, such indemnified party will, if a claim in respect thereof is to be made  against an indemnifying party under this Section 10, notify the indemnifying party  

 

  46  [[5258451]]  in writing of the commencement thereof, but the omission so to notify the  indemnifying party will not relieve it from any liability which it may have to any  indemnified party hereunder to the extent it is not prejudiced as a proximate result  of such failure, and in any event will not relieve it from any liability which it may  have to any indemnified party otherwise than under subsection (a) or (b) above. In  case any such action is brought against any indemnified party and such  indemnified party seeks or intends to seek indemnity from an indemnifying party,  the indemnifying party will be entitled to participate in and (to the extent that it  shall elect, jointly with all other indemnifying parties similarly notified, by  written notice delivered to the indemnified party promptly after receiving the  aforesaid notice from such indemnified party) to assume the defense thereof with  counsel reasonably satisfactory to such indemnified party; provided, however, if  the defendants in any such action include both the indemnified party and the  indemnifying party and the indemnified party shall have reasonably concluded  that a conflict may arise between the positions of the indemnifying party and the  indemnified party in conducting the defense of any such action or that there may  be legal defenses available to it and/or other indemnified parties which are  different from or additional to those available to the indemnifying party, the  indemnified party or parties shall have the right to select separate counsel to  assume such legal defenses and to otherwise participate in the defense of such  action on behalf of such indemnified party or parties.  Upon receipt of notice from  the indemnifying party to such indemnified party of such indemnifying party’s  election so to assume the defense of such action and approval by the indemnified  party of counsel, the indemnifying party will not be liable to such indemnified  party under this Section 10 for any legal expenses subsequently incurred by such  indemnified party in connection with the defense thereof unless (i) the  indemnified party shall have employed separate counsel in accordance with the  proviso to the preceding sentence (it being understood, however, that the  indemnifying party shall not be liable for the fees and expenses of more than one  separate counsel (together with local counsel), representing the indemnified  parties who are parties to such action), which counsel (together with any local  counsel) for the indemnified parties shall be selected by the applicable Agent(s)  and Forward Purchaser(s) (in the case of counsel for the indemnified parties  referred to in Section 10(a) above) or by the Company (in the case of counsel for  the indemnified parties referred to in Section 10(b) above)); (ii) the indemnifying  party shall not have employed counsel satisfactory to the indemnified party to  represent the indemnified party within a reasonable time after notice of  commencement of the action; or (iii) the indemnifying party has authorized in  writing the employment of counsel for the indemnified party at the expense of the  indemnifying party, in each of which cases the fees and expenses of counsel shall  be at the expense of the indemnifying party and shall be paid as they are incurred.  (d) Settlements.  The indemnifying party under this Section 10 shall not be liable for  any settlement of any proceeding effected without its written consent, but if  settled with such consent or if there shall be a final judgment for the plaintiff, the  indemnifying party agrees to indemnify the indemnified party against any loss,  claim, damage, liability or expense by reason of such settlement or judgment.   

 

  47  [[5258451]]  Notwithstanding the foregoing sentence, if at any time an indemnified party shall  have requested an indemnifying party to reimburse the indemnified party for fees  and expenses of counsel as contemplated by Section 10(c) hereof, the  indemnifying party agrees that it shall be liable for any settlement of any  proceeding effected without its written consent if (i) such settlement is entered  into more than 30 days after receipt by such indemnifying party of the aforesaid  request and (ii) such indemnifying party shall not have reimbursed the  indemnified party in accordance with such request prior to the date of such  settlement.  No indemnifying party shall, without the prior written consent of the  indemnified party, effect any settlement, compromise or consent to the entry of  judgment in any pending or threatened action, suit or proceeding in respect of  which any indemnified party is or could have been a party and indemnity was or  could have been sought hereunder by such indemnified party, unless such  settlement, compromise or consent includes an unconditional release of such  indemnified party from all liability on claims that are the subject matter of such  action, suit or proceeding and does not include a statement as to or an admission  of fault, culpability or a failure to act by or on behalf of any indemnified party.  11. Contribution.  If the indemnification provided for in Section 10 is for any reason held to  be unavailable to or otherwise insufficient to hold harmless an indemnified party in  respect of any losses, claims, damages, liabilities or expenses referred to therein, then  each indemnifying party shall severally contribute to the aggregate amount paid or  payable by such indemnified party, as incurred, as a result of any losses, claims,  damages, liabilities or expenses referred to therein (i) in such proportion as is appropriate  to reflect the relative benefits received by the Company, on the one hand, and the  applicable Agents and Forward Purchasers, on the other hand, from the offering of the  Shares pursuant to this Agreement or to any Confirmation or Terms Agreement or (ii) if  the allocation provided by clause (i) above is not permitted by applicable law, in such  proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)  above but also the relative fault of the Company, on the one hand, and the applicable  Agents and Forward Purchasers, on the other hand, in connection with the statements or  omissions which resulted in such losses, claims, damages, liabilities or expenses, as well  as any other relevant equitable considerations.  The relative benefits received by the  Company, on the one hand, and the applicable Agents and Forward Purchasers, on the  other hand, in connection with the offering of the Shares pursuant to this Agreement or  any Confirmation or Terms Agreement shall be deemed to be in the same respective  proportions as the sum of (i) the total Net Proceeds received by the Company from the  offering of Placement Shares pursuant to an applicable Placement (which shall be  deemed to include the proceeds that would be received by the Company upon physical  settlement of any Placement Shares sold under any Confirmation assuming that the  aggregate amount payable by the applicable Forward Purchaser under such Confirmation  is equal to the aggregate amount of the net proceeds realized upon the sales of the  Placement Shares) and (ii) the net proceeds received by the Company pursuant to a sale  of Shares under an applicable Terms Agreement, bears to the total compensation received  by the applicable Agents and Forward Purchasers, or to which the applicable Agents and  Forward Purchasers are entitled to receive but have not yet received (whether through the  sale of Shares through a Placement or pursuant to a Terms Agreement).  For the  

 

  48  [[5258451]]  avoidance of doubt, the “Net Proceeds” received by a Forward Purchaser upon the sale of  Shares by an Agent as forward seller shall be calculated based on the aggregate value of  the Spread (as defined in the related Confirmation) retained by such Forward Purchaser  in respect of the forward stock purchase transaction related to such Shares (net of any  hedging and other costs associated with such transaction and the related Confirmation).   The relative fault of the Company, on the one hand, and the applicable Agents and  Forward Purchasers, on the other hand, shall be determined by reference to, among other  things, whether any such untrue or alleged untrue statement of a material fact or omission  or alleged omission to state a material fact relates to information supplied by the  Company, on the one hand, or the applicable Agents and Forward Purchasers, on the  other hand, and the parties’ relative intent, knowledge, access to information and  opportunity to correct or prevent such statement or omission.  The amount paid or payable by a party as a result of the losses, claims, damages,  liabilities and expenses referred to above shall be deemed to include, subject to the  limitations set forth in Section 10(c), any legal or other fees or expenses reasonably  incurred by such party in connection with investigating or defending any action or claim.   The provisions set forth in Section 10(c) with respect to notice of commencement of any  action shall apply if a claim for contribution is to be made under this Section 11;  provided, however, that no additional notice shall be required with respect to any action  for which notice has been given under Section 10(c) for purposes of indemnification.  The Company, the Agents and the Forward Purchasers agree that it would not be just and  equitable if contribution pursuant to this Section 11 were determined by pro rata  allocation or by any other method of allocation which does not take account of the  equitable considerations referred to in this Section 11.  Notwithstanding the provisions of this Section 11, an Agent or Forward Purchaser shall  not be required to contribute any amount in excess of the compensation received by it in  connection with a sale of Shares to the public through (i) a Placement and (ii) any  applicable Confirmation or Terms Agreement. No person guilty of fraudulent  misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be  entitled to contribution from any person who was not guilty of such fraudulent  misrepresentation.  For purposes of this Section 11, each officer, director, affiliate,  employee and agent of an Agent or Forward Purchaser and each person, if any, who  controls such Agent or Forward Purchaser within the meaning of the Securities Act or the  Exchange Act shall have the same rights to contribution as such Agent or Forward  Purchaser, and each director of the Company, each officer of the Company who signed  the Registration Statement, and each person, if any, who controls the Company within the  meaning of the Securities Act and the Exchange Act shall have the same rights to  contribution as the Company.  12. Representations and Indemnities to Survive Delivery.  The respective indemnities,  agreements, representations, warranties and other statements of the Company, of its  officers and of the Agents and Forward Purchasers set forth in or made pursuant to this  Agreement will remain in full force and effect, regardless of any investigation made by or  on behalf of the Agents, the Forward Purchasers or the Company or any of its or their  

 

  49  [[5258451]]  officers, directors, affiliates, employees or agents or any controlling person, as the case  may be, and, anything herein to the contrary notwithstanding, will survive delivery of and  payment for the Shares sold under this Agreement and pursuant to any Confirmation or  any Terms Agreement, and any termination of this Agreement.  13. Termination of This Agreement.  (a) Each Agent and each Forward Purchaser shall have the right, by giving notice as  hereinafter specified at any time, to terminate its obligations pursuant to a  Placement Notice or any Terms Agreement if (i) trading in any of the Company’s  securities shall have been suspended or limited by the Commission or by the  Exchange or in any over-the-counter market, or trading in securities generally on  either the Nasdaq Stock Market or the New York Stock Exchange shall have been  suspended or limited, or minimum or maximum prices shall have been generally  established on any of such stock exchanges by the Commission or FINRA; (ii) a  general banking moratorium shall have been declared by any of federal, New  York or California authorities; (iii) there shall have occurred any outbreak or  escalation of national or international hostilities or any crisis or calamity, or any  change in the United States or international financial markets, or any substantial  change or development involving a prospective substantial change in the United  States’ or international political, financial or economic conditions, as in the  judgment of such Agent or Forward Purchaser is material and adverse and makes  it impracticable to market the Shares in the manner and on the terms described in  the Prospectus or to enforce contracts for the sale of securities; (iv) in the  judgment of such Agent or Forward Purchaser there shall have occurred any  Material Adverse Change; (v) the Company or any of its subsidiaries shall have  sustained a loss by strike, fire, flood, earthquake, accident or other calamity of  such character as in the judgment of such Agent or Forward Purchaser may  interfere materially with the conduct of the business and operations of the  Company and any of its subsidiaries taken as a whole regardless of whether or not  such loss shall have been insured; or (vi) any material disruption of settlements of  securities or clearance services in the United States that would materially impair  settlement and clearance with respect to the Shares.  Any termination pursuant to  this Section 13(a) shall be without liability on the part of (A) the Company to  such Agent or Forward Purchaser, except that the Company shall be obligated to  reimburse the expenses of such Agent pursuant to Section 7(h) hereof, (B) such  Agent or Forward Purchaser to the Company, or (C) of any party hereto to any  other party except that the provisions of Section 10 and Section 11 shall at all  times be effective and shall survive such termination.  (b) The Company shall have the right to terminate this Agreement in its sole  discretion at any time after the date of this Agreement.  Any such termination  hereunder shall be without liability of any party to any other party except that the  provisions of Section 5(c), 7(h), Section 10, Section 11, Section 18 and Section 19  hereof shall remain in full force and effect notwithstanding such termination.  

 

  50  [[5258451]]  (c) Each Agent and each Forward Purchaser shall have the right to terminate its  obligations hereunder or pursuant to any Terms Agreement (in each case, as to  itself only) in its sole discretion at any time after the date of this Agreement.  Any  such termination shall be without liability of any party to any other party except  that the provisions of Section 7(h), Section 10, Section 11, Section 18 and Section  19 hereof shall remain in full force and effect notwithstanding such termination.  (d) Unless earlier terminated pursuant to this Section 13, this Agreement and any  Terms Agreement shall automatically terminate upon the issuance and sale of all  of the Shares through the Agents on the terms and subject to the conditions set  forth herein; provided that the provisions of Section 7(h), Section 10, Section 11,  Section 18 and Section 19 hereof shall remain in full force and effect  notwithstanding such termination.  (e) This Agreement shall remain in full force and effect unless terminated pursuant to  Sections 13(a), (b), (c) or (d) above or otherwise by mutual agreement of the  parties; provided, however, that any such termination by mutual agreement shall  in all cases be deemed to provide that Section 7(h), Section 10, Section 11,  Section 18 and Section 19 shall remain in full force and effect.  (f) Any termination of this Agreement, any Confirmation or any Terms Agreement  shall be effective on the date specified in such notice of termination; provided,  however, that such termination shall not be effective until the close of business on  the date of receipt of such notice by such Agent, Forward Purchaser or the  Company, as the case may be.  If such termination shall occur prior to the  Settlement Date for any sale of Placement Shares, or prior to the Time of Delivery  (as defined in Exhibit 5) for any sale of Shares pursuant to a Terms Agreement,  such Shares shall settle in accordance with the provisions of this Agreement, such  Confirmation or such Terms Agreement, as applicable.  (g) Notwithstanding anything to the contrary contained in this Agreement, no  termination of this Agreement shall effect the validity, effectiveness or  enforceability of any executed Confirmation or Terms Agreement and any such  executed Confirmation and Terms Agreement shall remain in full force and effect  notwithstanding such termination (subject to the terms and conditions of such  Confirmation or Terms Agreement).  (h) Notwithstanding anything to the contrary contained in this Agreement, no  termination of this Agreement shall affect or impair the Agents’ or, if applicable,  the Placement Forward Purchasers’ respective rights or obligations with respect to  Shares sold or borrowed and sold under this Agreement, or, if applicable, any  Confirmation prior to such termination (including with respect to Shares sold that  have not yet settled and, in the case of any Shares borrowed by or on behalf of a  Forward Purchaser and sold by or through an Agent in connection with a Forward  Sale, the obligation to enter into the resulting Confirmation).  

 

  51  [[5258451]]  14. Notices.  All communications hereunder shall be in writing and shall be mailed, hand  delivered or emailed and confirmed to the parties hereto as follows:  If to an Agent or Forward Purchaser:  The applicable Agent or Forward Purchaser at the address set forth in Schedule 2  hereto.  with a copy to:  Cravath, Swaine & Moore LLP  825 Eighth Avenue  New York, New York 10019  Attention:  Sasha Rosenthal-Larrea  Email:  srosenthal-larrea@cravath.com    If to the Company:  Sabra Health Care REIT, Inc.  18500 Von Karman Avenue, Suite 550  Irvine, California 92612  Attention:  Richard K. Matros  Email:  rmatros@sabrahealth.com    with a copy to:  O’Melveny & Myers LLP  610 Newport Center Drive, 17th Floor  Newport Beach, California 92660  Attention:  Andor D. Terner  Email:  aterner@omm.com    Any party hereto may change the address for receipt of communications by giving written notice  to the others.  15. Successors and Assigns.  This Agreement shall inure to the benefit of and be binding  upon the Company, the Agents and the Forward Purchasers and their respective  successors and the affiliates, controlling persons, officers, directors, employees and  agents referred to in Section 10 hereof.  References to any of the parties contained in this  Agreement shall be deemed to include the successors and permitted assigns of such party.   Nothing in this Agreement, express or implied, is intended to confer upon any party other  than the parties hereto or their respective successors and permitted assigns any rights,  remedies, obligations or liabilities under or by reason of this Agreement, except as  expressly provided in this Agreement.  No party may assign its rights or obligations  under this Agreement without the prior written consent of the other parties; provided,  however, that each Agent and each Forward Purchaser may assign its rights and  obligations hereunder to an affiliate of such Agent or Forward Purchaser without  

 

  52  [[5258451]]  obtaining the Company’s or any other Agent’s or Forward Purchaser’s consent.  The term  “successors” shall not include any purchaser of the Shares as such from the Agents or  Forward Purchasers merely by reason of such purchase.  16. Adjustments for Stock Splits.  The parties acknowledge and agree that all stock-related  numbers contained in this Agreement shall be adjusted to take into account any stock  split, stock dividend or similar event effected with respect to the Shares.  17. Entire Agreement; Amendment; Severability.  This Agreement constitutes the entire  agreement of the parties to this Agreement and supersedes all prior written or oral and all  contemporaneous oral agreements, understandings and negotiations with respect to the  subject matter hereof.  This Agreement may not be amended or modified unless in  writing by all of the parties hereto, and no condition herein (express or implied) may be  waived unless waived in writing by each party whom the condition is meant to benefit.   In the event that any one or more of the provisions contained herein, or the application  thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court  of competent jurisdiction, then such provision shall be given full force and effect to the  fullest possible extent that it is valid, legal and enforceable, and the remainder of the  terms and provisions herein shall be construed as if such invalid, illegal or unenforceable  term or provision was not contained herein, but only to the extent that giving effect to  such provision and the remainder of the terms and provisions hereof shall be in  accordance with the intent of the parties as reflected in this Agreement.  The Section  headings herein are for the convenience of the parties only and shall not affect the  construction or interpretation of this Agreement.  18. Applicable Law; Consent to Jurisdiction.  This Agreement, any Confirmation and any  Terms Agreement, and any claim, controversy or dispute arising under or related thereto,  shall be governed by and construed in accordance with the internal laws of the State of  New York applicable to agreements made and to be performed in such state.  Any legal  suit, action or proceeding arising out of or based upon this Agreement, any Confirmation,  any Terms Agreement or the transactions contemplated hereby or thereby shall be  instituted in the federal courts of the United States of America located in the Borough of  Manhattan in the City of New York or the courts of the State of New York in each case  located in the Borough of Manhattan in the City of New York (collectively, the  “Specified Courts”), and each party irrevocably submits to the exclusive jurisdiction  (except for proceedings instituted in regard to the enforcement of a judgment of any such  court, as to which such jurisdiction is non-exclusive) of such courts in any such suit,  action or proceeding.  Service of any process, summons, notice or document by mail to  such party’s address set forth above shall be effective service of process for any suit,  action or other proceeding brought in any such court.  The parties irrevocably and  unconditionally waive any objection to the laying of venue of any suit, action or other  proceeding in the Specified Courts and irrevocably and unconditionally waive and agree  not to plead or claim in any such court that any such suit, action or other proceeding  brought in any such court has been brought in an inconvenient forum. Notwithstanding  the foregoing, this Agreement does not prohibit or restrict the Company from filing an  arbitration claim in the FINRA arbitration forum as specified in FINRA rules.  

 

  53  [[5258451]]  19. Waiver of Jury Trial.  The Company, each Agent and each Forward Purchaser each  hereby irrevocably waive any right it may have to a trial by jury in respect of any claim  based upon or arising out of this Agreement, any Confirmation, any Terms Agreement or  any transaction contemplated hereby or thereby.  20. Absence of Fiduciary Relationship.  The Company acknowledges and agrees that:  (a) Each Agent and each Forward Purchaser has been retained solely to act as agent  in the capacity of an arm’s-length contractual counterparty to the Company in  connection with the sale of the Shares and that no fiduciary, advisory or agency  relationship between the Company and any Agent or Forward Purchaser has been  created in respect of any of the transactions contemplated by this Agreement, any  Confirmation or any Terms Agreement, irrespective of whether such Agent or  Forward Purchaser has advised or is advising the Company on other matters;  (b) the Company is capable of evaluating and understanding and understands and  accepts the terms, risks and conditions of the transactions contemplated by this  Agreement, any Confirmation and any Terms Agreement;  (c) the Company has been advised that the Agents and Forward Purchasers and their  affiliates are engaged in a broad range of transactions which may involve interests  that differ from those of the Company and that the Agents and Forward  Purchasers have no obligation to disclose such interests and transactions to the  Company by virtue of any fiduciary, advisory or agency relationship; and  (d) the Company waives, to the fullest extent permitted by law, any claims it may  have against the Agents or Forward Purchasers for breach of fiduciary duty or  alleged breach of fiduciary duty and agrees that the Agents and Forward  Purchasers shall have no liability (whether direct or indirect) to the Company in  respect of such a fiduciary claim or to any person asserting a fiduciary duty claim  on behalf of or in right of the Company, including stockholders, partners,  employees or creditors of the Company.  21. Counterparts.  This Agreement, any Confirmation and any Terms Agreement may be  executed in two or more counterparts, each of which shall be deemed an original, but all  of which together shall constitute one and the same instrument.  Delivery of an executed  counterpart of a signature page to this Agreement, any Confirmation or any Terms  Agreement by one party to the other made by telecopier, facsimile or other electronic  transmission (i.e., a “pdf” or “tif”) shall be effective as delivery of a manually executed  counterpart hereof.  22. Definitions.  As used in this Agreement, the following terms have the respective  meanings set forth below:  (a) “Applicable Time” means the date of this Agreement, each Representation Date,  the date on which a Notice is given, any date on which Placement Shares  (including Forward Hedge Shares) are sold hereunder, each Settlement Date and  each “Trade Date”, “Effective Date” and “Settlement Date” (each as defined  

 

  54  [[5258451]]  under the applicable Confirmation), or such other time as agreed to by the  Company, the Agents and the Forward Purchasers.  (b) “GAAP” means United States generally accepted accounting principles, applied  on a consistent basis throughout the periods involved.  (c) “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall  be interpreted in accordance with, 12 U.S.C. § 1841(k).  (d) “Covered Entity” means any of the following:  (i) a “covered entity” as that term is defined in, and interpreted in accordance  with, 12 C.F.R. § 252.82(b);  (ii) a “covered bank” as that term is defined in, and interpreted in accordance  with, 12 C.F.R. § 47.3(b); or  (iii) a “covered FSI” as that term is defined in, and interpreted in accordance  with, 12 C.F.R. § 382.2(b).  (e) “Default Right” has the meaning assigned to that term in, and shall be interpreted  in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.  (f) “U.S. Special Resolution Regime” means each of (i) the Federal Deposit  Insurance Act and the regulations promulgated thereunder and (ii) Title II of the  Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations  promulgated thereunder.  23. Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub.  L. 107-56 (signed into law October 26, 2001)), the Agents and Forward Purchasers are  required to obtain, verify and record information that identifies their respective clients,  including the Company, which information may include the name and address of their  respective clients, as well as other information that will allow the Agents and Forward  Purchasers to properly identify their respective clients.  24. Recognition of the U.S. Special Resolution Regimes.  (a) In the event that any Agent or Forward Purchaser that is a Covered Entity  becomes subject to a proceeding under a U.S. Special Resolution Regime, the  transfer from such Agent or Forward Purchaser of this Agreement, any  Confirmation or any Terms Agreement, and any interest and obligation in or  under this Agreement, any Confirmation or any Terms Agreement, will be  effective to the same extent as the transfer would be effective under the U.S.  Special Resolution Regime if this Agreement, any Confirmation or any Terms  Agreement, and any such interest and obligation, were governed by the laws of  the United States or a state of the United States.   

 

  55  [[5258451]]  (b) In the event that any Agent or Forward Purchaser that is a Covered Entity or a  BHC Act Affiliate of such Agent or Forward Purchaser becomes subject to a  proceeding under a U.S. Special Resolution Regime, Default Rights under this  Agreement, any Confirmation or any Terms Agreement that may be exercised  against such Agent or Forward Purchaser are permitted to be exercised to no  greater extent than such Default Rights could be exercised under the U.S. Special  Resolution Regime if this Agreement, any Confirmation or any Terms Agreement  were governed by the laws of the United States or a state of the United States.  Each of the parties hereto acknowledges that it is a sophisticated business person  who was adequately represented by counsel during negotiations regarding the provisions hereof,  including, without limitation, the indemnification provisions of Section 10 and the contribution  provisions of Section 11, and is fully informed regarding said provisions.  Each of the parties  hereto further acknowledges that the provisions of Sections 10 and 11 hereto fairly allocate the  risks in light of the ability of the parties to investigate the Company, its affairs and its business in  order to assure that adequate disclosure has been made in the Registration Statement, each free  writing prospectus and the Prospectus (and any amendments and supplements thereto), as  required by the Securities Act and the Exchange Act.  [Signature Pages Follow]  

 

 

 

 

 

  [Signature Page to Equity Distribution Agreement]  [[5258451]]  ACCEPTED as of the date first-above written:      BMO CAPITAL MARKETS CORP., as Agent    by      Name: Nick Stamou   Title: Director, Derivatives Operations        BANK OF MONTREAL, as Forward Purchaser    by      Name: Andrew Henderson   Title: Director, Derivatives Operations                                             

 

  [Signature Page to Equity Distribution Agreement]  [[5258451]]  ACCEPTED as of the date first-above written:      BOFA SECURITIES, INC., as Agent  by      Name: Gray Hampton   Title: Managing Director       BANK OF AMERICA, N.A., as Forward Purchaser  by      Name: Gray Hampton   Title: Managing Director                                                               

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  [Signature Page to Equity Distribution Agreement]  [[5258451]]  ACCEPTED as of the date first-above written:      MUFG SECURITIES AMERICAS INC., as Agent  by      Name: Jason Demark   Title: Director       MUFG SECURITIES EMEA PLC, as Forward  Purchaser  by      Name:    Title:                                                           

 

 

 

 

 

 

 

 

 

 

 

 

 

  [Signature Page to Equity Distribution Agreement]  [[5258451]]  ACCEPTED as of the date first-above written:      STIFEL, NICOLAUS & COMPANY,  INCORPORATED, as Agent  by      Name:    Title:                                                                           

 

 

 

 

 

SCHEDULE 1-A    [[5258451]]  FORM OF DIRECT INSTRUCTION NOTICE  From: [ ]  Cc: [ ]  To: [ ]  Subject:  Direct Sale Notice  Ladies and Gentlemen:  Pursuant to the terms and subject to the conditions contained in the Equity Distribution  Agreement among Sabra Health Care REIT, Inc. (the “Company”) and Barclays Capital Inc.,  BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Credit  Agricole Securities (USA) Inc., Fifth Third Securities, Inc., The Huntington Investment  Company, Jefferies LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Morgan  Stanley & Co. LLC, MUFG Securities Americas Inc., Raymond James & Associates, Inc., RBC  Capital Markets, LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., Stifel,  Nicolaus & Company, Incorporated, SunTrust Robinson Humphrey, Inc. and Wells Fargo  Securities, LLC, each as agent, forward seller, and/or as principal under any Terms Agreement  (as defined in Section 3 below) (in any such capacity, each an “Agent”, and collectively, the  “Agents”) and Barclays Bank PLC, Bank of Montreal, Bank of America, N.A., Citibank, N.A.,  Crédit Agricole Corporate and Investment Bank c/o Credit Agricole Securities (USA) Inc., as  agent, Jefferies LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, MUFG  Securities EMEA plc, Raymond James & Associates, Inc., Royal Bank of Canada, The Bank of  Nova Scotia and Wells Fargo Bank, National Association, each as a forward purchaser (in such  capacity, each a “Forward Purchaser”, and collectively, the “Forward Purchasers”), dated  December 11, 2019 (the “Distribution Agreement”), I hereby request on behalf of the Company  that [  ], acting as the Placement Agent on behalf of the Company, sell up to [[          ] shares] [$[                 ] in aggregate gross proceeds] of the Company’s Common Stock, issued pursuant to the  Distribution Agreement, at a minimum market price of $_______ per share, [with no limitation  on the number of Shares that may be sold on any single Trading Day][with no more than  [[          ] Shares][[          ] in aggregate gross proceeds] sold on any single Trading Day], during  the time period beginning [month, day, time] and ending [month, day, time] [the first date on  which the Placement Agent sells $[                ] in aggregate gross proceeds of the Company’s  Common Stock] [such date in the future as the Company shall notify the Placement Agent in  writing (including by email)].    Defined terms that are used but not defined herein shall have the meanings ascribed to them in  the Distribution Agreement.    

 

SCHEDULE 1-B    [[5258451]]  FORM OF FORWARD INSTRUCTION NOTICE  From: [ ]  Cc: [ ]  To: [ ]  Subject:  Forward Sale Notice  Ladies and Gentlemen:  Pursuant to the terms and subject to the conditions contained in the Equity Distribution  Agreement among Sabra Health Care REIT, Inc. (the “Company”) and Barclays Capital Inc.,  BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Credit  Agricole Securities (USA) Inc., Fifth Third Securities, Inc., The Huntington Investment  Company, Jefferies LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Morgan  Stanley & Co. LLC, MUFG Securities Americas Inc., Raymond James & Associates, Inc., RBC  Capital Markets, LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., Stifel,  Nicolaus & Company, Incorporated, SunTrust Robinson Humphrey, Inc. and Wells Fargo  Securities, LLC, each as agent, forward seller, and/or as principal under any Terms Agreement  (as defined in Section 3 below) (in any such capacity, each an “Agent”, and collectively, the  “Agents”) and Barclays Bank PLC, Bank of Montreal, Bank of America, N.A., Citibank, N.A.,  Crédit Agricole Corporate and Investment Bank c/o Credit Agricole Securities (USA) Inc., as  agent, Jefferies LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, MUFG  Securities EMEA plc, Raymond James & Associates, Inc., Royal Bank of Canada, The Bank of  Nova Scotia and Wells Fargo Bank, National Association, each as a forward purchaser (in such  capacity, each a “Forward Purchaser”, and collectively, the “Forward Purchasers”), dated  December 11, 2019 (the “Distribution Agreement”), the Company desires to enter into a  Forward, including a related Confirmation substantially consistent with the Form Confirmation,  in each case on the following terms:  Aggregate Maximum Forward Hedge Amount: $[●]  Minimum Price per Share: $[●]  Maturity Date: [●], 20[●]  Percentage for purposes of the Initial Forward Price: [●]%  Spread: [●]%  Minimum Settlement Shares: [●]  Initial Stock Loan Rate: [●]%  Maximum Stock Loan Rate: [●]%  

 

  [[5258451]]  Hedge Completion Date: [●], 20[●]  Forward Price Reduction Dates / Amounts ($): [●], 20[●]  / $[●]  [●], 20[●]  / $[●]  [●], 20[●]  / $[●]  [●], 20[●]  / $[●]      Defined terms that are used but not defined herein shall have the meanings ascribed to them in  the Distribution Agreement. 

 

SCHEDULE 2    [[5258451]]  THE COMPANY  SABRA HEALTH CARE REIT, INC.  Richard K. Matros  rmatros@sabrahealth.com  Harold W. Andrews, Jr. handrews@sabrahealth.com  Michael Costa   mcosta@sabrahealth.com  AGENTS AND FORWARD PURCHASERS  Barclays Capital Inc., as Agent  745 Seventh Avenue, New York, New York 10019  Attention: Daniel Sinni  Email: Daniel.Sinni@barclayscapital.com, nicholas.cunningham@barclays.com     Barclays Bank PLC, as Forward Purchaser  745 Seventh Avenue, New York, New York 10019  Attention: Paul Robinson  Email: paul.robinson1@barclays.com, nicholas.cunningham@barclays.com    BMO Capital Markets Corp., as Agent  3 Times Square, 25th Floor, New York, New York 10036  Attention: Eric Benedict  Facsimile: 212 702 1231  E-mail: Eric.Benedict@bmo.com, Jonathan.Li@bmo.com, Alexander.Watson@bmo.com,  Anthony.Albrecht@bmo.com, David1.Friedman@bmo.com, Jaryd.Banach@bmo.com,  Sarah.Bloom@bmo.com, Patrick.Rosenthal@bmo.com, Alice.liou@bmo.com,  William.levin@bmo.com; neil.dave@bmo.com, Steven.Devilbiss@bmo.com,  Andrew.Previc@bmo.com, jeff.brunswick@bmo.com    Bank of Montreal, as Forward Purchaser  3 Times Square, 25th Floor, New York, New York 10036  Attention: Eric Benedict  Facsimile: 212 702 1231  E-mail: Eric.Benedict@bmo.com, Jonathan.Li@bmo.com, Alexander.Watson@bmo.com,  Anthony.Albrecht@bmo.com, David1.Friedman@bmo.com, Jaryd.Banach@bmo.com,  Sarah.Bloom@bmo.com, Patrick.Rosenthal@bmo.com, Alice.liou@bmo.com,  William.levin@bmo.com; neil.dave@bmo.com, Steven.Devilbiss@bmo.com,  Andrew.Previc@bmo.com, jeff.brunswick@bmo.com    BofA Securities, Inc., as Agent  One Bryant Park, New York, New York 10036  Attention: DG ATM Execution, So Young Lee  E-mail: dg.atm_execution@bofa.com, soyoung.lee@bofa.com, rstewart4@bofa.com,  rohan.handa@bofa.com     

 

  [[5258451]]  Bank of America, N.A., as Forward Purchaser  One Bryant Park, New York, New York 10036  Attention: Robert Stewart, Rohan Handa  E-mail: dg.atm_execution@bofa.com, soyoung.lee@bofa.com, rstewart4@bofa.com,  rohan.handa@bofa.com     Citigroup Global Markets Inc., as Agent  388 Greenwich Street, New York, New York 10013  Attention: Robert G. Leonard, Matthew T. Morris, Adam Muchnick   E-mail: robert.g.leonard@citi.com, matthew.t.morris@citi.com, adam.muchnick@citi.com    Citibank, N.A., as Forward Purchaser  388 Greenwich Street, New York, New York 10013  Attention: Robert G. Leonard, Matthew T. Morris, Adam Muchnick   E-mail: robert.g.leonard@citi.com, matthew.t.morris@citi.com, adam.muchnick@citi.com    Credit Agricole Securities (USA) Inc., as Agent  1301 Avenue of the Americas, New York, New York 10019  Attention: Douglas Cheng  Facsimile: (212) 408-5652  E-mail: douglas.cheng@ca-cib.com, yuliya.nisnevich@ca-cib.com, luis.vonhoroch@ca- cib.com, paul.magliola@ca-cib.com, george.qian@ca-cib.com, equitycapitalmarkets@ca- cib.com, jean.bel@ca-cib.com, jonathan.fecowicz@ca-cib.com, antoine.jounet@ca-cib.com    Crédit Agricole Corporate and Investment Bank, c/o Credit Agricole Securities (USA) Inc.,  as agent, as Forward Purchaser  1301 Avenue of the Americas, New York, New York 10019  Attention: Douglas Cheng  Facsimile: (212) 408-5652  E-mail: douglas.cheng@ca-cib.com, yuliya.nisnevich@ca-cib.com, luis.vonhoroch@ca- cib.com, paul.magliola@ca-cib.com, george.qian@ca-cib.com, equitycapitalmarkets@ca- cib.com, jean.bel@ca-cib.com, jonathan.fecowicz@ca-cib.com, antoine.jounet@ca-cib.com    Fifth Third Securities, Inc., as Agent  424 Church Street, Suite 600, Nashville, Tennessee 37219  Attention: Michael Ryan  Facsimile: 615-687-3088   E-mail: Michael.Perillo@53.com, michael.ryan@53.com, susannah.lunke@53.com,  paul.gerwe@53.com, ioanis.jorgali@53.com, michael.bertkau@53.com, Kyle.sieg@53.com    The Huntington Investment Company, as Agent  41 South High Street, Columbus, Ohio 43215  Attention: Peter Dippolito  Facsimile: 888-409-9487  

 

  [[5258451]]  E-mail: Matt.Milcetich@Huntington.com, Peter.Dippolito@Huntington.com,  Jay.Clutter@Huntington.com, Barry.Fredrickson@Huntington.com,   Elizabeth.M.Hill@Huntington.com, John.Szwagulak@Huntington.com    Jefferies LLC, as Agent  520 Madison Avenue, New York, New York 10022  Attention: : Keith Lockwood, Mike Judlowe, Mike Magarro, Don Lynaugh  Facsimile: (646) 619-4437  E-mail: klockwood@Jefferies.com, mjudlowe@jefferies.com, mmagarro@jefferies.com,  dlynaugh@jefferies.com    Jefferies LLC, as Forward Purchaser  520 Madison Avenue, New York, New York 10022  Attention: : Colyer Curtis, Tim O’Connor , Sonia Han Levovitz and Dawn Pieper  Facsimile: (646) 619-4437  E-mail: ccurtis@jefferies.com, Tim.OConnor@Jefferies.com, shan@jefferies.com,  dpieper@jefferies.com    KeyBanc Capital Markets Inc., as Agent  127 Public Square, 4th Floor, Cleveland, Ohio 44114  Attention: Dave Gruber, John Horrigan, Paul Hodermarsky, Michael Jones  E-mail: dgruber@key.com, jhorrigan@key.com, phodermarsky@key.com,  Michael.c.jones@key.com    KeyBanc Capital Markets Inc., as Forward Purchaser  127 Public Square, 4th Floor, Cleveland, Ohio 44114  Attention: Dave Gruber, John Horrigan, Paul Hodermarsky, Michael Jones  E-mail: dgruber@key.com, jhorrigan@key.com, phodermarsky@key.com,  Michael.c.jones@key.com    Mizuho Securities USA LLC, as Agent  320 Park Avenue – 12th Floor, New York, New York 10022  Attention: Equity Capital Markets Desk   Email:  US-ECM@mizuhogroup.com  With a copy to: legalnotices@mizuhogroup.com, Attention: Office of the General Counsel    Morgan Stanley & Co. LLC, as Agent  1585 Broadway, New York, New York 10036  Attention: Equity Syndicate Desk  Copy to: Legal Department  E-mail: matthew.johnson@morganstanley.com; kent.leung@morganstanley.com;  kevin.moran@morganstanley.com; jesse.treverton@morganstanley.com;  joanna.wan@morganstanley.com; edward.molloy@morganstanley.com;  jon.sierant@morganstanley.com; minoshka.narayan@morganstanley.com;  kyle.mcdonnell@morganstanley.com; michael.m.kim@morganstanley.com;  

 

  [[5258451]]  mona.shin@morganstanley.com; alexander.csordas@morganstanley.com;  Steven.Seltzer1@morganstanley.com    Morgan Stanley & Co. LLC, as Forward Purchaser  1585 Broadway, New York, New York 10036  Attention: Equity Syndicate Desk  Copy to: Legal Department  E-mail: matthew.johnson@morganstanley.com; kent.leung@morganstanley.com;  kevin.moran@morganstanley.com; jesse.treverton@morganstanley.com;  joanna.wan@morganstanley.com; edward.molloy@morganstanley.com;  jon.sierant@morganstanley.com; minoshka.narayan@morganstanley.com;  kyle.mcdonnell@morganstanley.com; michael.m.kim@morganstanley.com;  mona.shin@morganstanley.com; alexander.csordas@morganstanley.com;  Steven.Seltzer1@morganstanley.com    MUFG Securities Americas Inc., as Agent  1221 Avenue of the Americas, 6th Floor, New York, New York 10020  Attention: ETG  E-mail: jason.demark@mufgsecurities.com; andrew.wedderburn-maxwell@mufgsecurities.com;  buck.dodd@mufgsecurities.com; anastasios.wallingford@mufgsecurities.com;  suzy.trdoslavic@mufgsecurities.com;     MUFG Securities EMEA plc, as Forward Purchaser  Ropemaker Place, 25 Ropemaker Street, London EC2Y 9AJ, United Kingdom   Attention: Derivative Confirmations   Facsimilie: +44 207 577 2898 / 2875  E-mail: EquitySolutions-Notifications@int.sc.mufg.jp; Michael.Gordon@mufgsecurities.com;  Kathleen.Considine@mufgsecurities.com; ESG-ETG-Americas@mufgsecurities.com     Raymond James & Associates, Inc., as Agent  880 Carillon Parkway, St. Petersburg, Florida 33716  Attention: General Counsel  Facsimile: (727) 567-8247  E-mail: jozsi.popper@raymondjames.com, nolan.rivers@raymondjames.com,  michael.hatch@raymondjames.com, kent.nelson@raymondjames.com,  sean.wolf@raymondjames.com, logan.lane@raymondjames.com,  jeff.fordham@raymondjames.com, jeanna.bryan@raymondjames.com,  omar.delarosa@raymondjames.com, brandon.moore@raymondjames.com,  nicole.castillo@raymondjames.com, brad.cole@raymondjames.com    Raymond James & Associates, Inc., as Forward Purchaser  880 Carillon Parkway, St. Petersburg, Florida 33716  Attention: General Counsel  Facsimile: (727) 567-8247  E-mail: jozsi.popper@raymondjames.com, nolan.rivers@raymondjames.com,  michael.hatch@raymondjames.com, kent.nelson@raymondjames.com,  

 

  [[5258451]]  sean.wolf@raymondjames.com, logan.lane@raymondjames.com,  jeff.fordham@raymondjames.com, jeanna.bryan@raymondjames.com,  omar.delarosa@raymondjames.com, brandon.moore@raymondjames.com,  nicole.castillo@raymondjames.com, brad.cole@raymondjames.com    RBC Capital Markets, LLC, as Agent   200 Vesey Street, New York, NY 10281  Attention: RBC Equity Capital Markets Team  Facsimile: (212) 428-6260  E-mail: Ivana.Rupcic-Hulin@rbccm.com,  Andrew.Jones@rbccm.com     Royal Bank of Canada, as Forward Purchaser  200 Vesey Street, New York, NY 10281  Attention: RBC Equity-Linked Team  Facsimile: (212) 428-6260  E-mail: RBCECMCorporateEquityLinkedDocumentation@rbc.com     Scotia Capital (USA) Inc., as Agent  250 Vesey Street, 24th Floor, New York, New York 10281  Attention: Chief Legal Officer, U.S.  Copies (which shall not constitute notice) to:  Chief Legal Officer, U.S.  Facsimile: (212) 225-6550  E-mail: us.ecm@scotiabank.com, us.legal@scotiabank.com    The Bank of Nova Scotia, as Forward Purchaser  250 Vesey Street, 24th Floor, New York, New York 10281  Attention: Chief Legal Officer, U.S.  Copies (which shall not constitute notice) to:  Chief Legal Officer, U.S.  Facsimile: (212) 225-6550  E-mail: us.ecm@scotiabank.com, us.legal@scotiabank.com    SMBC Nikko Securities America, Inc., as Agent  277 Park Avenue, 5th Floor, New York, New York 10172  Attention: Equity Capital Markets   Facsimile: (212) 224-4954   E-mail: james_d_benko@smbcgroup.com, MPetropoulos@smbcnikko-si.com, jae- in_hwang@smbcgroup.com, MikeAWalsh@smbcnikko-si.com, garpaia@smbcnikko-si.com,  elarrison@smbcnikko-si.com, sshin@smbcnikko-si.com, patrick_brake@smbcgroup.com,  nyecm@smbcnikko-si.com     Stifel, Nicolaus & Company, Incorporated, as Agent  One South Street, 15th Floor, Baltimore, Maryland 21202  Attention: Syndicate Department  Facsimile: (443) 224-1273  E-mail: cmgorsuch@stifel.com, zimmermans@stifel.com, dcovatta@stifel.com,  whitem@stifel.com, sahill@stifel.com  

 

  [[5258451]]    SunTrust Robinson Humphrey, Inc., as Agent  3333 Peachtree Rd., NE, 11th Floor, Atlanta, Georgia 30326  Attention: Keith Carpenter and Geoff Fennel  Facsimile: (404) 926-5872  E-mail: keith.carpenter@suntrust.com; geoff.fennel@suntrust.com; james.pirouz@suntrust.com;  alan.germano@suntrust.com; garrett.tash@suntrust.com; adam.j.humphreys@suntrust.com;  carney.simpson@suntrust.com; christine.gallagher@suntrust.com; elise.lind@suntrust.com;  william.turner@suntrust.com; jonathan.coutts@suntrust.com; bill.monroe@suntrust.com    Wells Fargo Securities, LLC, as Agent  375 Park Avenue, New York, New York 10152  Attention: Equity Syndicate Department  Facsimile: (212) 214- 5918  E-mail: CorporateDerivativeNotifications@wellsfargo.com    Wells Fargo Bank, National Association, as Forward Purchaser  375 Park Avenue, New York, New York 10152  Attention: Structuring Services Group  Facsimile: (212) 214- 5913  E-mail: CorporateDerivativeNotifications@wellsfargo.com      

 

SCHEDULE 3  [[5258451]]  FREE WRITING PROSPECTUS  None.  

 

SCHEDULE 4    [[5258451]]  AGENT AND FORWARD PURCHASER CONTACTS FOR FUTURE REPORTS  Barclays Capital Inc., as Agent  745 Seventh Avenue, New York, New York 10019  Attention: Daniel Sinni  Email: Daniel.Sinni@barclayscapital.com    Barclays Bank PLC, as Forward Purchaser  745 Seventh Avenue, New York, New York 10019  Attention: Paul Robinson  Email: paul.robinson1@barclays.com    BMO Capital Markets Corp., as Agent  3 Times Square, 25th Floor, New York, New York 10036  Attention: Eric Benedict  E-mail: Eric.Benedict@bmo.com, Jonathan.Li@bmo.com, Alexander.Watson@bmo.com,  Anthony.Albrecht@bmo.com, David1.Friedman@bmo.com, Jaryd.Banach@bmo.com,  Sarah.Bloom@bmo.com, Patrick.Rosenthal@bmo.com, Alice.liou@bmo.com,  William.levin@bmo.com; neil.dave@bmo.com, Steven.Devilbiss@bmo.com,  Andrew.Previc@bmo.com, jeff.brunswick@bmo.com    Bank of Montreal, as Forward Purchaser  3 Times Square, 25th Floor, New York, New York 10036  Attention: Eric Benedict  E-mail: Eric.Benedict@bmo.com, Jonathan.Li@bmo.com, Alexander.Watson@bmo.com,  Anthony.Albrecht@bmo.com, David1.Friedman@bmo.com, Jaryd.Banach@bmo.com,  Sarah.Bloom@bmo.com, Patrick.Rosenthal@bmo.com, Alice.liou@bmo.com,  William.levin@bmo.com; neil.dave@bmo.com, Steven.Devilbiss@bmo.com,  Andrew.Previc@bmo.com, jeff.brunswick@bmo.com    BofA Securities, Inc., as Agent  One Bryant Park, New York, New York 10036  Attention: DG ATM Execution, So Young Lee  E-mail: dg.atm_execution@bofa.com, soyoung.lee@bofa.com, rstewart4@bofa.com,  rohan.handa@bofa.com     Bank of America, N.A., as Forward Purchaser  One Bryant Park, New York, New York 10036  Attention: Robert Stewart, Rohan Handa  E-mail: dg.atm_execution@bofa.com, soyoung.lee@bofa.com, rstewart4@bofa.com,  rohan.handa@bofa.com     Citigroup Global Markets Inc., as Agent  388 Greenwich Street, New York, New York 10013  Attention: Robert G. Leonard, Matthew T. Morris, Adam Muchnick   E-mail: robert.g.leonard@citi.com, matthew.t.morris@citi.com, adam.muchnick@citi.com  

 

    [[5258451]]    Citibank, N.A., as Forward Purchaser  388 Greenwich Street, New York, New York 10013  Attention: Robert G. Leonard, Matthew T. Morris, Adam Muchnick   E-mail: robert.g.leonard@citi.com, matthew.t.morris@citi.com, adam.muchnick@citi.com    Credit Agricole Securities (USA) Inc., as Agent  1301 Avenue of the Americas, New York, New York 10019  Attention: Equity Capital Markets Desk  Email: equitycapitalmarkets@ca-cib.com    Crédit Agricole Corporate and Investment Bank, as Forward Purchaser  1301 Avenue of the Americas, New York, New York 10019  Attention: Equity Capital Markets Desk  Email: equitycapitalmarkets@ca-cib.com    Fifth Third Securities, Inc., as Agent  424 Church Street, Suite 600, Nashville, Tennessee 37219  Attention: Michael Ryan, Susannah Lunke & Paul Gerwe  Email:  michael.ryan@53.com, Susannah.lunke@53.com, paul.gerwe@53.com    The Huntington Investment Company, as Agent  41 South High Street, Columbus, Ohio 43215  Attention: Peter Dippolito & Elizabeth Hill    Jefferies LLC, as Agent  520 Madison Avenue, New York, New York 10022  Attention: General Counsel  E-mail: klockwood@Jefferies.com, mjudlowe@jefferies.com, mmagarro@jefferies.com,  dlynaugh@jefferies.com    Jefferies LLC, as Forward Purchaser  520 Madison Avenue, New York, New York 10022  Attention: General Counsel  E-mail: ccurtis@jefferies.com, Tim.OConnor@Jefferies.com, shan@jefferies.com,  dpieper@jefferies.com    KeyBanc Capital Markets Inc., as Agent  127 Public Square, 4th Floor, Cleveland, Ohio 44114  Attention: Dave Gruber, John Horrigan, Paul Hodermarsky, Michael Jones  E-mail: dgruber@key.com, jhorrigan@key.com, phodermarsky@key.com,  Michael.c.jones@key.com    KeyBanc Capital Markets Inc., as Forward Purchaser  127 Public Square, 4th Floor, Cleveland, Ohio 44114  Attention: Dave Gruber, John Horrigan, Paul Hodermarsky, Michael Jones  

 

    [[5258451]]  E-mail: dgruber@key.com, jhorrigan@key.com, phodermarsky@key.com,  Michael.c.jones@key.com    Mizuho Securities USA LLC, as Agent  320 Park Avenue – 12th Floor, New York, New York 10022  Attention: Equity Capital Markets Desk, : Office of the General Counsel  Email:  US-ECM@mizuhogroup.com, legalnotices@mizuhogroup.com    Morgan Stanley & Co. LLC, as Agent  1585 Broadway, New York, New York 10036  Attention: Equity Syndicate Desk  Email: matthew.johnson@morganstanley.com; kent.leung@morganstanley.com;  kevin.moran@morganstanley.com; jesse.treverton@morganstanley.com;  joanna.wan@morganstanley.com; edward.molloy@morganstanley.com;  jon.sierant@morganstanley.com; minoshka.narayan@morganstanley.com;  kyle.mcdonnell@morganstanley.com; michael.m.kim@morganstanley.com;  mona.shin@morganstanley.com; alexander.csordas@morganstanley.com;  Steven.Seltzer1@morganstanley.com    Morgan Stanley & Co. LLC, as Forward Purchaser  1585 Broadway, New York, New York 10036  Attention: Equity Syndicate Desk  Email: matthew.johnson@morganstanley.com; kent.leung@morganstanley.com;  kevin.moran@morganstanley.com; jesse.treverton@morganstanley.com;  joanna.wan@morganstanley.com; edward.molloy@morganstanley.com;  jon.sierant@morganstanley.com; minoshka.narayan@morganstanley.com;  kyle.mcdonnell@morganstanley.com; michael.m.kim@morganstanley.com;  mona.shin@morganstanley.com; alexander.csordas@morganstanley.com;  Steven.Seltzer1@morganstanley.com    MUFG Securities Americas Inc., as Agent  1221 Avenue of the Americas, 6th Floor, New York, New York 10020  Attention: ETG  Email: ETG@us.sc.mufg.jp    MUFG Securities EMEA plc, as Forward Purchaser  Ropemaker Place, 25 Ropemaker Street, London EC2Y 9AJ, United Kingdom   Attention: Derivative Confirmations   Email: docsconfirms@int.sc.mufg.jp, EquitySolutions-Notifications@int.sc.mufg.jp,  Michael.Gordon@mufgsecurities.com, Kathleen.Considine@mufgsecurities.com, ESG-ETG- Americas@mufgsecurities.com    Raymond James & Associates, Inc., as Agent  880 Carillon Parkway, St. Petersburg, Florida 33716  Attention: General Counsel  

 

    [[5258451]]  E-mail: jozsi.popper@raymondjames.com, nolan.rivers@raymondjames.com,  michael.hatch@raymondjames.com, kent.nelson@raymondjames.com,  sean.wolf@raymondjames.com, logan.lane@raymondjames.com,  jeff.fordham@raymondjames.com, jeanna.bryan@raymondjames.com,  omar.delarosa@raymondjames.com, brandon.moore@raymondjames.com,  nicole.castillo@raymondjames.com, brad.cole@raymondjames.com    Raymond James & Associates, as Forward Purchaser  880 Carillon Parkway, St. Petersburg, Florida 33716  Attention: General Counsel  E-mail: jozsi.popper@raymondjames.com, nolan.rivers@raymondjames.com,  michael.hatch@raymondjames.com, kent.nelson@raymondjames.com,  sean.wolf@raymondjames.com, logan.lane@raymondjames.com,  jeff.fordham@raymondjames.com, jeanna.bryan@raymondjames.com,  omar.delarosa@raymondjames.com, brandon.moore@raymondjames.com,  nicole.castillo@raymondjames.com, brad.cole@raymondjames.com    RBC Capital Markets, LLC, as Agent   Royal Bank of Canada, as Forward Purchaser   200 Vesey Street, New York, NY 10281  Attention:  RBC ECM Equity-Linked Team    Scotia Capital (USA) Inc., as Agent  250 Vesey Street, 24th Floor, New York, New York 10281  Attention: Chief Legal Officer, U.S.  E-mail: us.ecm@scotiabank.com, us.legal@scotiabank.com    The Bank of Nova Scotia, as Forward Purchaser  250 Vesey Street, 24th Floor, New York, New York 10281  Attention: Chief Legal Officer, U.S.  E-mail: us.ecm@scotiabank.com, us.legal@scotiabank.com    SMBC Nikko Securities America, Inc., as Agent  277 Park Avenue, 5th Floor, New York, New York 10172  Attention: Equity Capital Markets  E-mail: james_d_benko@smbcgroup.com, MPetropoulos@smbcnikko-si.com, jae- in_hwang@smbcgroup.com, MikeAWalsh@smbcnikko-si.com, garpaia@smbcnikko-si.com,  elarrison@smbcnikko-si.com, sshin@smbcnikko-si.com, patrick_brake@smbcgroup.com,  nyecm@smbcnikko-si.com     Stifel, Nicolaus & Company, Incorporated, as Agent  One South Street, 15th Floor, Baltimore, Maryland 21202  Attention: Syndicate Department  E-mail: cmgorsuch@stifel.com, zimmermans@stifel.com, dcovatta@stifel.com,  whitem@stifel.com, sahill@stifel.com    

 

    [[5258451]]  SunTrust Robinson Humphrey, Inc., as Agent  3333 Peachtree Rd., NE, 11th Floor, Atlanta, Georgia 30326  Attention: Keith Carpenter and Geoff Fennel  E-mail: keith.carpenter@suntrust.com; geoff.fennel@suntrust.com; james.pirouz@suntrust.com;  alan.germano@suntrust.com; garrett.tash@suntrust.com; adam.j.humphreys@suntrust.com;  carney.simpson@suntrust.com; christine.gallagher@suntrust.com; elise.lind@suntrust.com;  william.turner@suntrust.com; jonathan.coutts@suntrust.com; bill.monroe@suntrust.com    Wells Fargo Securities, LLC, as Agent  375 Park Avenue, New York, New York 10152  Attention: Equity Syndicate Department  E-mail: CorporateDerivativeNotifications@wellsfargo.com    Wells Fargo Bank, National Association, as Forward Purchaser  375 Park Avenue, New York, New York 10152  Attention: Structuring Services Group  Email: CorporateDerivativeNotifications@wellsfargo.com 

 

Exhibit 3(b)    [[5556494]]  FORM OF FORWARD CONFIRMATION  Date:  [●], 20[●]  To: Sabra Health Care REIT, Inc.  18500 Von Karman Avenue, Suite 550   Irvine, California 92612  From:  [DEALER NAME AND NOTICE INFORMATION]    Re:  Registered Forward Transaction  Ladies and Gentlemen:  The purpose of this letter agreement is to set forth certain terms and conditions of the  transaction entered into between [DEALER NAME] (“Forward Purchaser”) and Sabra Health  Care REIT, Inc. (the “Company”) in accordance with and subject to the terms of the Equity  Distribution Agreement (as defined below) on the Trade Date specified below (the  “Transaction”). This letter agreement, as supplemented by the pricing supplement in respect of  the Transaction in substantially the form of Annex B hereto (the “Pricing Supplement”) is a  “Confirmation” for purposes of the Agreement specified below and a confirmation for purposes  of Rule 10b-10 promulgated under the Securities Exchange Act of 1934, as amended (the  “Exchange Act”).     The definitions and provisions contained in the 2002 ISDA Equity Derivatives  Definitions (the “Definitions”), as published by the International Swaps and  Derivatives Association, Inc., are incorporated into this Confirmation.  In the event of  any inconsistency between the Definitions and this Confirmation, this Confirmation  will govern.   Each party further agrees that this Confirmation, as supplemented by the Pricing  Supplement delivered hereunder and the Agreement, together evidence a complete binding  agreement between Forward Purchaser and the Company as to the subject matter and terms of  the Transaction to which this Confirmation relates, and shall supersede all prior or  contemporaneous written or oral communications with respect thereto.  This Confirmation,  together with any Confirmations relating to additional registered forward transactions entered  into between Forward Purchaser and the Company in connection with the Equity Distribution  Agreement (as defined below) (each such registered forward transaction, an “Additional  Transaction” and each Confirmation relating thereto, an “Additional Confirmation”) shall  supplement, form a part of, and be subject to an agreement in the form of the 2002 ISDA Master  Agreement (the “Agreement”) as if Forward Purchaser and the Company had executed an  agreement in such form on the Trade Date and with a schedule thereto setting forth (i) the  election of New York law (without regard to New York’s choice of laws doctrine other than Title  14 of Article 5 of the New York General Obligations Law) as the governing law and U.S.  Dollars (“USD”) as the Termination Currency and (ii) the elections set forth in this  Confirmation.  In the event of any inconsistency between the Agreement, this Confirmation and  the Definitions, the following will prevail for purposes of the Transaction in the order of  

 

2      [[5556494]]  precedence indicated: (i) this Confirmation; (ii) the Definitions; and (iii) the Agreement.  The  parties hereby agree that no Transaction other than the Transaction to which this Confirmation  relates and the Additional Transactions shall be governed by the Agreement.  For purposes of the  Definitions, the Transaction is a Share Forward Transaction.   Forward Purchaser and the Company each represent to the other that it has entered into  the Transaction in reliance upon such tax, accounting, regulatory, legal and financial advice as it  deems necessary and not upon any view expressed by the other.    The terms of the particular Transaction to which this Confirmation relates are as  follows:   General Terms:  Trade Date: [●], 20[●]  Effective Date: The first day occurring on or after the Trade Date on which  Shares that are sold through [AGENT NAME]1, acting as  forward seller for Forward Purchaser (in such capacity, the  “Agent”) pursuant to the Equity Distribution Agreement,  dated December 11, 2019 among Forward Purchaser, the  Company, the Agent and the other parties thereto (the  “Equity Distribution Agreement”), settle, or such later date  on which the conditions set forth in Section 3 of this  Confirmation shall have been satisfied.  Initial Base Amount: The aggregate number of Shares sold through the Agent,  acting as forward seller for Forward Purchaser pursuant to  the Equity Distribution Agreement, during the period from  and including the Trade Date through and including the  Hedge Completion Date.  Base Amount: On any day, the Initial Base Amount, reduced by the number  of Settlement Shares for Settlements occurring on or before  such day and as adjusted in accordance with the terms of this  Confirmation.  Maturity Date: The earlier of (i) [DATE]2 (or, if such date is not a Scheduled  Trading Day, the next following Scheduled Trading Day) and  (ii) the date on which the Base Amount is reduced to zero.                                                    1 Insert name of Agent affiliate party to Equity Distribution Agreement.  2 To be the Maturity Date specified in the Forward Instruction Notice accepted by the Forward Purchaser and a  date no later than the one year anniversary of the Trade Date.  

 

3      [[5556494]]  Hedge Completion Date: The earliest of (i) [DATE]3 (or, if such date is not a  Scheduled Trading Day, the next following Scheduled  Trading Day), (ii) the date specified in the Pricing  Supplement and (iii) the 20th Scheduled Trading Day  following, but not including, the Trade Date.  No later than  7:00 p.m. New York time, on the Scheduled Trading Day  immediately following the Hedge Completion Date, Forward  Purchaser will furnish the Company with the Pricing  Supplement specifying the Hedge Completion Date, the Base  Amount as of the Hedge Completion Date (the “Initial Base  Amount”) and the Initial Forward Price, each determined in  accordance with the terms hereof.  Upon request of the  Company, Forward Purchaser shall provide written support  for the calculation of the Initial Forward Price, it being  agreed and understood that Forward Purchaser shall not be  obligated to disclose any confidential or proprietary models  or other information that Forward Purchaser believes to be  confidential, proprietary or subject to contractual, legal or  regulatory obligations not to disclose such information, in  each case, used by it for such calculation.  Forward Hedge Selling  Period:  The period of consecutive Exchange Business Days  beginning on and including, the later of the date specified in  the Forward Instruction Notice or the Trade Date and ending  on and including the Hedge Completion Date; provided,  however, that if, at any time on or prior to the Hedge  Completion Date (x) any event occurs that would permit the  Forward Purchaser to designate a “Termination Settlement  Date” (as defined below) or an Early Termination Date or (y)  a “Bankruptcy Termination Event” (as defined below)  occurs, then the Forward Hedge Selling Period shall  terminate, and the Hedge Completion Date be deemed to  occur, immediately upon the Forward Purchaser becoming  aware of any such event.  Forward Price: On the Hedge Completion Date, the Initial Forward Price,  and on any other day, as determined by the Calculation  Agent, the Forward Price as of the immediately preceding  calendar day multiplied by the sum of (i) 1 and (ii) the Daily  Rate for such day; provided that on each Forward Price  Reduction Date4, the Forward Price in effect on such date                                                    3 To be the Hedge Completion Date specified in the Forward Instruction Notice accepted by the Forward  Purchaser.  4 Forward Price Reduction Dates to be the “ex-dividend” dates for each quarterly dividend as set forth in the  Forward Instruction Notice.    

 

4      [[5556494]]  shall be the Forward Price otherwise in effect on such date,  minus the Forward Price Reduction Amount for such  Forward Price Reduction Date.   Notwithstanding anything to the contrary contained herein, to  the extent the Company delivers Shares hereunder on or after  a Forward Price Reduction Date and at or before the record  date for an ordinary cash dividend with an ex-dividend date  corresponding to such Forward Price Reduction Date, the  Calculation Agent shall adjust the Forward Price to the  extent it determines, in good faith and its commercially  reasonable discretion, that such an adjustment is practicable  and appropriate to preserve the economic intent of the parties  hereto (taking into account Forward Purchaser’s  commercially reasonable hedge positions in respect of the  Transaction).  Initial Forward Price: [●]%5 of the volume-weighted average price at which the  Shares are sold through the Agent acting as forward seller for  Forward Purchaser pursuant to the Equity Distribution  Agreement during the period from and including the Trade  Date through and including the Hedge Completion Date, as  adjusted by the Calculation Agent to (x) reflect on each day  during such period (i) the sum of 1 and the Daily Rate for such  day multiplied by the then-Initial Forward Price as of such day  and (ii) the number of Shares sold on or prior to such day and  (y) reduce the then-Initial Forward Price by the relevant  Forward Price Reduction Amount on each Forward Price  Reduction Date occurring on or before the Hedge Completion  Date.  Daily Rate: For any day, as determined by the Calculation Agent, a rate  equal to (i)(A) the Overnight Bank Rate for such day, minus  (B) the Spread, divided by (ii) 365.  Overnight Bank Rate: For any day, the rate set forth for such day opposite the  caption “Overnight Bank Funding Rate”, as such rate is  displayed on the page “OBFR01 <Index> <GO>” on the  BLOOMBERG Professional Service, or any successor page;  provided that, if no rate appears on any day on such page, the  rate for the immediately preceding day for which a rate does  so appear shall be used for such day.                                                    5 Insert percentage equal to 100 minus the agreed upon commission (which shall not exceed 1.5%), as specified  in the Forward Instruction Notice.  

 

5      [[5556494]]  Spread: [●]6 basis points.  Prepayment: Not Applicable.  Variable Obligation: Not Applicable.  Forward Price Reduction  Date:  Each date (other than the Trade Date) set forth on Schedule I  under the heading “Forward Price Reduction Date”.  Forward Price Reduction  Amount:  For each Forward Price Reduction Date, the Forward Price  Reduction Amount set forth opposite such date on Schedule I.  Shares: Common stock, USD 0.01 par value per share, of the  Company (also referred to herein as the “Issuer”) (Exchange  identifier: “SBRA”).  Exchange: Nasdaq Global Select Market.  Related Exchange(s): All Exchanges.  Clearance System: The Depository Trust Company.  Calculation Agent: Forward Purchaser.  In the event the Calculation Agent or the  Determining Party makes any calculations, adjustments or  determinations pursuant to this Confirmation, the Agreement  or the Definitions, the Calculation Agent or the Determining  Party, as the case may be, shall within a commercially  reasonable time after receipt of a request therefor by the  Company, provide to the Company at the email address  specified in such request, a report (in a commonly used file  format for the storage and manipulation of financial data)  displaying in reasonable detail the basis for any such  calculation, adjustment or determination (including any  quotations, market data or information from external sources  used in making such calculation, adjustment or determination,  as the case may be, but without disclosing its proprietary or  confidential models or other information that is proprietary or  subject to contractual, legal or regulatory obligations to not  disclose such information); provided that following the  occurrence and during the continuation of an Event of Default  under Section 5(a)(vii) of the Agreement with respect to  which Forward Purchaser is the Defaulting Party, the  Company shall have the right to designate a nationally- recognized third-party dealer in over-the-counter U.S.  corporate equity derivatives to act as the Calculation Agent.                                                     6 Insert Spread specified in the Forward Instruction Notice.   

 

6      [[5556494]]  Whenever the Calculation Agent or the Determining Party is  required or permitted to act or to exercise judgment in any  way with respect to any Transaction hereunder, including,  without limitation, with respect to calculations, adjustments  and determinations that are made in its sole discretion or  otherwise, the Calculation Agent or the Determining Party, as  applicable, shall do so in good faith and in a commercially  reasonable manner.  Settlement Terms:   Settlement Date: Any Scheduled Trading Day following the Effective Date and  up to and including the Maturity Date, as designated by  (a) Forward Purchaser pursuant to “Termination Settlement”  below or (b) the Company in a written notice that satisfies the  Settlement Notice Requirements (a “Settlement Notice”) and  is delivered to Forward Purchaser at least (i) two Scheduled  Trading Days prior to such Settlement Date, which may be  the Maturity Date, if Physical Settlement applies, and (ii) [●]7  Scheduled Trading Days prior to such Settlement Date, which  may be the Maturity Date, if Cash Settlement or Net Share  Settlement applies; provided that the Maturity Date shall be a  Settlement Date if on such date the Base Amount is greater  than zero; and provided, further, if Cash Settlement or Net  Share Settlement applies and Forward Purchaser shall have  fully unwound its hedge during an Unwind Period by a date  that is more than two Scheduled Trading Days prior to a  Settlement Date specified above, Forward Purchaser may, by  written notice to the Company, specify any Scheduled  Trading Day prior to such originally specified Settlement  Date as the Settlement Date.  Settlement Shares: With respect to any Settlement Date, a number of Shares, not  to exceed the Undesignated Shares and not less than the  Minimum Settlement Shares, designated as such by the  Company in a Settlement Notice meeting the Settlement  Notice Requirements or by Forward Purchaser pursuant to  “Termination Settlement” below; provided that on the  Maturity Date the number of Settlement Shares shall be equal  to the Base Amount on such date.                                                    7 To be the number of Scheduled Trading Days specified as the Unwind Period in the Forward Instruction  Notice.  

 

7      [[5556494]]  Undesignated Shares: As of any date, the Base Amount minus the number of Shares  designated as Settlement Shares for Settlements for which the  Settlement Date has not occurred.  Settlement: Physical Settlement, Cash Settlement or Net Share Settlement,  at the election of the Company, as set forth in a Settlement  Notice that satisfies the Settlement Notice Requirements,  delivered to Forward Purchaser on any Scheduled Trading Day  after the Effective Date.   Notwithstanding any election to the contrary in any Settlement  Notice, Physical Settlement shall be applicable (i) if no  Settlement Method is validly elected, (ii) with respect to any  Settlement Shares in respect of which Forward Purchaser is, or  at any time during the Unwind Period becomes, unable, in its  good faith and commercially reasonable judgment, to unwind  its hedge by the end of the Unwind Period (x) in a manner that,  in the reasonable judgment of Forward Purchaser, based on the  advice of counsel, (A) is consistent with the requirements for  qualifying for the safe harbor provided by Rule 10b-18 under  the Exchange Act and (B) would not raise material risks of  noncompliance with applicable securities laws or (y) due to  the occurrence of one or more Disrupted Days (in whole or in  part) or due to the lack of sufficient liquidity in the Shares on  any Exchange Business Day during the Unwind Period relative  to the liquidity on the Effective Date (iii) to any Termination  Settlement Date (as defined below under “Termination  Settlement”), (iv) if the Maturity Date is a Settlement Date  other than as the result of a valid Settlement Notice in respect  of such Settlement Date or (v) with respect to the Settlement  Shares in whole or in part as determined by the Forward  Purchaser if at any time from and including the date of  delivery of the Settlement Notice through and including the  last Exchange Business Day of the Unwind Period, the trading  price per Share on the Exchange (as determined by Forward  Purchaser in a commercially reasonable manner) is less than  $[●]8 (the “Threshold Price”).  Settlement Notice  Requirements; Valid  Election of Cash Settlement  or Net Share Settlement:  A Settlement Notice must be in writing and must specify a  number of Settlement Shares equal to or less than the  Undesignated Shares and equal to or greater than the  Minimum Settlement Shares.  Notwithstanding any other  provision hereof, a Settlement Notice delivered by the  Company that specifies Cash Settlement or Net Share                                                    8 To be equal to 50% of the Minimum Price specified in the Forward Instruction Notice.  

 

8      [[5556494]]  Settlement will not require Cash Settlement or Net Share  Settlement, and the Cash Settlement or Net Share Settlement  requested in such Settlement Notice will not, for purposes of  this Confirmation, be validly elected unless and until (A)  timely delivered in accordance with the provisions set forth  opposite “Settlement Date” above, (B) specifying a number of  Settlement Shares no greater than the Undesignated Shares and  not less than the Minimum Settlement Shares, (C) for which  the Unwind Period will not overlap with the unwind period (or  any similar such period) or any forward hedge selling period  (or any similar such period) in each case for any other  transaction with any other agent or forward purchaser pursuant  to the Equity Distribution Agreement and (D) including in the  Settlement Notice containing such election the following  representations and warranties to Forward Purchaser as of the  date of such Settlement Notice: (i) the Company is not aware  of any material nonpublic information concerning itself or the  Shares, (ii) the Company is electing the settlement method and  designating the First Unwind Date specified in such Settlement  Notice in good faith and not as part of a plan or scheme to  evade compliance with Rule 10b-5 under the Exchange Act  (“Rule 10b-5”) or any other provision of the federal securities  laws, (iii) the Company is not “insolvent” (as such term is  defined under Section 101(32) of the U.S. Bankruptcy Code  (Title 11 of the United States Code) (the “Bankruptcy  Code”)), (iv) the Company would be able to purchase a  number of Shares equal to the greater of (x) the number of  Settlement Shares designated in such Settlement Notice and  (y) a number of Shares with a value as of the date of such  Settlement Notice equal to the product of (I) such number of  Settlement Shares and (II) the applicable Relevant Forward  Price for such Cash Settlement or Net Share Settlement in  compliance with the laws of the Company’s jurisdiction of  organization, (v) such election, and settlement in accordance  therewith, does not violate or conflict with any law or  regulation applicable to the Company, or any order or  judgment of any court or other agency of government  applicable to it or any of its assets and (vi) the Unwind Period  will not overlap with the unwind period (or any similar such  period) or any forward hedge selling period (or any similar  such period) in each case for any other transaction with any  other agent or forward purchaser pursuant to the Equity  Distribution Agreement.   

 

9      [[5556494]]  Minimum Settlement Shares [●]9  Unwind Period: The period from and including the first Exchange Business  Day following the date on which Forward Purchaser has  received from the Company a Settlement Notice satisfying the  Settlement Notice Requirements and validly electing Cash  Settlement or Net Share Settlement in respect of a Settlement  Date through the second Exchange Business Day preceding  such Settlement Date; subject to “Termination Settlement”  below.    Unwind Period Disrupted  Days:  If any Scheduled Trading Day during an Unwind Period is a  Disrupted Day in whole or in part, the Calculation Agent shall  make commercially reasonable adjustments to the terms of the  Transaction (including, without limitation, the Cash Settlement  Amount, the number of Net Share Settlement Shares and the  Settlement Price) to account for the occurrence of each such  Disrupted Day.  Market Disruption Event: Section 6.3(a) of the Definitions is hereby amended by  replacing the first sentence in its entirety with the following:   “‘Market Disruption Event’ means in respect of a Share or an  Index, the occurrence or existence at any time of (i) a Trading  Disruption, (ii) an Exchange Disruption, (iii) an Early Closure  or (iv) a Regulatory Disruption, in each case, that the  Calculation Agent determines, in its commercially reasonable  judgment, is material.”  Early Closure: Section 6.3(d) of the Definitions is hereby amended by  deleting the remainder of the provision following the term  “Scheduled Closing Time” in the fourth line thereof.  Regulatory Disruption: Any event that Forward Purchaser, in its reasonable discretion,  based on advice of counsel, determines makes it appropriate  with regard to any legal, regulatory or self-regulatory  requirements or related policies and procedures (that generally  apply to transactions of a nature and kind similar to the  Transaction and have been adopted in good faith by Forward  Purchaser) for Forward Purchaser to refrain from or decrease  any market activity in connection with the Transaction.  For  the avoidance of doubt, a Scheduled Trading Day on which a  Regulatory Disruption occurs shall be a Disrupted Day in full.  Subject to applicable legal requirements and Forward  Purchaser’s internal policies and guidelines, Forward                                                    9 Insert the number specified as the Minimum Settlement Shares in the Forward Instruction Notice.  

 

10      [[5556494]]  Purchaser shall promptly notify the Company upon the  occurrence of a Regulatory Disruption and shall subsequently  promptly notify the Company on the day Forward Purchaser  believes that the circumstances giving rise to such Regulatory  Disruption have changed.  Forward Purchaser shall make its  determination of a Regulatory Disruption in a manner  consistent with the determinations made with respect to other  issuers under similar facts and circumstances.   Securities Act: The Securities Act of 1933, as amended from time to time.  Physical Settlement: On any Settlement Date in respect of which Physical  Settlement applies, the Company shall deliver to Forward  Purchaser through the Clearance System the Settlement Shares  for such Settlement Date, and Forward Purchaser shall deliver  to the Company, by wire transfer of immediately available  funds to an account designated by the Company, an amount in  cash equal to the Physical Settlement Amount for such  Settlement Date, on a delivery versus payment basis.  If, on  any Settlement Date, the Shares to be delivered by the  Company to Forward Purchaser hereunder are not so delivered  (the “Deferred Shares”), and a Forward Price Reduction Date  occurs during the period from, and including, such Settlement  Date to, but excluding, the date such Shares are actually  delivered to Forward Purchaser, then the portion of the  Physical Settlement Amount payable by Forward Purchaser to  the Company in respect of the Deferred Shares shall be  reduced by an amount equal to the Forward Price Reduction  Amount for such Forward Price Reduction Date, multiplied by  the number of Deferred Shares.  Physical Settlement Amount: For any Settlement Date in respect of which Physical  Settlement applies, an amount in cash equal to the product of  (i) the Forward Price on such Settlement Date and (ii) the  number of Settlement Shares for such Settlement Date.  Cash Settlement: On any Settlement Date in respect of which Cash Settlement  applies, if the Cash Settlement Amount for such Settlement  Date is a positive number, the Company will pay such Cash  Settlement Amount to Forward Purchaser.  If the Cash  Settlement Amount is a negative number, Forward Purchaser  will pay the absolute value of such Cash Settlement Amount to  the Company.  Such amounts shall be paid on the Settlement  Date by wire transfer of immediately available funds.  Cash Settlement Amount: Notwithstanding Section 8.5(c) of the Definitions, for any  Settlement Date and the number of Settlement Shares to which  

 

11      [[5556494]]  Cash Settlement or Net Share Settlement applies on such  Settlement Date, and subject to “Unwind Period Disrupted  Days” above, an amount determined by the Calculation Agent  equal to the sum of (X) the product, whether a positive or  negative number, of (i) the Settlement Price minus the  Relevant Forward Price times (ii) the number of Settlement  Shares for such Settlement Date plus (Y) the product,  expressed as a positive number, of (i) the Forward Price  Reduction Amount for any Forward Price Reduction Date that  occurs during such Unwind Period, and (ii) the number of  Settlement Shares with respect to which Forward Purchaser  has not unwound its hedge as of such Forward Price Reduction  Date.  Settlement Price: The weighted average price at which Forward Purchaser  purchases Shares during the Unwind Period (excluding any  Disrupted Days in full) to unwind its hedge with respect to the  Settlement Shares, taking into account Shares anticipated to be  delivered or received if Net Share Settlement applies and the  covenant of Forward Purchaser in Section 7(b) of this  Confirmation.   Relevant Forward Price: The arithmetic average of the Forward Prices over the period  beginning on, and including, the first day that is one  Settlement Cycle following the first day of the applicable  Unwind Period and ending on, and including, such Settlement  Date (calculated assuming no reduction to the Forward Price  for any Forward Price Reduction Date that occurs during the  Unwind Period), minus USD 0.02.  Net Share Settlement: On any Settlement Date in respect of which Net Share  Settlement applies, if the number of Net Share Settlement  Shares is a (i) positive number, the Company shall deliver a  number of Shares to Forward Purchaser equal to the Net Share  Settlement Shares or (ii) negative number, Forward Purchaser  shall deliver to the Company a number of shares equal to the  absolute value of the Net Share Settlement Shares; provided  that if Forward Purchaser determines in its good faith  judgment and in a commercially reasonable manner that it  would be required to deliver Net Share Settlement Shares to  the Company, Forward Purchaser may elect to deliver a  portion of such Net Share Settlement Shares on one or more  dates prior to the applicable Settlement Date.  Net Share Settlement Shares: For any Settlement Date in respect of which Net Share  Settlement applies, a number of Shares equal to the Cash  Settlement Amount for such Settlement divided by the  

 

12      [[5556494]]  Settlement Price for such Settlement, such quotient to be  rounded down to the nearest whole number, plus cash in lieu  of any fractional Shares valued at the relevant Settlement  Price.  Settlement Currency: USD.  Failure to Deliver: Not applicable.  Adjustments:   Method of Adjustment: Calculation Agent Adjustment.  Additional Adjustment:  If, in Forward Purchaser’s commercially reasonable  judgment, the stock loan fee to Forward Purchaser (or an  affiliate thereof), excluding the federal funds or other  interest rate component payable by the relevant stock lender  to Forward Purchaser or such affiliate (the “Stock Loan  Fee”), to borrow a number of Shares equal to the Base  Amount to hedge its exposure to the Transaction in a  commercially reasonable manner exceeds [●]10 basis points  per annum, the Calculation Agent shall reduce the Forward  Price in order to compensate Forward Purchaser for the  amount by which the Stock Loan Fee exceeds [●]11 basis  points per annum.  The Calculation Agent shall notify the  Company prior to making any such adjustment to the  Forward Price and, upon the request of the Company,  Forward Purchaser shall provide to Company an itemized  list of the Stock Loan Fees which need not name particular  stock lenders, or provide confidential models or other  information proprietary to Forward Purchaser, or include  other information that is proprietary or subject to  contractual, legal or regulatory obligations to not disclose  such information; provided that delivery of such  information need not precede any such adjustment by the  Calculation Agent.   Determining Party: Forward Purchaser  Account Details:    Payments to Forward  Purchaser:  To be advised under separate cover or telephone confirmed  prior to each Settlement Date.                                                    10 Insert Initial Stock Loan Rate specified in the Forward Instruction Notice.  11 Insert Initial Stock Loan Rate specified in the Forward Instruction Notice.  

 

13      [[5556494]]  Payments to the Company: To be advised under separate cover or telephone confirmed  prior to each Settlement Date.  Delivery of Shares to  Forward Purchaser:     To be advised.  Delivery of Shares to the  Company:     To be advised.   Conditions to Effectiveness.  This Transaction shall be effective if and only if Shares are sold by the Agent acting as  forward seller for Forward Purchaser on or after the Trade Date and on or before the Hedge  Completion Date pursuant to the Equity Distribution Agreement.  If the Equity Distribution  Agreement is terminated prior to any such sale of Shares thereunder, the parties shall have no  further obligations in connection with this Transaction, other than in respect of breaches of  representations or covenants on or prior to such date.  For the avoidance of doubt, if the Equity  Distribution Agreement is terminated prior to the Hedge Completion Date, this Confirmation  shall remain in effect with respect to any Shares that had been sold by the Agent acting as  forward seller for Forward Purchaser on or after the Trade Date and prior to such termination.   The effectiveness of this Transaction on the Effective Date shall be subject to the  satisfaction (or waiver by Forward Purchaser) of the following conditions:  (a) the representations and warranties of the Company in the Equity Distribution  Agreement, and any certificate delivered pursuant thereto by the Company shall be true and  correct on the Effective Date as if made as of the Effective Date;  (b) the Company shall have performed all of the obligations required to be performed  by it under the Equity Distribution Agreement on or prior to the Effective Date;  (c) all of the conditions set forth in Section 9 of the Equity Distribution Agreement  shall have been satisfied;  (d) the effective date of the Forward Instruction Notice shall have occurred as  provided in the Equity Distribution Agreement;  (e) all of the representations and warranties of the Company hereunder and under the  Agreement shall be true and correct on the Effective Date as if made as of the Effective Date;  (f) the Company shall have performed all of the obligations required to be performed  by it hereunder and under the Agreement on or prior to the Effective Date, including without  limitation its obligations under “Covenants of the Company” hereof; and  (g) the Company shall, if requested by Forward Purchaser prior to the Trade Date,  have delivered to Forward Purchaser opinions of each of O’Melveny & Myers LLP and Venable  LLP in form and substance reasonably satisfactory to Forward Purchaser, with respect to the  matters set forth in Section 3(a)(i)-(iv) of the Agreement and that the maximum number of  

 

14      [[5556494]]  Shares initially issuable under the Transaction have been duly authorized and, upon issuance  pursuant to the terms of the Transaction, will be validly issued, fully paid and nonassessable.  Notwithstanding the foregoing or any other provision of this Confirmation, if in respect  of the Transaction at any time on or prior to the Hedge Completion Date, (x) Forward Purchaser  determines in its sole judgment that it is unable, after using commercially reasonable efforts, to  borrow and deliver for sale the full number of Shares to be borrowed and sold in order to  establish its commercially reasonable hedge position in respect of the Transaction (based on the  Number of Shares specified in the Forward Instruction Notice) or (y) in Forward Purchaser’s  sole judgment, Forward Purchaser would incur a stock loan cost of more than a rate equal to the  Maximum Stock Loan Rate (as specified in the Forward Instruction Notice) with respect to all or  any portion of such full number of Shares specified in the Forward Instruction Notice, then in  each case the effectiveness of this Confirmation and the Transaction shall be limited to the  number of Shares Forward Purchaser is so able to borrow in connection with establishing its  commercially reasonable hedge position of this Transaction at a cost of not more than a rate  equal to the Maximum Stock Loan Rate, which, for the avoidance of doubt, may be zero.   Interpretive Letter.  The Company agrees and acknowledges that the Transaction is being entered into in  accordance with the October 9, 2003 interpretive letter from the staff of the Securities and  Exchange Commission to Goldman, Sachs & Co. (the “Interpretive Letter”).     Representations, Warranties and Agreements of the Company.   In addition to the representations and warranties elsewhere in this Confirmation, in the  Agreement and in Section 6 of the Equity Distribution Agreement, as of the Trade Date, the  Company represents and warrants to Forward Purchaser, and agrees with Forward Purchaser, as  follows, with each such representation, warranty and agreement of the Company deemed  repeated on the Effective Date, each date on which a Settlement Notice is delivered, each  Settlement Date and any other date specified in such representation, warranty or agreement:  (a) The representations and warranties of the Company set forth in Section 6  of the Equity Distribution Agreement are true and correct and are deemed to be repeated  to Forward Purchaser as if set forth herein.  (b) The Company (i) is not aware of any material non-public information  regarding itself or the Shares; (ii) is entering into this Transaction and will deliver any  Settlement Notice in good faith and not as part of a plan or scheme to evade compliance  with Rule 10b-5 or any other provision of the federal securities laws; (iii) has not entered  into or altered any hedging transaction relating to the Shares corresponding to or  offsetting the Transaction; and (iv) has consulted with its own advisors as to the legal  aspects of its adoption and implementation of this Confirmation under Rule 10b5-1 under  the Exchange Act (“Rule 10b5-1”).  (c) The Company is not entering into this Transaction and will not deliver any  Settlement Notice to create actual or apparent trading activity in the Shares (or any  security convertible into or exchangeable for Shares), or to raise or depress or otherwise  

 

15      [[5556494]]  manipulate the price of the Shares (or any security convertible into or exchangeable for  Shares), for the purpose of inducing the purchase or sale of the Shares (or any security  convertible into or exchangeable for Shares) by others or otherwise in violation of the  Exchange Act.  (d) Any Shares, when issued and delivered in accordance with the terms of  the Transaction, will be duly authorized and validly issued, fully paid and nonassessable,  and the issuance thereof will not be subject to any preemptive or similar rights.  (e) The Company has reserved and will keep available at all times, free from  preemptive rights, out of its authorized but unissued Shares, solely for the purpose of  issuance upon settlement of the Transaction, each Additional Transaction (if any) and  each other forward transaction with other Forward Purchasers (as defined in the Equity  Distribution Agreement) in accordance with the terms of the Equity Distribution  Agreement, the maximum number of Shares as shall be issuable at such time upon  settlement of the Transaction (as set forth below under the heading “Maximum Share  Delivery”), each Additional Transaction and each such other forward transaction.  All  Shares so issuable shall, upon such issuance, be accepted for listing or quotation on the  Exchange.  (f) No filing with, or approval, authorization, consent, license registration,  qualification, order or decree of, any court or governmental authority or agency, domestic  or foreign, is necessary or required for the execution, delivery and performance by the  Company of this Confirmation and the consummation of the Transaction (including,  without limitation, the issuance and delivery of Shares on any Settlement Date) except  such as have been obtained under the Securities Act.  (g) The Company will not, and will cause its affiliated purchasers (as  interpreted under Rule 10b-18, “Affiliated Purchasers”) not to, take or refrain from  taking any action (including, without limitation, any direct purchases or any purchases by  a party to a derivative transaction with the Company or any of its Affiliated Purchasers),  either under this Confirmation, under an agreement with another party or otherwise, that  is reasonably likely to cause any purchases of Shares by Forward Purchaser or any of its  affiliates in connection with any Cash Settlement or Net Share Settlement of the  Transaction not to meet the requirements of the safe harbor provided by Rule 10b-18  under the Exchange Act if such purchases were made by the Company.   (h) During any Unwind Period, except with the prior written consent of  Forward Purchaser, the Company will not, and will cause its Affiliated Purchasers not to,  directly or indirectly (including, without limitation, by means of a derivative instrument)  purchase, offer to purchase, place any bid or limit order that would effect a purchase of,  or announce or commence any tender offer relating to, any Shares (or equivalent interest,  including a unit of beneficial interest in a trust or limited partnership or a depository  share) or any security convertible into or exchangeable for the Shares.  (i) The Company will not be subject to any “restricted period” (as such term  is defined in Regulation M promulgated under the Exchange Act (“Regulation M”)) in  

 

16      [[5556494]]  respect of Shares or any security with respect to which the Shares are a “reference  security” (as such term is defined in Regulation M) during any Unwind Period for the  Transaction.  (j) The Company is not insolvent, nor will the Company be rendered  insolvent as a result of the Transaction.  (k) The Company is not, and after giving effect to the transactions  contemplated hereby will not be, required to register as an “investment company” as such  term is defined in the Investment Company Act of 1940, as amended.  (l) (1) The Company is capable of evaluating investment risks independently,  both in general and with regard to all transactions and investment strategies involving a  security or securities; (2) the Company is entering into the Transaction as principal (and  not as agent or in any other capacity); (3) neither the Forward Purchaser nor any of its  Affiliates or agents are acting as a fiduciary for the Company; (4) the Company is not  relying upon any representations except those expressly set forth herein or in the  Agreement; (5) the Company has consulted with its own legal, regulatory, tax, business,  investments, financial, and accounting advisors to the extent that it has deemed  necessary, and it has made its own investments, hedging, and trading decisions based  upon its own judgment and upon any advice from such advisors as it has deemed  necessary and not upon any view expressed by Forward Purchaser or any of its Affiliates  or agents; (6) the Company is entering into the Transaction with a full understanding of  the terms, conditions and risks thereof and it is capable of and willing to assume those  risks; (7) the Company will exercise independent judgment in evaluating the  recommendations of any broker-dealer or its associated persons, unless it has otherwise  notified the broker-dealer in writing; (8) the Company is entering into the Transaction for  a bona fide business purpose; and (9) the Company has total assets of at least USD 50  million as of the date hereof;  (m) The Company acknowledges and agrees that:  (1) during the term of the Transaction, Forward Purchaser and its  Affiliates may buy or sell Shares or other securities or buy or sell  options or futures contracts or enter into swaps or other derivative  securities in order to establish, adjust or unwind its hedge position  with respect to the Transaction;  (2) Forward Purchaser and its Affiliates may also be active in the  market for the Shares and Share-linked transactions other than in  connection with hedging activities in relation to the Transaction;  (3) Except as and to the extent specified in a Forward Instruction  Notice as agreed by Forward Purchaser with respect to the sale of  Forward Hedge Shares (as defined in the Equity Distribution  Agreement) during the Forward Hedge Selling Period, Forward  Purchaser shall make its own determination as to whether, when or  

 

17      [[5556494]]  in what manner any hedging or market activities in the Company’s  securities shall be conducted and shall do so in a manner that it  deems appropriate to hedge its price and market risk with respect  to the Forward Price and the Settlement Price;  (4) any market activities of Forward Purchaser and its Affiliates with  respect to the Shares may affect the market price and volatility of  the Shares, as well as the Forward Price and Settlement Price, each  in a manner that may be adverse to the Company; and  (5) the Transaction is a derivatives transaction in which it has granted  Forward Purchaser the right, under certain circumstances, to  receive cash or Shares, as the case may be; Forward Purchaser may  purchase Shares for its own account at an average price that may  be greater than, or less than, the effective price paid by the  Company under the terms of the Transaction;  (n) The assets of the Company do not constitute “plan assets” under the  Employee Retirement Income Security Act of 1974, as amended, the Department of  Labor Regulations promulgated thereunder or similar law.  (o) Without limiting the generality of Section 13.1 of the Definitions, the  Company acknowledges that Forward Purchaser is not making any representations or  warranties or taking any position or expressing any view with respect to the treatment of  the Transaction under any accounting standards including ASC Topic 260, Earnings Per  Share, ASC Topic 815, Derivatives and Hedging, or ASC Topic 480, Distinguishing  Liabilities from Equity and ASC 815-40, Derivatives and Hedging — Contracts in  Entity’s Own Equity (or any successor issue statements) or under FASB’s Liabilities &  Equity Project.  (p) The Company understands no obligations of Forward Purchaser to it  hereunder will be entitled to the benefit of deposit insurance and that such obligations  will not be guaranteed by any affiliate of Forward Purchaser or any governmental agency.  (q) No federal, state or local (including non-U.S. jurisdictions) law, rule,  regulation or regulatory order applicable to the Company or the Shares would give rise to  any reporting, consent, registration or other requirement (including without limitation a  requirement to obtain prior approval from any person or entity) as a result of Forward  Purchaser or its affiliates owning or holding (however defined) the Base Amount of  Shares as a commercially reasonable hedge position in connection with the Transaction in  accordance with the terms of this Confirmation and the Agreement, other than Sections  13 and 16 under the Exchange Act and Sections 3-601 through 3-605 and Sections 3-701  through 3-710 of the Maryland General Corporation Law (the “MGCL”).  (r) The Company represents to Forward Purchaser that Forward Purchaser,  solely in its capacity as “Forward Purchaser” or “Forward Seller” (each as defined in the  Equity Distribution Agreement) and solely with respect to its entering into and  

 

18      [[5556494]]  consummating the transactions contemplated by this Confirmation and the Equity  Distribution Agreement (including any other “Confirmation” thereunder) will not  collectively with the other Forward Purchasers or Forward Sellers under the Equity  Distribution Agreement be a “Person” (as defined in the Articles (as defined below)) by  virtue of being a member of a “group” (as referenced in the definition of Person in the  Articles) with such Forward Purchasers or Forward Sellers or both.  (s) The Company is not and has not been the subject of any civil proceeding  of a judicial or administrative body of competent jurisdiction that could reasonably be  expected to impair materially the Company’s ability to perform its obligations hereunder.   (t) Ownership positions of the Shares held by Forward Purchaser or any of its  affiliates solely in its capacity as a nominee or fiduciary do not constitute “beneficial  ownership” or “constructive ownership” by Forward Purchaser for the purposes of  Article VII of the Company’s charter (the “Articles”).  (u) Other than as set forth in Article VII of the Articles, none of the  Company’s constitutive, governing or organizational documents and no contract or  agreement to which the Company or any of its assets are subject, would give rise to  reporting or registration obligations or other requirements (including without limitation a  requirement to obtain prior approval from any person or entity) of a Forward Purchaser or  that would give rise to any consequences potentially adverse to the Company as a result  of Forward Purchaser or its affiliates owning or holding (however defined) the Base  Amount of Shares as a commercially reasonable hedge position in connection with the  Transaction in accordance with the terms of this Confirmation and the Agreement.  (v) The Company agrees that the Company shall not deliver a Forward  Instruction Notice specifying a Base Number of shares that, together with the number of  Shares under any Additional Transactions (but not any other Shares, including, for the  avoidance of doubt, any other Shares otherwise owned by the Forward Purchaser), in  aggregate, would result in an Ownership Event (as defined below).   Covenants of the Company.  (a) Subject to the circumstances described under “Private Placement Procedures”, the  parties acknowledge and agree that any Shares delivered by the Company to Forward Purchaser  on any Settlement Date will be newly issued Shares and when delivered by Forward Purchaser  (or an affiliate of Forward Purchaser) to securities lenders from whom Forward Purchaser (or an  affiliate of Forward Purchaser) borrowed Shares in connection with hedging its exposure to the  Transaction will be freely saleable without further registration or other restrictions under the  Securities Act, in the hands of those securities lenders, irrespective of whether such stock loan is  effected by Forward Purchaser or an affiliate of Forward Purchaser.  Accordingly, the Company  agrees that the Shares that it delivers to Forward Purchaser on each Settlement Date will not bear  a restrictive legend and that such Shares will be deposited in, and the delivery thereof shall be  effected through the facilities of, the Clearance System.  To the extent Forward Purchaser is  obligated to deliver Shares under any Transaction, the provisions of Sections 9.2 (last sentence  only), 9.8, 9.9, 9.10, 9.11 and 9.12 of the Definitions will be applicable as if “Physical  

 

19      [[5556494]]  Settlement” applied to the Transaction; provided that the Representation and Agreement  contained in Section 9.11 of the Definitions shall be modified by excluding any representations  therein relating to restrictions, obligations, limitations or requirements under applicable securities  laws that exist as a result of the fact that the Company is the issuer of the Shares.  (b) In addition to the agreements of the Company set forth above, the Company  agrees to provide Forward Purchaser prior written notice (an “Issuer Repurchase Notice”) prior  to executing any repurchase of Shares by the Company or any of its subsidiaries (or entering into  any contract that would require, or give the option to, the Company or any of its subsidiaries to  purchase or repurchase Shares), whether out of profits or capital or whether the consideration for  such repurchase is cash, securities or otherwise (an “Issuer Repurchase”), that alone or in the  aggregate would result in the Base Amount Percentage (as defined below) being greater by 0.5%  or more than the Base Amount Percentage at the time of the immediately preceding Issuer  Repurchase Notice (or in the case of the first such Issuer Repurchase Notice, greater than the  Base Amount Percentage as of the later of the date hereof or the immediately preceding  Settlement Date, if any).  The “Base Amount Percentage” as of any day is the fraction (1) the  numerator of which is the aggregate of the Base Amount and each “Base Amount” (as defined in  the applicable Additional Confirmation) under any outstanding Additional Transactions and (2)  the denominator of which is the number of Shares outstanding on such day.  (c) The Company shall (i) notify Forward Purchaser prior to the opening of trading in  the Shares on any day during any Unwind Period on which the Company makes or expects to be  made any public announcement (as defined in Rule 165(f) under the Securities Act) by any party  of any merger, acquisition, or similar transaction involving a recapitalization relating to the  Company (other than any such transaction in which the consideration consists solely of cash and  there is no valuation period), (ii) promptly notify Forward Purchaser following any such  announcement that such announcement has been made, (iii) promptly deliver to Forward  Purchaser following the making of any such announcement information indicating (A) the  Company’s average daily Rule 10b-18 purchases (as defined in Rule 10b-18) during the three  full calendar months preceding the date of the announcement of such transaction and (B) the  Company’s block purchases (as defined in Rule 10b-18) effected pursuant to paragraph (b)(4) of  Rule 10b-18 during the three full calendar months preceding the date of the announcement of  such transaction and (iv) promptly notify Forward Purchaser of the earlier to occur of the  completion of such transaction and the completion of the vote by target shareholders.  (d) The Company has reserved and will keep available at all times, free from  preemptive rights, out of its authorized but unissued Shares, solely for the purpose of issuance  upon settlement of the Transaction as herein provided, the maximum number of Shares as shall  be issuable at such time upon settlement of the Transaction as set forth below under the heading  “Maximum Share Delivery”.  All Shares so issuable shall, upon such issuance, be accepted for  listing or quotation on the Exchange.  (e) Neither the Company nor any of its affiliates shall take or refrain from taking any  action (including, without limitation, any direct purchases by the Company or any of its affiliates  or any purchases by a party to a derivative transaction with the Company or any of its affiliates),  either under this Confirmation, under an agreement with another party or otherwise, that is  reasonably likely to cause any purchases of Shares by Forward Purchaser or any of its affiliates  

 

20      [[5556494]]  in connection with any Cash Settlement or Net Share Settlement of the Transaction not to meet  the requirements of the safe harbor provided by Rule 10b-18 under the Exchange Act if such  purchases were made by the Company.  (f) Without limiting the obligations of the Company hereunder, the Company shall,  at least one day prior to the first day of any Unwind Period, notify Forward Purchaser of the total  number of Shares purchased in Rule 10b-18 purchases of blocks pursuant to the once-a-week  block exception contained in Rule 10b-18(b)(4) by or for the Company or any of its Affiliated  Purchasers during each of the four calendar weeks preceding the first day of any Unwind Period  and during the calendar week in which the first day of an Unwind Period occurs (“Rule 10b-18  purchase” and “blocks” each being used as defined in Rule 10b-18).   (g) Upon obtaining knowledge of the occurrence of any event that would constitute  an Event of Default or Potential Event of Default, the Company will so notify Forward Purchaser  in writing within one Scheduled Trading Day.   Covenants of Forward Purchaser.  (a) Unless the provisions set forth below under “Private Placement Procedures” shall  be applicable, Forward Purchaser shall use any Shares delivered by the Company to Forward  Purchaser on any Settlement Date to return to securities lenders to close out open Share loans  created by Forward Purchaser or an affiliate of Forward Purchaser in the course of Forward  Purchaser’s or such affiliate’s hedging activities related to Forward Purchaser’s exposure under  this Confirmation.  (b) In connection with bids and purchases of Shares in connection with any Net Share  Settlement or Cash Settlement, Forward Purchaser shall use commercially reasonable, good faith  efforts to conduct its activities, or cause its affiliates to conduct their activities, in a manner  consistent with the requirements of the safe harbor provided by Rule 10b-18 under the Exchange  Act, as if such provisions were applicable to such purchases and taking into account any  applicable Securities and Exchange Commission no-action letters as appropriate, and subject to  any delays between the execution and reporting of a trade of the Shares on the Exchange and  other circumstances beyond Forward Purchaser’s control provided however, that the foregoing  agreement shall not apply to purchases made to dynamically hedge for Forward Purchaser’s  own  account or the account of its affiliate(s) the optionality arising under the Transaction (including,  for the avoidance of doubt, timing optionality).   Insolvency Filing.  The parties hereto agree that, notwithstanding anything to the contrary in the Agreement  or the Definitions, the Transaction constitutes a contract to issue a security of the Company as  contemplated by Section 365(c)(2) of the Bankruptcy Code and that the Transaction and the  obligations and rights of the Company and Forward Purchaser (except for any liability as a result  of breach of any of the representations or warranties provided by the Company above under the  headings “Representations, Warranties and Agreements of the Company” and “Covenants of the  Company”) shall immediately terminate, without the necessity of any notice, payment (whether  directly, by netting or otherwise) or other action by the Company or Forward Purchaser, if, on or  

 

21      [[5556494]]  prior to the final Settlement Date, an Insolvency Filing occurs or any other proceeding  commences with respect to the Company under the Bankruptcy Code (a “Bankruptcy  Termination Event”).    Acceleration Events.  Each of the following events shall constitute an “Acceleration Event”:  (a) Stock Borrow Events.  In the commercially reasonable judgment of Forward  Purchaser (i) Forward Purchaser (or its affiliate) is unable to hedge Forward Purchaser’s  exposure to the Transaction because of the lack of sufficient Shares being made available by  lenders for Share borrowing, or (ii) Forward Purchaser (or its affiliate) would incur a Stock Loan  Fee to borrow a number of Shares equal to the Base Amount of more than a rate of [●]12 basis  points per annum (each, a “Stock Borrow Event”).  (b) Extraordinary Dividends; Excess Dividend; Other Distributions.  On any day  occurring on or after the Trade Date (i) the Company declares an Extraordinary Dividend (as  defined below); (ii) the ex-dividend date for any Excess Dividend (as defined below) occurs or  (iii) the Company declares any distribution, issue or dividend to existing holders of the Shares of  (A) Shares, (B) other share capital or securities granting the right to payment of dividends and/or  the proceeds of liquidation of the Company equally or proportionately with such payments to  holders of Shares or (C) share capital, securities, rights, warrants or other instruments, property  or assets of any kind whatsoever of the Company or another issuer, in each case ((A), (B) or (C))  without payment therefor or for payment (cash or other consideration) at less than the prevailing  market price therefor, as determined by Forward Purchaser in a commercially reasonable  manner.  “Extraordinary Dividend” means the per Share amount or value, as determined in the  Forward Purchaser’s commercially reasonable judgment of any dividend or distribution declared  by the Company with respect to the Shares that is designated by the board of directors of the  Company as an “extraordinary” or “special” dividend. “Excess Dividend” means with respect to  the Shares and any date of determination, any dividend or distribution to existing holder of  Shares (other than an Extraordinary Dividend) the amount or value of which per Share (as  determined by the Calculation Agent) when aggregated with the amount or value on a per Share  basis (as determined by the Calculation Agent) of all previous dividends and distributions (other  than Extraordinary Dividends) having an ex-dividend date during the period from and including  any Forward Price Reduction Date (as determined by the Calculation Agent on the basis that the  Trade Date is a Forward Price Reduction Date for purposes of this clause only) to but excluding  the next subsequent Forward Price Reduction Date exceeds the Forward Price Reduction  Amount set forth for such period on Schedule I.  (c) ISDA Event.  As to Company or Forward Purchaser, the occurrence of any Event  of Default or Termination Event, other than an Event of Default or Termination Event that also  constitutes a Bankruptcy Termination Event, that with notice or the passage of time would give  rise to the right of the other party to designate an Early Termination Date pursuant to Section 6  of the Agreement.                                                    12 Insert Maximum Stock Loan Rate from Forward Instruction Notice.   

 

22      [[5556494]]  (d) Equity Definitions Event.  The announcement of any event that if consummated,  would result in an Extraordinary Event or the occurrence of any Change in Law or a Delisting;  provided that in case of a Delisting, in addition to the provisions of Section 12.6(a)(iii) of the  Definitions, it will also constitute a Delisting if the Exchange is located in the United States and  the Shares are not immediately re-listed, re-traded or re-quoted on any of the New York Stock  Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or their respective  successors); provided further that Section 12.1(b) of the Definitions is hereby amended by  deleting the remainder of such Section beginning with the words “in each case if the Merger  Date is on or before” in the fourth to last line thereof; and provided further that the definition of  “Change in Law” provided in Section 12.9(a)(ii) of the Definitions is hereby amended by  (i) replacing the phrase “the interpretation” in the third line thereof with the phrase “, or public  announcement of, the formal or informal interpretation” and (ii) replacing the parenthetical  beginning after the word “regulation” in the second line thereof the words “(including, for the  avoidance of doubt and without limitation, (x) any tax law or (y) adoption, effectiveness or  promulgation of new regulations authorized or mandated by existing statute)”.  (e) Ownership Event.  In the reasonable judgment of Forward Purchaser, on any day,  an Excess Section 13 Ownership Position, Excess Exchange Ownership Position, Excess Charter  Ownership Position or Excess Regulatory Ownership Position (each as defined below) exists or  would exist but for the limitations set forth in Section 17 hereof, in each case as determined by  Forward Purchaser in good faith and in its reasonable discretion.    Termination Settlement.  Upon the occurrence of any Acceleration Event, Forward Purchaser shall have the right  to designate, upon at least one Scheduled Trading Days’ notice, any Scheduled Trading Day  following such occurrence to be a Settlement Date hereunder (a “Termination Settlement  Date”) to which Physical Settlement shall apply, and to select the number of Settlement Shares  (which in the sole discretion of the Forward Purchaser may be the Base Amount at such time)  relating to such Termination Settlement Date; provided that (i) in the case of an Acceleration  Event arising out of an Ownership Event (as defined below), the number of Settlement Shares so  designated by Forward Purchaser shall not exceed the number of Shares reasonably necessary, in  the reasonable judgment of Forward Purchaser, to reduce the Settlement Shares, or the Base  Amount, as applicable, to comply with the Applicable Share Limit and (ii) in the case of an  Acceleration Event arising out of a Stock Borrow Event, the number of Settlement Shares so  designated by Forward Purchaser shall not exceed the number of Shares (if less than the Base  Amount) as to which such Stock Borrow Event exists.  If, upon designation of a Termination  Settlement Date by Forward Purchaser pursuant to the preceding sentence, the Company fails to  deliver the Settlement Shares relating to such Termination Settlement Date when due or  otherwise fails to perform its obligations in respect of the Transaction, an Early Termination  Date shall be deemed to occur and Section 6 of the Agreement shall apply, on the basis that such  failure is an Event of Default.  If an Acceleration Event occurs during an Unwind Period relating  to a number of Settlement Shares to which Cash Settlement or Net Share Settlement applies, then  on the Termination Settlement Date relating to such Acceleration Event, at the election of  Forward Purchaser in its sole discretion, and notwithstanding any election to the contrary by the  Company, Cash Settlement or Net Share Settlement shall apply to the portion of the Settlement  Shares relating to such Unwind Period as to which Forward Purchaser has unwound its hedge, as  

 

23      [[5556494]]  reasonably determined by Forward Purchaser and Physical Settlement shall apply in respect of  (x) the remainder (if any) of such Settlement Shares and (y) the Settlement Shares designated by  Forward Purchaser in respect of such Termination Settlement Date.  If an Acceleration Event  occurs after the Company has designated a Settlement Date to which Physical Settlement applies  but before the relevant Settlement Shares have been delivered to Forward Purchaser, Forward  Purchaser shall have the right to cancel such Settlement Date and designate a Termination  Settlement Date in respect of such Settlement Shares and any other Shares pursuant to the first  sentence hereof.     Private Placement Procedures.  If the Company is unable to comply with the provisions of Section 6(a) “Covenants of the  Company” above because of a change in law or a change in the policy of the Securities and  Exchange Commission or its staff, or Forward Purchaser otherwise reasonably determines, based  on advice of counsel, that any Settlement Shares to be delivered to Forward Purchaser by the  Company may not be freely returned by Forward Purchaser or its affiliates to securities lenders  as described under “Covenants of the Company” above, then delivery of any such Settlement  Shares (the “Restricted Shares”) shall be effected pursuant to Annex A hereto, unless waived  by Forward Purchaser.   Rule 10b5-1; Unwind Period Communications.  (a) It is the intent of Forward Purchaser and the Company that following any election  of Cash Settlement or Net Share Settlement by the Company, the purchase of Shares by Forward  Purchaser during any Unwind Period comply with the requirements of Rule 10b5-1(c)(1)(i)(B) of  the Exchange Act and that this Confirmation shall be interpreted to comply with the  requirements of Rule 10b5-1(c).  (b) The Company agrees that it will not attempt to exercise any influence on Forward  Purchaser (or its agent or affiliate) over how, when or whether to effect purchases of Shares in  connection with any Cash Settlement or Net Share Settlement.  (c) The Company hereby agrees with Forward Purchaser that during any Unwind  Period the Company shall not communicate, directly or indirectly, any Material Non-Public  Information (as defined herein) to any Derivatives Personnel (as defined below).  For purposes  of the Transaction, “Material Non-Public Information” means information relating to the  Company or the Shares that (a) has not been widely disseminated by wire service, in one or more  newspapers of general circulation, by communication from the Company to its shareholders or in  a press release, or contained in a public filing made by the Company with the Securities and  Exchange Commission and (b) a reasonable investor might consider to be of importance in  making an investment decision to buy, sell or hold Shares.  For the avoidance of doubt and solely  by way of illustration, information should be presumed “material” if it relates to such matters as  dividend increases or decreases, earnings estimates, changes in previously released earnings  estimates, significant expansion or curtailment of operations, a significant increase or decline of  orders, significant merger or acquisition proposals or agreements, significant new products or  discoveries, extraordinary borrowing, major litigation, liquidity problems, extraordinary  management developments, purchase or sale of substantial assets, or other similar information.  

 

24      [[5556494]]  For purposes of the Transaction, “Derivatives Personnel” means any employee on the trading  side of the Equity Derivatives of Forward Purchaser and does not include [●] or [●] (or any other  person or persons designated from time to time by the Compliance Group of Forward Purchaser).   Maximum Share Delivery.  Notwithstanding any other provision of this Confirmation, in no event will the Company  be required to deliver on any Settlement Date, whether pursuant to Physical Settlement, Net  Share Settlement, Termination Settlement or any Private Placement Settlement, more than a  number of Shares equal to 1.5 times the Initial Base Amount, subject to reduction by the number  of any Shares delivered by the Company on any prior Settlement Date and subject to adjustment  from time to time in accordance with the provisions of this Confirmation and the Definitions (the  “Share Cap”).   Transfer and Assignment.  Forward Purchaser may assign or transfer all, but not less than all, of its rights and duties  hereunder to any affiliate of Forward Purchaser; provided that, under the applicable law effective  on the date of such transfer or assignment, the Company will not be required, as a result of such  transfer or assignment, to pay to the transferee an amount in respect of an Indemnifiable Tax  greater than the amount, if any, that the Company would have been required to pay Forward  Purchaser in the absence of such transfer or assignment; and the Company will not receive a  payment from which an amount has been withheld or deducted, on account of a Tax in respect of  which the other party is not required to pay an additional amount, unless the Company would not  have been entitled to receive any additional amount in respect of such payment in the absence of  such transfer or assignment, and Forward Purchaser shall cause the transferee or assignee to  make such Payee Tax Representations and to provide such tax documentation as may be  reasonably requested by the Company to permit the Company to make any necessary  determinations pursuant to this proviso; provided further that (A) the affiliate’s obligations  hereunder are fully and unconditionally guaranteed by Forward Purchaser or its parent or (B) the  affiliate’s long-term issuer rating is equal to or better than the credit rating of Forward Purchaser  at the time of such assignment or transfer.  Notwithstanding the above or any other provision in  this Confirmation to the contrary requiring or allowing Forward Purchaser to purchase, sell,  receive or deliver any Shares or other securities to or from the Company, Forward Purchaser may  designate any of its affiliates to purchase, sell, receive or deliver such Shares or other securities  and otherwise to perform Forward Purchaser’s obligations in respect of the Transaction and any  such designee may assume such obligations.  Forward Purchaser shall be discharged of its  obligations to the Company to the extent of any such performance.   Additional Provisions under the Definitions:   Non-Reliance: Applicable   Additional Acknowledgments: Applicable   Agreements and Acknowledgments  Regarding Hedging Activities: Applicable  

 

25      [[5556494]]   No Collateral or Setoff; Claims in Bankruptcy.  (a) Notwithstanding Section 6(f) or any other provision of the Agreement or any  other agreement between the parties to the contrary, the obligations of the Company hereunder  are not secured by any collateral.  Obligations under the Transaction shall not be set off against  any other obligations of the parties, whether arising under the Agreement, this Confirmation,  under any other agreement between the parties hereto, by operation of law or otherwise, and no  other obligations of the parties shall be set off against obligations under the Transaction, whether  arising under the Agreement, this Confirmation, under any other agreement between the parties  hereto, by operation of law or otherwise, and each party hereby waives any such right of setoff.   In calculating any amounts under Section 6(e) of the Agreement, notwithstanding anything to the  contrary in the Agreement, (a) separate amounts shall be calculated as set forth in such Section  6(e) with respect to (i) the Transaction and (ii) all other Transactions, and (b) such separate  amounts shall be payable pursuant to Section 6(d)(ii) of the Agreement.  (b) Forward Purchaser acknowledges and agrees that this confirmation is not intended  to convey to Forward Purchaser rights with respect to the transactions contemplated hereby that  are senior to the claims of common stockholders in any U.S. bankruptcy proceedings of the  Company; provided, however, that nothing herein shall limit or shall be deemed to limit Forward  Purchaser’s right to pursue remedies in the event of a breach by the Company of its obligations  and agreements with respect to this Confirmation and the Agreement; and provided further, that  nothing herein shall limit or shall be deemed to limit Forward Purchaser’s rights in respect of any  transaction other than the Transaction.   Limit on Beneficial Ownership.  Notwithstanding any other provision in the Agreement, this Confirmation or any  Additional Confirmation, in no event shall Forward Purchaser be entitled to receive, or be  deemed to receive, or, with respect to clause (y) below, have the “right to acquire” (within the  meaning of Nasdaq Listing Rule 5635(e)), Shares to the extent that, upon such receipt of such  Shares, (i) the “beneficial ownership” (within the meaning of Section 13 or Section 16 of the  Exchange Act and the rules promulgated thereunder) of Shares by Forward Purchaser, together  with any of its affiliates and any of its affiliates’ business units that are subject to aggregation  with Forward Purchaser for purposes of the “beneficial ownership” test under Section 13 and  Section 16 of the Exchange Act and all persons who may form a “group” (within the meaning of  Rule 13d-5(b)(1) under the Exchange Act) with Forward Purchaser with respect to “beneficial  ownership” of any Shares (collectively, “Forward Purchaser Group”) would be equal to or  greater than the lesser of (x) 4.5% of the outstanding Shares (such condition, an “Excess Section  13 Ownership Position”), and (y) 4.9% of the outstanding Shares as of the Trade Date for any  Transaction (such number of Shares, the “Threshold Number of Shares” and such condition,  the “Excess Exchange Ownership Position”), (ii) violation would occur in respect of any  restriction on ownership and/or transfers set forth in Article VII of the Articles (such condition,  an “Excess Charter Ownership Position”) or (iii) Forward Purchaser, Forward Purchaser  Group or any person whose ownership position would be aggregated with that of Forward  Purchaser or Forward Purchaser Group (Forward Purchaser, Forward Purchaser Group or any  such person, a “Forward Purchaser Person”) under Sections 3-601 through 3-605 and Sections  3-701 through 3-710 of the MGCL, Article VII of the Articles or any state or federal bank  

 

26      [[5556494]]  holding company or banking laws, or any federal, state or local laws, regulations or regulatory  orders applicable to ownership of Shares (“Applicable Laws” and such condition described in  this clause (iii), an “Excess Regulatory Ownership Position” and an Excess Section 13  Ownership Position, an Excess Exchange Ownership Position, an Excess Charter Ownership  Position and an Excess Regulatory Ownership Position, individually and collectively, an  “Ownership Event”), would own, beneficially own, constructively own, control, hold the power  to vote or otherwise meet a relevant definition of ownership in excess of a number of Shares  equal to (x) the lesser of (A) the maximum number of Shares that would be permitted under  Applicable Laws and (B) the minimum number of Shares that would give rise to reporting or  registration obligations or other requirements (including obtaining prior approval by a state or  federal regulator) of a Forward Purchaser Person under Applicable Laws or that would give rise  to any consequences potentially adverse to the Company under the Articles, in each case minus  (y) one percent (1%) of the number of Shares outstanding on the date of determination (such  number of Shares, the “Applicable Share Limit”). If any delivery owed to Forward Purchaser in  connection with this Transaction is not made, in whole or in part, as a result of this Section 17,  (i) the Company’s obligation to make such delivery shall not be extinguished and the Company  shall make such delivery as promptly as practicable after, but in no event later than one  Exchange Business Day after, Forward Purchaser gives notice to the Company that such delivery  would not result in (x) Forward Purchaser Group directly or indirectly so beneficially owning in  excess of the lesser of (A) 4.5% of the outstanding Shares and (B) the Threshold Number of  Shares or (y) the occurrence of an Excess Regulatory Ownership Position and (ii) if such  delivery relates to a Physical Settlement, notwithstanding anything to the contrary herein,  Forward Purchaser shall not be obligated to satisfy the portion of its payment obligation with  respect to such Transaction corresponding to any Shares required to be so delivered until the date  the Company makes such delivery.  The Company agrees to provide Forward Purchaser at least 10 Scheduled Trading Days’  written notice prior to any amendment, supplement, waiver or other modification to the Articles,  bylaws or any other constitutive document of the Company that would reduce the ownership  threshold set forth in Article VII of the Articles to a percentage lower than 9.9% or that would,  based on the advice of counsel to the Company, give rise to any other restrictions under  Applicable Laws applicable to Forward Purchaser (including with respect to its commercially  reasonable hedge positions) with respect to the Transaction (a “Charter Notice”).  Upon receipt  of a Charter Notice, Forward Purchaser may designate an Additional Termination Event with  respect to any portion of the Transaction that Forward Purchaser (or its affiliate), reasonably  determines, based on advice of counsel, is necessary to reduce the Charter Percentage to (i) the  lowest ownership level contemplated by Article VII of the Articles (or, if lower, the ownership  level contemplated in any such other Applicable Restriction) minus (ii) 1.0%.  The “Charter  Percentage” shall be a fraction, the numerator of which is (i) the Base Amount plus (ii) any  other Shares that Forward Purchaser, its affiliates and each other person subject to aggregation of  Shares with Forward Purchaser under the Articles (or such other Applicable Restriction)  reasonably determines, based on advice of counsel, may be “Beneficially Owned” or  “Constructively Owned” (howsoever defined) under the Articles (or such other Applicable  Laws), and the denominator of which is the number of Shares outstanding.    Indemnification.  The Company agrees to indemnify and hold harmless Forward  Purchaser, its affiliates and its assignees and their respective directors, officers and  

 

27      [[5556494]]  controlling persons (Forward Purchaser and each such person being an “Indemnified  Party”) from and against any and all losses, claims, damages and liabilities, joint or  several, incurred by or asserted against such Indemnified Party arising out of, in  connection with, or relating to, any breach of any covenant, agreement or  representation of the Company in this Confirmation (including the Pricing  Supplement thereto) or the Agreement.  The Company will not be liable under the  foregoing indemnification provision to the extent that any loss, claim, damage,  liability or expense is found in a nonappealable judgment by a court of competent  jurisdiction to have resulted from Forward Purchaser’s willful misconduct, gross  negligence or bad faith in performing the services that are subject of the Transaction.   If for any reason the foregoing indemnification is unavailable to any Indemnified  Party or insufficient to hold harmless any Indemnified Party, then the Company shall  contribute, to the maximum extent permitted by law, to the amount paid or payable by  the Indemnified Party as a result of such loss, claim, damage or liability.  In addition,  the Company will reimburse any Indemnified Party for all reasonable expenses  (including reasonable counsel fees and expenses) as they are incurred in connection  with the investigation of, preparation for or defense or settlement of any pending or  threatened claim or any action, suit or proceeding arising therefrom, whether or not  such Indemnified Party is a party thereto and whether or not such claim, action, suit  or proceeding is initiated or brought by or on behalf of the Company.  The Company  also agrees that no Indemnified Party shall have any liability to the Company or any  person asserting claims on behalf of or in right of the Company in connection with or  as a result of any matter referred to in this Confirmation (including the Pricing  Supplement thereto) or the Agreement except to the extent that any losses, claims,  damages, liabilities or expenses incurred by the Company result from the gross  negligence, willful misconduct or bad faith of the Indemnified Party.  The provisions  of this Section 18 shall survive the completion of the Transaction contemplated by  this Confirmation and any assignment and/or delegation of the Transaction made  pursuant to the Agreement or this Confirmation shall inure to the benefit of any  permitted assignee of Forward Purchaser.  For the avoidance of doubt, any payments  due as a result of this provision may not be used to set off any obligation of Forward  Purchaser upon settlement of the Transaction.   Delivery of Cash:  For the avoidance of doubt, nothing in this Confirmation shall be interpreted as requiring  the Company to deliver cash in respect of the settlement of this Transaction, except in  circumstances where the required cash settlement thereof is permitted for classification of the  contract as equity by ASC 815-40 (formerly EITF 00-19) as in effect on the Trade Date  (including, without limitation, where the Company so elects to deliver cash or fails timely to  elect to deliver Shares in respect of such settlement).   Wall Street Transparency and Accountability Act.  In connection with Section 739 of the Wall Street Transparency and Accountability Act  of 2010 (the “WSTAA”), the parties hereby agree that neither the enactment of the WSTAA or  any regulation under the WSTAA, nor any requirement under the WSTAA or an amendment  

 

28      [[5556494]]  made by the WSTAA, shall limit or otherwise impair either party’s otherwise applicable rights to  terminate, renegotiate, modify, amend or supplement this Confirmation or the Agreement, as  applicable, arising from a termination event, force majeure, illegality, increased costs, regulatory  change or similar event under this Confirmation, the Definitions incorporated herein, or the  Agreement (including, but not limited to, rights arising from any Acceleration Event or Illegality  (as defined in the Agreement)).   Miscellaneous.  (a) Notices.  Addresses for Notices.  For the purpose of Section 12(a) of the  Agreement:  Address for notices or communications to Forward Purchaser:    [INSERT DEALER NAME AND NOTICE INFORMATION]  Address for notices or communications to the Company:  Sabra Health Care REIT, Inc.  18500 Von Karman Avenue, Suite 550   Irvine, California 92612  Attn: Harold W. Andrews, Jr. and Michael Costa   Telephone: (949) 679-0243 and (949) 679-0328   Facsimile: (949) 679-8868   (b) Waiver of Trial by Jury. EACH PARTY WAIVES, TO THE FULLEST  EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL  BY JURY IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR  RELATING TO THE AGREEMENT, THIS CONFIRMATION, ANY TRANSACTION  HEREUNDER AND/OR ALL MATTERS ARISING IN CONNECTION WITH THE  AGREEMENT, THIS CONFIRMATION AND/OR ANY TRANSACTION  HEREUNDER.  EACH PARTY (I) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR  ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR  OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF SUCH A  SUIT, ACTION OR PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER AND  (II) ACKNOWLEDGES THAT IT AND THE OTHER PARTY HAVE BEEN INDUCED TO  ENTER INTO THE TRANSACTIONS, AS APPLICABLE, BY, AMONG OTHER THINGS,  THE MUTUAL WAIVERS AND CERTIFICATIONS PROVIDED HEREIN.  (c) Offices.  The Office of Forward Purchaser for the Transaction is: [New York] [OTHER]  The Office of the Company for the Transaction is: Irvine, CA  (d) Acknowledgements.  The parties hereto intend for:  

 

29      [[5556494]]  (1) the Transaction to be a “securities contract” as defined in  Section 741(7) of Title 11 of the United States Code (the “Bankruptcy  Code”), qualifying for the protections under Section 555 of the  Bankruptcy Code;  (2) a party’s right to liquidate the Transaction and to exercise  any other remedies upon the occurrence of any Event of Default under the  Agreement with respect to the other party to constitute a “contractual  right” as defined in the Bankruptcy Code;  (3) Forward Purchaser to be a “financial institution” within the  meaning of Section 101(22) of the Bankruptcy Code or a “financial  participant” within the meaning of Section 101(22A) of the Bankruptcy  Code; and  (4) all payments for, under or in connection with the  Transaction, all payments for the Shares and the transfer of such Shares to  constitute “settlement payments” as defined in the Bankruptcy Code.  (e) Severability.  If any term, provision, covenant or condition of this  Confirmation, or the application thereof to any party or circumstance, shall be held to be  invalid or unenforceable in whole or in part for any reason, the remaining terms,  provisions, covenants, and conditions hereof shall continue in full force and effect as if  this Confirmation had been executed with the invalid or unenforceable provision  eliminated, so long as this Confirmation as so modified continues to express, without  material change, the original intentions of the parties as to the subject matter of this  Confirmation and the deletion of such portion of this Confirmation will not substantially  impair the respective benefits or expectations of both parties to the Transaction; provided,  however, that this severability provision shall not be applicable if any provision of  Section 2, 5, 6 or 13 of the Agreement (or any definition or provision in Section 14 of the  Agreement) to the extent that it relates to, or is used in or in connection with any such  Section) shall be so held to be invalid or unenforceable.  (f) Governing Law/Jurisdiction.  This Confirmation and any claim,  controversy or dispute arising under or related to this Confirmation shall be governed by  the laws of the State of New York without reference to the conflict of laws provisions  thereof.  The parties hereto irrevocably submit to the exclusive jurisdiction of the courts  of the State of New York and the United States Court for the Southern District of New  York in connection with all matters relating hereto and waive any objection to the laying  of venue in, and any claim of inconvenient forum with respect to, these courts.  (g) Disclosure.  Effective from the date of commencement of discussions  concerning the Transaction, each of Forward Purchaser and the Company and each of  their employees, representatives, or other agents may disclose to any and all persons,  without limitation of any kind, the tax treatment and tax structure of the Transaction and  all materials of any kind (including opinions or other tax analyses) relating to such tax  treatment and tax structure.  

 

30      [[5556494]]  (h) Commodity Exchange Act.  Each of Forward Purchaser and the Company  agrees and represents that it is an “eligible contract participant” as defined in  Section 1a(18) of the U.S. Commodity Exchange Act, as amended (the “CEA”), the  Agreement and the Transaction are subject to individual negotiation by the parties and  have not been executed or traded on a “trading facility” as defined in Section 1a(51) of  the CEA.  (i) Tax Matters.  For the purposes of Section 3(e) of the Agreement, Forward Purchaser and the  Company each makes the following representation:  It is not required by any applicable law, as modified by the practice of any  relevant governmental revenue authority, of any Relevant Jurisdiction to make any  deduction or withholding for or on account of any Tax from any payment (other than  interest under Section 9(h) of the Agreement or imputed interest for United States federal  income tax purposes) to be made by it to the other party under the Agreement.  In making  this representation, it may rely on: (i) the accuracy of any representations made by the  other party pursuant to Section 3(f) of the Agreement; (ii) the satisfaction of the  agreement contained in Section 4(a)(i) or 4(a)(iii) of the Agreement and the accuracy and  effectiveness of any document provided by the other party pursuant to Section 4(a)(i) or  4(a)(iii) of the Agreement; and (iii) the satisfaction of the agreement of the other party  contained in Section 4(d) of the Agreement, except that it will not be a breach of this  representation where reliance is placed on clause (ii) above and the other party does not  deliver a form or document under Section 4(a)(iii) of the Agreement by reason of  material prejudice to its legal or commercial position.  For the purpose of Section 3(f) of the Agreement:  Forward Purchaser makes the following representations:  (a) [It is a U.S. corporation duly organized and incorporated  under the laws of [INSERT DEALER’S JURISDICTION OF  ORGANIZATION], an exempt recipient under Section 1.6049-4(c)(1)(ii)  of the United States Treasury Regulations and a “U.S. person” (as that  term is used in sections 1.1441-1(c)(2)(i) and 1.1441-4(a)(3)(ii) of United  States Treasury Regulations) for U.S. federal income tax purposes.]13  (b) [All payments received or to be received by it under the  Transaction will be effectively connected with its conduct of a trade or  business carried on in the United States.                                                    13 Insert if U.S. dealer.  

 

31      [[5556494]]  (c) It is a “foreign person” (as that term is used in Section  1.6041-4(a)(4) of United States Treasury Regulations) for United States  federal income tax purposes.]14  The Company makes the following representations:  (a) It is a “U.S. person” (as that term is used in  sections 1.1441-1(c)(2)(i) and 1.1441-4(a)(3)(ii) of United States Treasury  Regulations) for U.S. federal income tax purposes.  (b) It is a real estate investment trust for U.S. federal income  tax purposes and is organized under the laws of the State of Maryland, and  is an exempt recipient under Treasury Regulation Section 1.6049- 4(c)(1)(ii)(J).  (j) Withholding Tax imposed on payments to non-US counterparties under  the United States Foreign Account Tax Compliance Act.  “Tax”, as used in the payer tax  representation set forth at the beginning of Section 21(i) of this Confirmation, and  “Indemnifiable Tax”, as defined in Section 14 of the Agreement, shall not include any  U.S. federal withholding tax imposed or collected pursuant to Sections 1471 through  1474 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”), any current  or future regulations or official interpretations thereof, any agreement entered into  pursuant to Section 1471(b) of the Code, or any fiscal or regulatory legislation, rules or  practices adopted pursuant to any intergovernmental agreement entered into in  connection with the implementation of such Sections of the Code (a “FATCA  Withholding Tax”).  For the avoidance of doubt, a FATCA Withholding Tax is a Tax  the deduction or withholding of which is required by applicable law for the purposes of  Section 2(d) of the Agreement.  (k) HIRE Act.  To the extent that either party to the Agreement with respect to  this Transaction is not an adhering party to the ISDA 2015 Section 871(m) Protocol  published by the ISDA on November 2, 2015 and available at www.isda.org (the  “871(m) Protocol”), the parties agree that the definitions and provisions contained in the  Attachment to the 871(m) Protocol are incorporated into and apply to the Agreement with  respect to this Transaction as if set forth in full herein, with any such conforming changes  as are necessary to deal with what would otherwise be inappropriate or incorrect cross  references.  The parties further agree that, solely for purposes of applying such  definitions and provisions to the Agreement with respect to this Transaction, references  to “each Covered Master Agreement” in the 871(m) Protocol will be deemed to be  references to the Agreement with respect to this Transaction, and references to the  “Implementation Date” in the 871(m) Protocol will be deemed to be references to the  Trade Date of this Transaction. For greater certainty, if there is any inconsistency  between this provision and the provisions contained in any other agreement between the                                                    14 Insert if non-U.S. dealer (transacting through U.S. office).  

 

32      [[5556494]]  parties with respect to this Transaction, this provision shall prevail unless such other  agreement expressly overrides the provisions of the Attachment to the 871(m) Protocol.  (l) Tax documentation.  For the purposes of Sections 4(a)(i) and 4(a)(ii) of  the Agreement, Forward Purchaser shall provide to the Company a valid and duly  executed U.S. Internal Revenue Service [Form W-9]15[Form W-8ECI]16, or any  successor[s] thereto, and the Company shall provide to Forward Purchaser, a valid and  duly executed U.S. Internal Revenue Service Form W-9, or any successor thereto, in each  case, (i) on or before the date of execution of this Confirmation; (ii) promptly upon  reasonable demand by the other party; and (iii) promptly upon learning that any such tax  form previously provided by Forward Purchaser or the Company, respectively, has  become invalid, obsolete, or incorrect.  Additionally, each of Forward Purchaser and the  Company shall, promptly upon request by the other party, provide such other tax forms  and documents requested by the other party.  (m) [U.S. Resolution Stay Protocol.17  The parties agree that the terms of Section 1 and Section 2 and the related defined terms  (together, the “Bilateral Terms”) of the form of bilateral template entitled “Full-Length  Omnibus (for use between U.S. G-SIBs and Corporate Groups) published by ISDA on  November 2, 2018 (currently available on the 2018 ISDA U.S. Resolution Stay Protocol  (the “Protocol”) page at www.isda.org, a copy of which is available upon request), the  effect of which is to amend the qualified financial contracts between the parties thereto to  conform with the requirements of the QFC Stay Rules, are hereby incorporated into and  form a part of the Agreement, and for such purposes, the Agreement shall be deemed a  “Covered Agreement,” Forward Purchaser shall be deemed a “Covered Entity” and the  Company shall be deemed a “Company Entity”.  In the event that, after the date of the  Agreement, both parties hereto become adhering parties to the Protocol, the terms of the  Protocol will replace the terms of this paragraph.  In the event of any inconsistencies  between the Agreement and the terms of the Protocol, the Bilateral Agreement or the  Bilateral Terms (each, the “QFC Stay Terms”), as applicable, the QFC Stay Terms will  govern.  Terms used in this paragraph without definition shall have the meanings  assigned to them under the QFC Stay Rules.  For purposes of this paragraph, references  to “the Agreement” include any related credit enhancements entered into between the  parties or provided by one to the other.  In addition, the parties agree that the terms of this  paragraph shall be incorporated into any related covered affiliate credit enhancements,  with all references to Forward Purchaser replaced by references to the covered affiliate  support provider.  “QFC Stay Rules” means the regulations codified at 12 C.F.R.  252.2, 252.81—8, 12  C.F.R. 382.1-7 and 12 C.F.R. 47.1-8, which, subject to limited exceptions, require an                                                    15 Insert if U.S. dealer.  16 Insert if non-U.S. dealer (transacting through U.S. office).  17 Include as applicable.  

 

33      [[5556494]]  express recognition of the stay-and-transfer powers of the FDIC under the Federal  Deposit Insurance Act and the Orderly Liquidation Authority under Title II of the Dodd  Frank Wall Street Reform and Consumer Protection Act and the override of default rights  related directly or indirectly to the entry of an affiliate into certain insolvency  proceedings and any restrictions on the transfer of any covered affiliate credit  enhancements.]  (n) [Certain Regulatory Matters.18  (1) 2013 EMIR Portfolio Reconciliation, Dispute Resolution  and Disclosure Protocol.  The parties agree that the terms of the 2013  EMIR Portfolio Reconciliation, Dispute Resolution and Disclosure  Protocol published by ISDA on July 19, 2013 (“Protocol”) apply to the  Agreement as if the parties had adhered to the Protocol without  amendment.  In respect of the Attachment to the Protocol, (i) the definition  of “Adherence Letter” shall be deemed to be deleted and references to  “Adherence Letter” shall be deemed to be to this section (and references to  “such party’s Adherence Letter” and “its Adherence Letter” shall be read  accordingly), (ii) references to “adheres to the Protocol” shall be deemed  to be “enters into the Agreement”, (iii) references to “Protocol Covered  Agreement” shall be deemed to be references to the Agreement (and each  “Protocol Covered Agreement” shall be read accordingly), and (iv)  references to “Implementation Date” shall be deemed to be references to  the date of this Confirmation.  For the purposes of this section:  (a) Forward Purchaser is a Portfolio Data Sending  Entity and the Company is a Portfolio Data Receiving Entity.  (b) Forward Purchaser and the Company may use a  Third Party Service Provider, and each of Forward Purchaser and  the Company consents to such use including the communication of  the relevant data in relation to Forward Purchaser and the  Company to such Third Party Service Provider for the purposes of  the reconciliation services provided by such entity.  (c) The Local Business Days for such purposes in  relation to Forward Purchaser and the Company is [●].  (d) The following are the applicable email addresses.   Portfolio Data:    Forward Purchaser: [●]                                                    18 Include as applicable.  

 

34      [[5556494]]  The Company: [●]   Notice of discrepancy:  Forward Purchaser: [●]  The Company: [●]   Dispute Notice:   Forward Purchaser: [●]  The Company: [●]  (2) NFC Representation Protocol.  The parties agree that the  provisions set out in the Attachment to the ISDA 2013 EMIR NFC  Representation Protocol published by ISDA on March 8, 2013 (the “NFC  Representation Protocol”) shall apply to the Agreement as if each party  were an Adhering Party under the terms of the NFC Representation  Protocol.  In respect of the Attachment to the NFC Representation  Protocol, (i) the definition of “Adherence Letter” shall be deemed to be  deleted and references to “Adherence Letter” shall be deemed to be to this  section (and references to “the relevant Adherence Letter” and “its  Adherence Letter” shall be read accordingly), (ii) references to “adheres to  the Protocol” shall be deemed to be “enters into the Agreement”,  (iii) references to “Covered Master Agreement” shall be deemed to be  references to the Agreement (and each “Covered Master Agreement” shall  be read accordingly), and (iv) references to “Implementation Date” shall  be deemed to be references to the date of this Confirmation.  The  Company confirms that it enters into this Confirmation as a party making  the NFC Representation (as such term is defined in the NFC  Representation Protocol).  The Company shall promptly notify Forward  Purchaser of any change to its status as a party making the NFC  Representation.  (3) Bail-In Protocol.  Notwithstanding anything contained in  the Agreement, the parties agree that the provisions of the ISDA 2016  Bail-In Article 55 BRRD Protocol published by the International Swaps  and Derivatives Association, Inc. on 14 July 2016 (the “Bail-In Protocol”)  shall be deemed to be incorporated into and apply to the Agreement with  effect from the date of this Confirmation as if references in those  provisions to “Protocol Covered Agreement” as defined in the Bail-in  Protocol were references to the Agreement, and on the basis that  references to the “Implementation Date” in the Bail-in Protocol shall be  deemed to be references to the date of this Confirmation.  (4) Contractual Recognition of UK Stay Resolution.   Notwithstanding anything contained in the Agreement, the parties agree  

 

35      [[5556494]]  that the provisions of paragraphs 1 to 4 (inclusive) of the UK (PRA Rule)  Jurisdictional Module (the “UK Module”) published by the International  Swaps and Derivatives Association, Inc. on 3 May 2016, as amended from  time to time, shall be deemed to be incorporated into the Agreement as if  references in those provisions to “Covered Agreement” were references to  the Agreement, and on the basis that: (i) Forward Purchaser shall be  treated as a “Regulated Entity” and as a “Regulated Entity “the  Company”” with respect to “the Company”, (ii) “the Company” shall be  treated as a “Module Adhering Party”, and (iii) references to the  “Implementation Date” in the UK Module shall be deemed to be  references to the date of this Confirmation.]  (o) Counterparts.  This Confirmation may be executed in any number of  counterparts, all of which shall constitute one and the same instrument, and any party  hereto may execute this Confirmation by signing and delivering one or more  counterparts.  (p) Pricing Supplement19. Company and Forward Purchaser acknowledge that  (i) the transactions contemplated by this Confirmation and the Pricing Supplement will be  entered into in reliance on the fact that this Confirmation and the Pricing Supplement  form a single agreement between Company and Forward Purchaser, and Forward  Purchaser would not otherwise enter into the Transaction, (x) this Confirmation, together  with the Pricing Supplement, is a “qualified financial contract”, as such term is defined in  Section 5-701(b)(2) of the General Obligations Law of New York (the “General  Obligations Law”), (ii) the Pricing Supplement, regardless of whether the Pricing  Supplement is transmitted electronically or otherwise, constitutes a “confirmation in  writing sufficient to indicate that a contract has been made between the parties” hereto, as  set forth in Section 5-701(b)(3)(b) of the General Obligations Law; and (z) this letter  agreement constitutes a prior “written contract”, as set forth in Section 5-701(b)(1)(b) of  the General Obligations Law, and each party hereto intends and agrees to be bound by  this letter agreement, as supplemented by the Pricing Supplement.   U.S. QFC Mandatory Contractual Requirements  (a) Limitation on Exercise of Certain Default Rights Related to a Dealer  Affiliate’s Entry Into Insolvency Proceedings. Notwithstanding anything to the contrary  in the Master Confirmation or any other agreement, the parties hereto expressly  acknowledge and agree that subject to Section 22(b), Counterparty shall not be permitted  to exercise any Default Right against Dealer with respect to the Master Confirmation or  any other Relevant Agreement that is related, directly or indirectly, to a Dealer Affiliate  becoming subject to an Insolvency Proceeding.                                                    19 If applicable, additional representations and covenants related to Forward Purchaser regulatory requirements  such as Forward Purchaser’s use of agents, Company acknowledgement of risk disclosure, Company consent to  transaction reporting, etc. to be added to particular confirmations as customary.  

 

36      [[5556494]]  (b) General Creditor Protections. Nothing in Section 22(a) shall restrict the  exercise by Counterparty of any Default Right against Dealer with respect to the Master  Confirmation or any other Relevant Agreement that arises as a result of:  (1) Dealer becoming subject to an Insolvency Proceeding; or  (2) Dealer not satisfying a payment or delivery obligation pursuant to  (A) the Master Confirmation or any other Relevant Agreement, or  (B) another contract between Dealer and Counterparty that gives  rise to a Default Right under the Master Confirmation or any other  Relevant Agreement.  (c) Burden of Proof. After a Dealer Affiliate has become subject to an  Insolvency Proceeding, if Counterparty seeks to exercise any Default Right with respect  to the Master Confirmation or any other Relevant Agreement, Counterparty shall have  the burden of proof, by clear and convincing evidence, that the exercise of such Default  Right is permitted hereunder or thereunder.  (d) General Conditions  (1) Effective Date. The provisions set forth in this Section 22 will  come into effect on the later of the Applicable Compliance Date  and the date of this Master Confirmation.  (2) Prior Adherence to the U.S. Protocol. If Dealer and Counterparty  have adhered to the ISDA U.S. Protocol prior to the date of this  Master Confirmation, the terms of the ISDA U.S. Protocol shall be  incorporated into and form a part of the Master Confirmation and  shall replace the terms of this Section 22. For purposes of  incorporating the ISDA U.S. Protocol, Dealer shall be deemed to  be a Regulated Entity, Counterparty shall be deemed to be an  Adhering Party and the Master Confirmation and this Master  Confirmation shall each be deemed to be a Protocol Covered  Agreement.  (3) Subsequent Adherence to the U.S. Protocol. If, after the date of  this Master Confirmation, both Dealer and Counterparty shall have  become adhering parties to the ISDA U.S. Protocol, the terms of  the ISDA U.S. Protocol will supersede and replace this Section 22.  (e) Definitions. For the purposes of Section 22, the following definitions  apply:  “Applicable Compliance Date” with respect to this Master Confirmation shall be  determined as follows: (a) if Counterparty is an entity subject to the requirements of the QFC  Stay Rules, January 1, 2019, (b) if Counterparty is a Financial Counterparty (other than a Small  Financial Institution) that is not an entity subject to the requirements of the QFC Stay Rules, July  1, 2019 and (c) if Counterparty is not described in clause (a) or (b), January 1, 2020.   

 

37      [[5556494]]   “BHC Affiliate” has the same meaning as the term “affiliate” as defined  in, and shall be interpreted in accordance with, 12 U.S.C. 1813(w) and 12 U.S.C. 1841(k).   “Credit Enhancement” means, with respect to the Master Confirmation or any  other Relevant Agreement, any credit enhancement or other credit support arrangement in  support of the obligations of Dealer or Counterparty hereunder or thereunder or with respect  hereto or thereto, including any guarantee or collateral arrangement (including any pledge,  charge, mortgage or other security interest in collateral or title transfer arrangement), trust or  similar arrangement, letter of credit, transfer of margin or any similar arrangement.  “Dealer Affiliate” means, with respect to Dealer, a BHC Affiliate of that party.  “Default Right” means, with respect to the Master Confirmation (including any  Transaction under the Master Confirmation) or any other Relevant Agreement, any:  (i) right of a party, whether contractual or otherwise (including, without  limitation, rights incorporated by reference to any other contract, agreement, or  document, and rights afforded by statute, civil code, regulation, and common  law), to liquidate, terminate, cancel, rescind, or accelerate such agreement or  transactions thereunder, set off or net amounts owing in respect thereto (except  rights related to same-day payment netting), exercise remedies in respect of  collateral or other credit support or property related thereto (including the  purchase and sale of property), demand payment or delivery thereunder or in  respect thereof (other than a right or operation of a contractual provision arising  solely from a change in the value of collateral or margin or a change in the  amount of an economic exposure), suspend, delay, or defer payment or  performance thereunder, or modify the obligations of a party thereunder, or any  similar rights; and   (ii) right or contractual provision that alters the amount of collateral or margin  that must be provided with respect to an exposure thereunder, including by  altering any initial amount, threshold amount, variation margin, minimum transfer  amount, the margin value of collateral, or any similar amount, that entitles a party  to demand the return of any collateral or margin transferred by it to the other party  or a custodian or that modifies a transferee’s right to reuse collateral or margin (if  such right previously existed), or any similar rights, in each case, other than a  right or operation of a contractual provision arising solely from a change in the  value of collateral or margin or a change in the amount of an economic exposure;  but   (iii) solely with respect to Section 22(a) does not include any right under a  contract that allows a party to terminate the contract on demand or at its option at  a specified time, or from time to time, without the need to show cause.  “Financial Counterparty” has the meaning given to such term in, and shall be  interpreted in accordance with, 12 C.F.R. 252.81, 12 C.F.R. 382.1 and 12 C.F.R. 47.2.  

 

38      [[5556494]]  “Insolvency Proceeding” means a receivership, insolvency, liquidation,  resolution, or similar proceeding.  “ISDA U.S. Protocol” means the ISDA 2018 U.S. Resolution Stay Protocol, as  published by ISDA on July 31, 2018.   “QFC Stay Rules” means the regulations codified at 12 C.F.R. 252.81–8 (the  “Federal Reserve Rule”), 12 C.F.R. 382.1-7 (the “FDIC Rule”) and 12 C.F.R. 47.1-8 (the  “OCC Rule”), respectively. All references herein to the specific provisions of the Federal  Reserve Rule, the FDICs Rule and the OCC Rule shall be construed, with respect to Dealer, to  the particular QFC Stay Rule(s) applicable to it.  “Relevant Agreement” means the Master Confirmation (as amended hereto and  including all Transactions under the Master Confirmation) and any Credit Enhancement relating  hereto or thereto .  “Small Financial Institution” has the meaning given to such term in, and shall  be interpreted in accordance with, 12 C.F.R. 252.81, 12 C.F.R. 382.1 and 12 C.F.R. 47.2.    [Remainder of page intentionally left blank]    

 

  [[5556494]]  Please confirm that the foregoing correctly sets forth the terms of our agreement by  signing and returning this Confirmation.  Yours Faithfully,  [DEALER NAME]  by      Name:   Title:     Confirmed as of the date first written above:    SABRA HEALTH CARE REIT, INC.    by      Name:   Title:         

 

    [[5556494]]  SCHEDULE I  FORWARD PRICE REDUCTION DATES AND AMOUNTS  Forward Price   Reduction Date(1) Forward Price Reduction Amount(2)  Trade Date USD $0.00  [●] USD [●]  [●] USD [●]  [●] USD [●]  [●] USD [●]  [●] USD [●]    (1) Insert Forward Price Reduction Dates from Forward Instruction Notice.  (Such Forward Price Reduction Dates  to be the expected “ex-dividend” dates for each quarterly dividend of the Company.)  (2) Insert Forward Price Reduction Amounts from Forward Instruction Notice.  (Such Forward Price Reduction  Amounts to be the expected amount of the regular quarterly cash dividend for the corresponding ex-dividend  date.)      

 

    [[5556494]]  ANNEX A  PRIVATE PLACEMENT PROCEDURES  (i) If the Company delivers the Restricted Shares pursuant to this clause (i) (a  “Private Placement Settlement”), then delivery of Restricted Shares by the Company shall be  effected in customary private placement procedures with respect to such Restricted Shares  reasonably acceptable to Forward Purchaser; provided that if, on or before the date that a Private  Placement Settlement would occur, the Company has taken, or caused to be taken, any action  that would make unavailable either the exemption pursuant to Section 4(a)(2) of the Securities  Act for the sale by the Company to Forward Purchaser (or any affiliate designated by Forward  Purchaser) of the Restricted Shares or the exemption pursuant to Section 4(a)(1) or  Section 4(a)(3) of the Securities Act for resales of the Restricted Shares by Forward Purchaser  (or any such affiliate of Forward Purchaser) or the Company fails to deliver the Restricted Shares  when due or otherwise fails to perform obligations within its control necessary to effect a Private  Placement Settlement, it shall be an Event of Default with respect to the Company and Section 6  of the Agreement shall apply.  The Private Placement Settlement of such Restricted Shares shall  include customary representations, covenants, blue sky and other governmental filings and/or  registrations, indemnities to Forward Purchaser, due diligence rights (for Forward Purchaser or  any designated buyer of the Restricted Shares by Forward Purchaser), opinions and certificates,  and such other documentation as is customary for private placement agreements, all reasonably  acceptable to Forward Purchaser.  In the case of a Private Placement Settlement, Forward  Purchaser shall, in its good faith discretion, adjust the number of Restricted Shares to be  delivered to Forward Purchaser hereunder and/or the Forward Price in a commercially  reasonable manner to reflect the fact that such Restricted Shares may not be freely returned to  securities lenders by Forward Purchaser and may only be saleable by Forward Purchaser at a  discount to reflect the lack of liquidity in Restricted Shares.  Notwithstanding the Agreement or  this Confirmation, the date of delivery of such Restricted Shares shall be the Clearance System  Business Day following notice by Forward Purchaser to the Company of the number of  Restricted Shares to be delivered pursuant to this clause (i).  For the avoidance of doubt, delivery  of Restricted Shares shall be due as set forth in the previous sentence and not be due on the  Settlement Date or Termination Settlement Date that would otherwise be applicable.  (ii) If the Company delivers any Restricted Shares in respect of the Transaction, the  Company agrees that (i) such Shares may be transferred by and among Forward Purchaser and  its affiliates and (ii) after the minimum “holding period” within the meaning of Rule 144(d)  under the Securities Act has elapsed after the applicable Settlement Date, the Company shall  promptly remove, or cause the transfer agent for the Shares to remove, any legends referring to  any transfer restrictions from such Shares upon delivery by Forward Purchaser (or such affiliate  of Forward Purchaser) to the Company or such transfer agent of seller’s and broker’s  representation letters customarily delivered by Forward Purchaser or its affiliates in connection  with resales of restricted securities pursuant to Rule 144 under the Securities Act, each without  any further requirement for the delivery of any certificate, consent, agreement, opinion of  counsel, notice or any other document, any transfer tax stamps or payment of any other amount  or any other action by Forward Purchaser (or such affiliate of Forward Purchaser). 

 

    [[5556494]]  ANNEX B  PRICING SUPPLEMENT    [DEALER NAME AND ADDRESS]    Sabra Health Care REIT, Inc.  18500 Von Karman Avenue, Suite 550   Irvine, California 92612  Attn: Harold W. Andrews, Jr. and Michael Costa   Telephone: (949) 679-0243 and (949) 679-0328    Facsimile: (949) 679-8868    Ladies and Gentlemen:  This Pricing Supplement is the Pricing Supplement forming part of the Confirmation  dated [●], 20[●] in respect of the Registered Forward Transaction dated as of [●], 20[●] (the  “Confirmation”) between Sabra Health Care REIT, Inc., (the “Company”) and [DEALER  NAME] (“Forward Purchaser”).  For all purposes under the Confirmation,  (a) the Hedge Completion Date is [●];  (b) the Initial Base Amount shall be [●]; and  (c) the Initial Forward Price shall be USD [●].    Very truly yours,  [DEALER NAME]  by      Name:   Title:       

 

Exhibit 3(g)    [[5258451]]  Form of Terms Agreement  SABRA HEALTH CARE REIT, INC.  Common Stock   TERMS AGREEMENT    , 20[●]  [ ]1  Ladies and Gentlemen:  Sabra Health Care REIT, Inc. (the “Company”) proposes, subject to the terms and  conditions set forth herein and in the Equity Distribution Agreement, dated December 11, 2019  (the “Equity Distribution Agreement”), among the Company and Barclays Capital Inc., BMO  Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Credit Agricole  Securities (USA) Inc., Fifth Third Securities, Inc., The Huntington Investment Company,  Jefferies LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Morgan Stanley &  Co. LLC, MUFG Securities Americas Inc., Raymond James & Associates, Inc., RBC Capital  Markets, LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., Stifel,  Nicolaus & Company, Incorporated, SunTrust Robinson Humphrey, Inc. and Wells Fargo  Securities, LLC, each as agent, forward seller, and/or as principal under any Terms Agreement  and Barclays Bank PLC, Bank of Montreal, Bank of America, N.A., Citibank, N.A., Crédit  Agricole Corporate and Investment Bank c/o Credit Agricole Securities (USA) Inc., as agent,  Jefferies LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, MUFG Securities  EMEA plc, Raymond James & Associates, Inc., Royal Bank of Canada, The Bank of Nova  Scotia and Wells Fargo Bank, National Association, each as a forward purchaser, to issue and  sell to the undersigned, as principal (the “Agent”) for resale the shares of the Company’s  Common Stock specified in the Schedule attached hereto (the “Purchased Shares”). [The  Company also proposes to issue and sell to the Agent the additional shares of Common Stock,  specified in the Schedule attached hereto (“Additional Shares”), if and to the extent that the  Agent shall have determined to exercise its right to purchase such Additional Shares.]  Subject to the terms and conditions set forth herein and in the Equity Distribution  Agreement, which are incorporated herein by reference, the Company agrees to issue and sell to  the Agent and the latter agrees to purchase from the Company the Purchased Shares at the Time  of Delivery and Closing Location (each as set forth in the Schedule attached hereto) and at the  purchase price (“Purchase Price”) set forth in the Schedule attached hereto.   [In addition, the Company agrees to sell to the Agent the Additional Shares, and  the Agent shall have the right to purchase up to [●] Additional Shares at the Purchase Price,  provided, however, that the amount paid by the Agent for any Additional Shares shall be reduced  by an amount per Share equal to any dividends declared by the Company and payable on the                                                    1 To be name and address of the applicable Agent.  

 

    [[5258451]]  Purchased Shares but not payable on such Additional Shares. The Agent may exercise this right,  in whole or from time to time in part by giving written notice to the Company not later than 30  days after the date of this Terms Agreement. Any exercise notice shall specify the number of  Additional Shares to be purchased by the Agent and the date on which such Additional Shares  are to be purchased (such date and time being herein referred to as the “Option Settlement  Date”). Each Option Settlement Date must be at least one business day after the written notice is  given and may not be earlier than the Time of Delivery for the Purchased Shares set forth in the  Schedule attached hereto, nor later than ten business days after the date of such notice. Payment  of the Purchase Price for the Additional Shares shall be made at the Option Settlement Date in  the same manner and at the same location as the payment for the Purchased Shares.]  The Purchased Shares [and the Additional Shares] shall be registered in such  names and in such denominations as the Agent shall request in writing not later than one full  business day prior to the Time of Delivery [or the applicable Option Settlement Date, as the case  may be.] The Purchased Shares [and the Additional Shares] shall be delivered to the Agent at the  Time of Delivery [or an Option Settlement Date, as the case may be,] with any transfer taxes  payable in connection with the transfer of the Shares to the Agent duly paid, against payment of  the Purchase Price therefor.  All capitalized terms used herein and not otherwise defined shall have the  respective meanings assigned to them in the Equity Distribution Agreement. Each of the  provisions of the Equity Distribution Agreement not specifically related to the solicitation by the  Agent, as agent of the Company, of offers to purchase Shares is incorporated herein by reference  in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if  such provisions had been set forth in full herein.  Each of the representations and warranties set  forth therein shall be deemed to have been made at and as of the date of this Terms Agreement  and the Time of Delivery [and any Option Settlement Date], except that each representation and  warranty in Section 6 of the Equity Distribution Agreement which makes reference to the  Prospectus (as therein defined) shall be deemed to be a representation and warranty as of the date  of the Equity Distribution Agreement in relation to the Prospectus, and also a representation and  warranty as of the date of this Terms Agreement[,] [and] the Time of Delivery [and any Option  Settlement Date] in relation to the Prospectus as amended and supplemented to relate to the  Purchased Shares [and the Additional Shares].  An amendment to the Registration Statement (as defined in the Equity  Distribution Agreement), or a supplement to the Prospectus, as the case may be, relating to the  Purchased Shares [and the Additional Shares], in the form heretofore delivered to the Agent is  now proposed to be filed with the Securities and Exchange Commission, and will be filed  promptly.  This Terms Agreement and any claim, controversy or dispute arising under or  related to this Terms Agreement shall be governed by, and construed in accordance with, the  laws of the State of New York, without regard to its choice of law provisions.  

 

    [[5258451]]  If the foregoing is in accordance with your understanding, please sign and return  to us a counterpart hereof, whereupon this Terms Agreement, including those provisions of the  Equity Distribution Agreement incorporated herein by reference, shall constitute a binding  agreement between the Agent and the Company.  SABRA HEALTH CARE REIT, INC.,  by      Name:    Title:       ACCEPTED as of the date first above written:  [ ]2,  by      Name:    Title:                                                       2 To be name of the applicable Agent.  

 

    [[5258451]]  Schedule to Exhibit 3(g)    Title of Purchased Shares [and Additional Shares]:  Common Stock, par value $0.01 per share  Number of Purchased Shares:  []  [Number of Additional Shares:  []]  Price to Public:  []  Purchase Price (by the Agent):  []  Method of and Specified Funds for Payment of Purchase Price:  By wire transfer to a bank account specified by the Company in same day funds.  Method of Delivery:  Free delivery of the Shares to the Agent’s account at the Depository Trust Company in return for  payment of the purchase price.  Time of Delivery:  []  Closing Location:  []  Documents to be Delivered at the Time of Delivery:  The following documents referred to in the Equity Distribution Agreement shall be delivered at  the Time of Delivery:  (1) The opinions referred to in Section 9(e).  (2) The opinion referred to in Section 9(f).  (3) The accountants’ letters referred to in Section 9(g).  (4) The officers’ certificate referred to in Section 9(h).  (5) Such other documents as the Agent shall reasonably request.    [Documents to be Delivered at the Option Settlement Date:  The obligations of the Agent to purchase Additional Shares hereunder are subject to the delivery  to you on the applicable Option Settlement Date of such documents as you may reasonably  request with respect to the good standing of the Company, the due authorization and issuance of  the Additional Shares to be sold on such Option Settlement Date and other matters related to the  issuance of such Additional Shares.]  

 

Exhibit 7(n)    [[5258451]]  OFFICERS’ CERTIFICATE  Pursuant to Section 7(n) of the Equity Distribution Agreement among Sabra  Health Care REIT, Inc., a Maryland corporation (“Company”), and Barclays Capital Inc., BMO  Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Credit Agricole  Securities (USA) Inc., Fifth Third Securities, Inc., The Huntington Investment Company,  Jefferies LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Morgan Stanley &  Co. LLC, MUFG Securities Americas Inc., Raymond James & Associates, Inc., RBC Capital  Markets, LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., Stifel,  Nicolaus & Company, Incorporated, SunTrust Robinson Humphrey, Inc. and Wells Fargo  Securities, LLC, each as agent, forward seller, and/or as principal under any Terms Agreement  and Barclays Bank PLC, Bank of Montreal, Bank of America, N.A., Citibank, N.A., Crédit  Agricole Corporate and Investment Bank c/o Credit Agricole Securities (USA) Inc., as agent,  Jefferies LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, MUFG Securities  EMEA plc, Raymond James & Associates, Inc., Royal Bank of Canada, The Bank of Nova  Scotia and Wells Fargo Bank, National Association, each as a forward purchaser, dated  December 11, 2019 (the “Equity Distribution Agreement”), each of the undersigned, Richard K.  Matros, the duly qualified and elected Chairman, President and Chief Executive Officer of the  Company, and Harold W. Andrews, Jr., the duly qualified and elected Executive Vice President,  Chief Financial Officer and Secretary of the Company, hereby certifies solely in such capacity  and on behalf of the Company, that to the best of his knowledge:  (i) the representations and warranties of the Company in Section 6 of the  Equity Distribution Agreement (A) to the extent such representations and warranties are subject  to qualifications and exceptions contained therein relating to materiality or a Material Adverse  Change, are true and correct on and as of the date hereof with the same force and effect as if  expressly made on and as of the date hereof, except for those representations and warranties that  speak solely as of a specific date and which were true and correct as of such date, and (B) to the  extent such representations and warranties are not subject to any qualifications or exceptions, are  true and correct in all material respects as of the date hereof as if made on and as of the date  hereof with the same force and effect as if expressly made on and as of the date hereof except for  those representations and warranties that speak solely as of a specific date and which were true  and correct as of such date; and  (ii) the Company has complied with all agreements and satisfied all conditions  on its part to be performed or satisfied pursuant to the Equity Distribution Agreement at or prior  to the date hereof.  Capitalized terms used and not defined herein shall have the meanings ascribed to  them in the Equity Distribution Agreement.  

 

    [[5258451]]      by      Name: Richard K. Matros   Title: President and Chief Executive  Officer      by      Name: Harold W. Andrews, Jr.   Title: Executive Vice President, Chief  Financial Officer and Secretary      Date:     

 

Exhibit 7(o)(1)    [[5258451]]  Form of Legal Opinion of O’Melveny & Myers LLP  On the basis of such examination, our reliance upon the assumptions in this  opinion and our consideration of those questions of law we considered relevant, and subject to  the limitations and qualifications in this opinion, we are of the opinion that:  1. The Company is qualified as a foreign corporation to do business in the  State of California and is in good standing in such State.  2. Sabra Health Care Limited Partnership (“Sabra UPREIT”) has been duly  formed and is validly existing in good standing under the laws of the State of Delaware with  power under the Revised Uniform Limited Partnership Act of the State of Delaware (the  “RULPA”) and its certificate of limited partnership and partnership agreement (the “Partnership  Agreement” and, together with the certificate of limited partnership, the “Partnership  Organizational Documents”), to own its properties and assets and to carry on its business as  described in the Prospectus; and Sabra UPREIT is authorized as a foreign limited partnership to  do business in the State of California and is in good standing in such State.  3. Sabra Health Care Holdings III, LLC (“Sabra III”) (together with Sabra  UPREIT, the “Sabra Subsidiaries”), is a limited liability company existing under the laws of the  State of Delaware with power under the Limited Liability Company Act of the State of Delaware  (the “LLCA”), together with its certificate of formation and limited liability company agreement  (which we refer to collectively with the Partnership Organizational Documents as the  “Organizational Documents”), to own its properties and to carry on its business as described in  the Prospectus.  4. The Registration Statement, at the time it became effective, appeared on  its face to comply in all material respects with the requirements as to form for registration  statements on Form S-3 under the Act and the related rules and regulations in effect at such date,  except that we express no opinion concerning the financial statements and other financial  information contained therein or incorporated by reference. The Prospectus, as of its date,  appeared on its face to comply in all material respects with the requirements as to form under the  Act and the related rules and regulations in effect at such date, except that we express no opinion  concerning the financial statements and other financial information contained or incorporated by  reference therein. The Prospectus Supplement has been filed in accordance with Rule 424(b)  under the Act.  5. The Registration Statement became effective under the Act upon filing  with the Commission and, based solely on a review of a list of stop orders on the Commission’s  website at https://www.sec.gov/litigation/stoporders.shtml , no stop order suspending the  effectiveness of the Registration Statement has been issued or, to our knowledge, threatened by  the Commission; and the Prospectus has been filed pursuant to Rule 424 under the Act within the  time period required by Rule 424.  

 

    [[5258451]]  6. Assuming that the Equity Distribution Agreement and any Confirmations  have been duly authorized and executed, the Equity Distribution Agreement and any  Confirmations have been duly delivered.  7. The execution and delivery by the Company of the Equity Distribution  Agreement and any Confirmations do not, and the Company’s performance of its obligations  under the Equity Distribution Agreement and any Confirmations will not, (i) violate, breach, or  result in a default under, any existing obligation of or restriction on the Company under any  other agreement (the “Other Agreements”) listed in an exhibit to the Company’s most recent  Annual Report on Form 10-K, or Quarterly Report on Form 10-Q or Current Reports on Form 8- K filed subsequent to the date of the Company’s most recent Annual Report on Form 10-K, or  (ii) breach or otherwise violate any existing obligation of or restriction on the Company under  any order, judgment or decree of any California, New York or federal court or governmental  authority binding on the Company identified in the Company Certificate.  We express no opinion  with respect to any provision of any Other Agreements to the extent that an opinion with respect  to such provision would require making any financial, accounting or mathematical calculation or  determination.  8. The execution and delivery by the Company of the Equity Distribution  Agreement and any Confirmations do not, and the Company’s performance of its obligations  under the Equity Distribution Agreement and any Confirmations will not, violate any current  California, New York or federal statute, rule or regulation that we have, in the exercise of  customary professional diligence, recognized as applicable to the Company or to transactions of  the type contemplated by the Equity Distribution Agreement and any Confirmations, except that  we express no opinion regarding (i) any federal securities laws or Blue Sky or state securities  laws, or the rules or regulations of the Financial Industry Regulatory Authority, Inc., or (ii) the  indemnification and contribution provisions of the Equity Distribution Agreement and any  Confirmations, in each case except as expressly stated herein.  9. No order, consent, permit or approval of any California, New York or  federal governmental authority that we have, in the exercise of customary professional diligence,  recognized as applicable to the Company or to transactions of the type contemplated by the  Equity Distribution Agreement and any Confirmations is required on the part of the Company for  the execution and delivery of, and performance of its obligations under, the Equity Distribution  Agreement and any Confirmations, except for such as have been obtained under the Act or the  rules and regulations thereunder and such as may be required under Blue Sky or state securities  laws and the rules or regulations of the Financial Industry Regulatory Authority, Inc.  10. The Company is not, and after giving effect to the offering and sale of the  Shares and application of the net proceeds from such transaction as described under the caption  “Use of Proceeds” in the Prospectus, will not be, an investment company required to register  under the Investment Company Act of 1940, as amended.  11. Based solely on the Company Certificate and except as described in the  Prospectus, there is no pending action, suit, proceeding or investigation before any court or  governmental agency or authority or any arbitrator (i) against the Company of a character  

 

    [[5258451]]  required to be disclosed in the Prospectus, or (ii) that seeks to affect the enforceability of the  Equity Distribution Agreement and any Confirmations.    

 

Exhibit 7(o)(2)    [[5258451]]  Form of Legal Opinion of Venable LLP  Based upon the foregoing, and subject to the assumptions, limitations and  qualifications stated herein, it is our opinion that:  1. The Company is a corporation duly incorporated and validly existing  under the laws of the State of Maryland, is in good standing with the SDAT and has the  corporate power to own, lease and operate its properties and conduct its business as described in  the Prospectus under the caption “Summary – Our Company” and to execute, deliver and  perform its obligations under the Equity Distribution Agreement and any Confirmations.  2. The Company has an authorized capitalization as set forth in the  Prospectus under the caption “Description of Capital Stock,”  3. The information in the Prospectus under the caption “Description of  Capital Stock,” insofar as such information purports to summarize the Charter or the Bylaws or  the MGCL, is accurate in all material respects.  The terms of the Common Stock, including the  Shares, conform as to legal matters in all material respects to the description thereof contained in  the Registration Statement and the Prospectus under the caption “Description of Capital Stock”.  4. The execution and delivery of the Equity Distribution Agreement and any  Confirmations have been duly authorized, and the Equity Distribution Agreement have been duly  executed and, so far as is known to us, delivered by the Company.  5. The Shares have been duly authorized for issuance and sale pursuant to the  Resolutions (and any other resolutions adopted by the Securities Committee of the Board, as  contemplated in the Resolutions) and the Equity Distribution Agreement and any Confirmations  and, upon completion of all Corporate Proceedings relating to the Shares, when issued and  delivered in accordance with the terms of the Resolutions (and any other resolutions adopted by  the Securities Committee of the Board, as contemplated in the Resolutions) and the Equity  Distribution Agreement and any Confirmations against payment of the consideration set forth  therein, will be validly issued, fully paid and nonassessable.  6. The execution and delivery of the Equity Distribution Agreement and any  Confirmations by the Company, and the performance by the Company of its obligations  thereunder (other than performance by the Company of its obligations under the indemnification  section of the Equity Distribution Agreement, as to which no opinion is rendered), including the  issuance of the Shares, do not conflict with (a) the Charter or the Bylaws or (b) any Maryland  statute, rule or regulation applicable to the Company.  7. No consent, approval, authorization or order of, or registration or filing  with, any Maryland governmental authority or agency having jurisdiction over the Company is  required for the performance by the Company of its obligations under the Equity Distribution  Agreement and any Confirmations, except such as have been obtained or made by the Company,  if any (other than any consent, approval, authorization, order, registration or filing required in  connection with the securities laws of the State of Maryland, as to which no opinion is expressed  hereby).  

 

Exhibit 7(o)(3)    [[5258451]]  Form of Legal Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP  Based upon, subject to, and limited by the assumptions and qualifications set forth  herein and in the Registration Statement, we are of the opinion that:  1. Commencing with the Company’s taxable year beginning January 1, 2011,  the Company has been organized and has operated in conformity with the requirements for  qualification and taxation as a “real estate investment trust” (a “REIT”) under Sections 856  through 860 of the Code and the current and proposed method of operation for the Company and  its subsidiaries as described in the Prospectus will enable the Company to continue to meet the  requirements for qualification and taxation as a REIT under the Code; and  2. The statements set forth in the Prospectus under the caption “Material U.S.  Federal Income Tax Considerations,” insofar as such statements purport to summarize matters of  U.S. federal income tax laws or legal conclusions with respect thereto, and subject to the  limitations, qualifications and assumptions set forth therein, fairly and accurately summarize in  all material respects the matters set forth therein.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]